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Summary 
The prevalence of allergic diseases such as allergic asthma, atopic dermatitis and 
allergic rhinitis are increasing worldwide. House dust mites allergy is strongly 
associated with these allergic diseases. The skin is thought to be the primary entering 
site of allergens as the symptom of atopic dermatitis usually develops before asthma 
and rhinitis but the underlying mechanisms remain unresolved. This study aimed to 
use house dust mite allergens to establish a murine model for allergic dermatitis and 
asthma through skin sensitization, and to further exploit the model for mechanistic 
studies.  
 
The first part of this study focused on the cloning and characterization of a new 
isoform of Der p 8, a glutathione-S-transferase (GST), from Dermatophagoides 
pteronyssinus mites. This isoform represents one of the variants found in native Der p 
8. IgE binding studies using native and recombinant allergens revealed that Der p 8 
showed a high frequency but low titer of IgE reactivity to sera of asthmatic patients. 
Further studies demonstrated that Der p 8 showed considerable but variable IgE cross-
reactivity with cockroach but not parasite GST. The cross reactivity between mite and 
cockroach GSTs could have an important clinical impact in environments where both 
mites and cockroaches are important sources of indoor allergens.  
 
The second part of the study was to establish a mouse model for atopic dermatitis / 
asthma using recombinant Der p 8 by epicutaneous sensitization approach. Der p 8-
patched mice showed elevated total IgE and low but significant levels of specific IgE 
that were boostable by airway allergen challenge. Splenic T cells produced typical 
 xiv
Th2-polarized cytokines in response to allergen stimulation in vitro. The sensitized 
mice developed localized dermatitis characterized by pronounced epidermal 
hyperplasia and spongiosis, which was associated with infiltration of eosinophils, 
neutrophils, degranulated mast cells, CD4+ and CD8+ T cells, and dendritic cells. 
There was also increased innervation of calcitonin gene-related peptides and 
substance P positive neurofibers in inflamed skins. Interactions between nerve fibers 
and mast cells were observed, indicating the coexistence of neurogenic inflammation. 
These mice subsequently developed airway inflammation and hyperreactivity upon 
airway allergen challenge. In contrast, patching with nonallergenic protein Fve, a 
fungal immunomodulatroy protein isolated from the edible mushroom Flammulina 
velutipes, induced a Th1-polarized cytokines, indicating that nature of protein 
determined the quality of the immune responses. Despite the qualitative differences in 
immune resposes, both Der p2 and Fve patched mice developed skin and lung 
inflammation. Furthermore, allergenic and nonallergenic proteins induced differential 
chemokine mRNA expression profiles in dermal fibroblasts in vitro suggesting a 
possible regulatory role of mucosal tissue cells in inflammatory responses.  
 
This work supports the notion that the skin is an important site for the initiation of 
primary allergen sensitization and subsequent development of systemic allergic 
reactions verifying the concept of “atopic march”. This model is useful for basic 
studies of immunopathogenesis of AD and asthma. It is also useful for study of other 
stress-associated neuroinflammatory skin disorders such as neurogenic pruritus and 
psoriasis. 
 1
Chapter 1  
Literature review 
 
The prevalence of allergic diseases is increasing worldwide. The main 
pathophysiological feature of atopy is an enhanced ability of B cells to produce 
immunoglobulin (Ig) E antibodies in response to certain ubiquitous antigens 
(allergens) that are able to activate the immune system after inhalation, ingestion and 
perhaps diffusion through the skin. IgE antibodies can bind to high affinity Fcε 
receptors (FcεRI) expressed on mast cells, basophils, and dendritic cells such as 
Langerhans cells, as well as to low affinity IgE receptors (FcεRII, CD23) on 
monocytes/macrophages and lymphocytes. An allergic reaction is initiated when an 
antigen crosslinks the IgE antibodies that bind to the FcεRI on mast cells or basophils 
(Sutton BJ and Gould HJ, 1993). The allergen-induced FcεRI cross-linking triggers 
the release of powerful toxic products, vasoactive mediators, chemotactic factors and 
cytokines, which are responsible for several pathological changes, know as type I 
hypersensitivity. However FcεRI on antigen presenting cells (APC) plays a totally 
different role and it will be described later. 
 
1.1 Immunoglobulin E  
1.1.1 Signals involved in IgE production 
IL-4 is the most important cytokine mediating IgE synthesis. In 1988, the crucial role 
of IL-4 in the induction of human IgE synthesis was demonstrated in an in vitro 
model using T-cell clones (Pene J et al., 1988a; Del Prete G et al., 1988). 
Investigators found a positive correlation between the helper function of IgE synthesis 
by normal B cells and the production of IL-4 by the T cell clones. Conversely, an 
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inverse relationship was found between IgE synthesis and the production of IFN-γ by 
the T cell clones. The addition of recombinant human IL-4 into peripheral blood 
mononuclear cells (PBMC) cultures resulted in IgE synthesis and the effect was dose-
dependently inhibited by the addition of recombinant IFN-γ. The crucial role of IL-4 
in the induction of murine IgE synthesis has also been confirmed in vivo. Suppression 
of in vivo polyclonal IgE synthesis could be achieved by injection of an anti-IL-4 
antibody, and no IgE synthesis could be detected in IL-4 deficient mice (Kuhn R et al., 
1991). 
 
IL-13, which has 30% homology with IL-4, also induces IgE synthesis in human 
(Punnonen J et al., 1993) and murine (Emson CL et al., 1998) B cells. Although the 
receptors for IL-4 and IL-13 are distinct, they share the common alpha chain of the 
IL-4 receptor (IL-4Rα) (Zurawski SM et al., 1993). Engagement of the IL-4Rα 
initiates a signaling cascade that results in translocation of STAT-6 to the nucleus, the 
initiation of germline ε mRNA transcription and finally the ε class switching (Hou J et 
al., 1994). Other cytokines including IL-2 (Maggi E et al., 1989), IL-5 (Pene J et al., 
1988b), IL-6 (Vercelli D et al., 1989), TNF-α (Punnonen J et al., 1994) and IL-9 
(Dugas B et al., 1993), were demonstrated to enhance IL-4-induced IgE synthesis. 
Apart from the effect of cytokines, engagement of other receptors has been shown to 
modulate IgE response. Engagement of CD40 on B cells promotes IgE class 
switching (Kawabe T et al., 1994). As with IL-4Rα, complete deficiency of CD40 
abrogated in vivo IgE responses (Kawabe T et al., 1994, Hogan SP et al., 1997). T/B 
cell contact-mediated signals, other than CD40/CD40L interactions, may also be 
involved in the pathways leading to B-cell activation, proliferation, differentiation and 
IgE production (Kuchroo VK et al., 1995; Keane-Myers AM et al., 1998). A 
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monoclonal antibody against the 26-kD membrane anchor form of TNF-α strongly 
inhibited IgE synthesis induced by activated CD4+ T cells or their plasma membranes 
(Aversa G et al., 1993). Likewise, the ligation of B cell CD58 by CD2 or anti-
CD58mAb in concert with IL-4 induced the appearance of productive ε transcripts 
and IgE production. CD30L was also found to be involved in inducing CD40L-
independent IgE secretion (Shanebeck KD et al., 1995).  
 
1.1.2 Receptors for IgE 
Two types of IgE receptors have been reported - the high-affinity receptor, FcεRI, and 
the low-affinity receptor, FcεRII or CD23. FcεRI binds IgE at very high affinity 
(ka=109 M-1) and greatly prolonging the in vivo half-life of IgE (Tada T et al., 1975). 
The binding affinity of IgE to CD23 is 100-1000-fold lower (ka=106-107 M-1) than 
that of FcεRI and it does not participate directly in type I hypersensitivity.  
 
1.1.2.1 FcεRI 
The classical FcεRI is tetrameric: it consistis of a α-chain which provides the binding 
site of IgE, a β-chain, and the homodimeric γ-chain. The γ-subunits are responsible 
for transducing the initial cross-linking signal into the cell (Nadler MJ et al., 2000). 
The β-chain of FcεRI enhances receptor maturation, leading to an increase of FcεRI 
surface expression and signal transduction capacity within the cells (Donnadieu E et 
al., 2000). In human, the classical FcεRI (αβγ2) is constitutively expressed on 
effector cells of anaphylaxis (i.e. mast cells and basophils), whereas the expression of 
trimeric form of FcεRI (αγ2) is variably present on APCs such as monocytes and 
dendritic cells (DCs) including Langerhans cells (LCs) (Kraft S & Bieber T, 2001). 
IgE binding to FcεRI on mast cells and basophils not only prolongs the in vivo half-
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life of IgE but also substantially up regulates its own expression, indicating a 
mechanism for augmenting the biological effects of IgE when antigen is present (Hsu 
C et al., 1996, Lantz CS et al., 1997; Yamaguchi M et al., 1997; MacGlashan D Jr et 
al., 1999; Borkowski TA et al., 2001). Cross-linking of FcεRI on APCs facilitates 
antigen uptake and antigen presentation. Langerhans cells that express high-affinity 
IgE receptors and IgE on their cell surface are much more efficient on capturing 
allergens for antigen presentation to T cells than Langerhans cells which lack IgE on 
their cell surface (Mudde GC et al., 1990). Recently, new immunomodulatory 
functions of this receptor have been described. Ligation of FcεRI prevents apoptosis 
induced by serum deprivation or by Fas/Fas-ligand interactions of the non-atopic 
monocytes (Katoh N et al., 2000). In addition, monomeric IgE binding to FcεRI 
promotes the survival of cells (Asai K et al., 2001; Kalesnikoff J et al., 2001; 
Kawakami T & Galli SJ, 2002). These data indicated that IgE has the multifunctional 
roles in allergic responses. 
 
1.1.2.2 FcεRII 
Two forms of CD23, FcεRIIa and FcεRIIb, which differ only in their N-terminal 
cytoplasmic portion, are generated through the use of different transcriptional 
initiation sites and alternative RNA splicing (Yokota A et al., 1988). FcεRIIa is 
expressed by B cells following antigen activation, whereas FcεRIIb is expressed by 
monocytes and Langerhans cells upon activation by IL-4. CD23 is a labile protein, 
since a soluble fragment (sCD23) is released from the carboxyl-terminal extra cellular 
portion of the molecule by a membrane-bound metalloprotease (Marolewski AE et al., 
1998). Furthermore the major house mite allergen Der p 1, a homologue of cysteine 
protease, can proteolytically cleave CD23 (Schulz O et al., 1995; Hewitt CR et al., 
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1995). Alike FcεRI, FcεRIIa facilitates antigen presentation in murine and human B 
cells in vitro and murine B cells in vivo (Kehry MR & Yamashita LC 1989; Pirron U 
et al., 1990; Gustavsson S et al., 1994; Fujiwara H et al., 1994; Oshiba A et al., 
1997). CD23 in human B cells mediates IgE-dependent Der p 2 allergen presentation 
to autologous Der p 2- specific T cells clones in vitro (van der Heijden FL et al., 
1993; Santamaria LF et al., 1993). The regulatory role of CD23 on the IgE synthesis 
is controversial. The enhancement of IgE synthesis was shown in vitro by adding 
purified CD23 into the B cell culture (Sarfati M & Delespesse G, 1988). 
Administration of anti-CD23 mAbs to mice strongly inhibited antigen-specific IgE 
synthesis, suggesting a role for CD23 in the regulation of IgE production in vivo 
(Bonnefoy JY et al., 1990). However mice deficient in CD23 or with only low-level 
expression showed increased serum IgE levels (Gustavssin S et al., 1994; Stief A et 
al., 1994), particularly when antigen-specific IgE was measured (Yu P et al., 1994). A 
two-phase mechanism for the role of CD23 has been proposed by Corry DB (Corry 
DB & Kheradmand F, 1999). At the intermediate phase in allergic immune response, 
the IgE levels are sufficiently high for binding significantly to CD23. Antigens may 
be captured by B cells and presented to T cells which effectively augment the IL-4/IL-
13 production and the IgE response. On later phase, however, the increased IL-4 also 
facilitates the expression of CD23. In combination with excess IgE and antigens, 
CD23 becomes extensively crosslinked and provides an inhibitory signal that 




1.2. Development of Th1/Th2 cells 
T helper lymphocytes can be divided into two distinct subsets of effector cells based 
on their functional capabilities and the profile of cytokines they produce. Since the 
original findings of Th1/Th2 CD4+ T cells subsets by Mosmann and Coffman 
(Mosmann TR et al., 1986), the study of the Th1/Th2 CD4+ T cell dichotomy has 
become an active research field in itself. In general, Th1 cells are defined by their 
production of IFN-γ and TNF-β, whereas Th2 cells produce IL-4, IL-5, IL-6, IL-10 
and IL-13. CD4+ T cell which produce a mixture of the two cytokine profiles are 
thought to be an uncommitted population during the differentiation process. In 
addition to distinct cytokine profiles, several surface markers have demonstrated to be 
differentially expressed on Th cells. For example, the IL-12 receptor (IL-12R) β2 
chain, chemokine receptors CXCR3 and CCR5, and IL-18 receptor are found mainly 
on Th1 cells, while T1/ST2, CCR3, CCR4 and ICOS molecules are enriched on the 
surface of Th2 cells (Szabo SJ et al., 1997; Bonecchi R et al., 1998; D'Ambrosio D et 
al., 1998; Lohning M et al., 1998; Sallusto F et al., 1998; Xu D et al., 1998a & 1998b; 
McAdam AJ et al., 2000). The decision with which Th1 and Th2 effector responses 
develop is regulated by the interplay of three fundamental classes of ligand-receptor 
interactions at the cell surface. These are: (1) the nature of the interaction of the T-cell 
receptor with MHC-peptide complex. This interaction is important and can probably 
control features of differentiation, T-cell activation, clonal expansion, and survival. 
The antigen doses and whether a peptide is a potent agonist, mixed antagonist, or 
partial agonist influence the development of Th1 and Th2 cells in vivo (Constant SL 
and Bottomly K, 1997). (2) Signaling from APCs through costimulatory molecules, 
such as CD28 and inducible costimulator (ICOS), are also critical regulators (Cua DJ 
et al., 1996; Lenschow DJ et al., 1996; Constant SL & Bottomly K, 1997; Rulifson IC 
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et al., 1997; Maldonado-Lopez R et al., 1999; Yoshinaga SK et al., 1999; Akiba H et 
al., 2000). (3) Cytokines and transcription factors which exert potent influences on the 
efficiency of Th1 and Th2 development (Le Gros G et al., 1990; Paul WE & Seder 
RA, 1994; Glimcher LH & Singh H, 1999). These three interactions will be discussed 
further in detail. 
 
1.2.1 Nature of the interaction of the T-cell receptor with MHC-peptide complex 
The effects of antigen doses during CD4+ T cell priming in vivo are controversial. 
Several studies suggest that priming with high doses of an antigen will preferentially 
lead to Th2 development (Parish CR & Liew FY, 1972; Bretscher PA et al., 1992; 
Bancroft AJ et al., 1994; Sarzotti et al., 1996). However, other studies have 
demonstrated that priming with low doses of antigen lead to a Th2 response 
(HayGlass KT et al., 1986; Pfeiffer C et al., 1995; Wang LF et al., 1996; Guery JC et 
al., 1996; Chaturvedi P et al., 1996). It is interesting to note that parasites are used as 
immunogens in most of the studies in which low doses of antigen induce Th1-like 
responses, whereas low doses of soluble proteins tend to skew toward Th2-type cells. 
 
The effect of antigen doses on the priming of naïve CD4+ T cells in vitro was reported 
simultaneously by two different groups (Constant S et al., 1995; Hosken NA et al., 
1995). Both models used TCR transgenic mice and showed that intermediate doses of 
peptide induced the generation of Th1 cells and that priming with extremely high or 
low doses of the peptide led to Th2-like responses. When examining the primary and 
secondary IgE production induced by KLH-primed CD4+ T cells, they found 
significantly higher levels of IgE and IL-4 in cultures stimulated with 0.001-0.1 
µg/ml, as compared to 1-100 µg/ml of antigen (Marcelletti JF & Katz DH, 1992). 
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Researchers found that CD4+ T cells from donors allergic to either dust mite antigens 
or rye grass pollen produced high levels of IL-4 when stimulated with low 
concentration (0.003-0.01 µg/ml) of allergens but produced little IL-4 when 
stimulated with high concentrations (10-30 µg/ml) of allergens (Secrist H et al., 
1995). The same pattern of responses was reported by Carballido et al, using different 
doses of bee venom phospholipase A2 to stimulate CD4+ T cell clones generated from 
individuals allergic, hyposensitized, or immune to bee stings (Carballido JM et al., 
1992). Furthermore, Rogers and Croft demonstrated that the strength of signaling, 
concentration, affinity, and length of response to a naive CD4 cell may modulate its 
ability to differentiate and produce effector cells with the potential for both Th1 and 
Th2 cytokines, or predominantly one or the other (Rogers PR & Croft M., 1999).  
 
The nature of antigen itself seems to play a role in Th1/Th2 differentiation. The 
clones specific for bacterial antigens generally show a prevalent Th1/Th0 phenotype. 
In contrast, the majority of allergen-specific T cell clones generated from peripheral 
blood lymphocytes of atopic donors express a Th0/Th2 phenotype, producing high 
levels of IL-4 and IL-5 and no or low levels of IFN-γ (Wierenga EA et al., 1990; 
Parronchi P et al., 1991). Some bacteria contain conserved DNA sequences consisting 
of repeated cytosine and guanosine residues (CpG repeats) that are uncommon in 
eukaryotic DNA. These sequences are recognized by receptors on antigen-presenting 
cells and trigger the release of IL-12, which suppress IgE synthesis and attenuate the 
experimental asthma phenotype in mice (Finkelman FD et al., 1994; Kline JN et al., 
1998; Yoshimoto T et al., 1998). Components of the cell walls of these and related 
organisms may have a similar influence on APCs (Cleveland MG et al., 1996; Oswald 
IP et al., 1997). In contrast, it was shown that the protease activity of Der p 1 
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selectively cleaves surface CD23 of murine B cells, potentially interrupting an 
important negative regulator of IgE production (Hewitt CR et al., 1995). 
The specificity of TCR recognition is conferred by only a few residues, with a 
hierarchy of residues critical for contact and interaction with TCR. Stimulating T cell 
clones with an immunogenic peptide analog which the TCR contact sites have been 
manipulated showed different patterns of tyrosine phosphorylation as compared to 
that of agonist peptide (Sloan-Lancaster J et al., 1994; Madrenas J et al., 1995). 
Studies on the affinity of peptide to MHC molecule showed that Th1/Th2 
differentiation could be influenced by the affinity of an agonist peptide to an MHC 
molecule and suggested that the provision of a strong versus a weak ligating signal to 
TCR could be an alternative mechanism whereby immune responses might be skewed 
(Murray JS et al., 1992; Constant S et al., 1994; Kumar V et al., 1995; Pfeiffer C et 
al., 1995). 
 
1.2.2 APCs and costimulatory molecules  
The role of an APC in determining the differentiation pathway of a naïve Th cell is 
potentially powerful because the APC provides the precursor Th cell with its first 
activation signals. A feature of APCs that makes them potential candidates for 
skewing immune responses is their selective expression of ligand for T cell 
costimulatory molecules, particularly those of the B7 family. Activation of T cells 
through different costimulatory molecules has been demonstrated to influence the Th1 
and Th2 differentiation. Furthermore recent studies also demonstrated that different 
subsets of DCs may drive the naïve T cell towards Th1 or Th2 differentiation. 
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1.2.2.1 CD28/CTLA-4/ICOS/PD-1 and B7 family 
CD28 and CTLA-4 are important costimulatory molecules for T cell activation. The 
roles of CD28 in the differentiation of Th1/Th2 cells were extensively investigated by 
several researchers and CD28 signaling was shown to be important for the 
development of Th2 cells. Addition of hCTLA-4-Ig (human CTLA-4 immunoglobulin 
fusion protein) during priming stage blocked the CD28/B7 interaction and selectively 
blocked the generation of IL-4 producing T cells and had no effect on IFN-γ 
production in vitro (Seder RA et al., 1994; Tao X et al., 1997). A blockade of Th2-
type responses following the administration of hCTLA-4Ig was also shown in in vivo 
models (Corry DB et al., 1994; Lu P et al., 1994). Furthermore, study of CD28-/- mice 
demonstrated a selective impairment in Th2 differentiation (Lenschow DJ et al., 
1996). Expression of CTLA-4 on T cells was induced after T cell activation via TCR 
and CD28. CTLA-4 was shown to be a negative regulator for T cell activation (Tivol 
EA et al., 1995; Waterhouse P et al., 1995). However, there is no evidence showing 
the role of CTLA-4 in the differentiation of Th cells. CD28 and CTLA-4 bind to the 
same ligands, B7.1 (CD80) and B7.2 (CD86), but with different affinity. B7 ligands 
have a higher affinity for CTLA-4 than that for CD28 and B7.1 has a higher affinity 
for CD28 as compared to B7.2. Recently a new member of CD28 family was 
identified on T cells and designated as inducible co-stimulator (ICOS) (Hutloff A et 
al., 1999; Yoshinaga SK et al., 1999; McAdam AJ et al., 2000). ICOS is expressed at 
high levels by Th2 cells and at low levels by Th1 cells in mice (Coyle AJ et al., 
2000). ICOS deficient mice exhibited impaired humoral immunity and germinal 
center reactions (Dong C et al., 2001a & 2001b; McAdam AJ et al., 2001; Tafuri A et 
al., 2001). T cells from ICOS-/- mice had selective impairment in IL-4 expression but 
not the capability of IL-5 secretion after in vitro differentiation or in vivo priming by 
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protein antigens in complete Freund’s adjuvant or Alum. Furthermore ICOS-/- mice 
showed a deficiency in IgE production (Dong C et al., 2001a). The ligand for ICOS, 
B7h, also called B7-related protein 1 (B7RP-1), has been identified (Swallow MM et 
al., 1999; Yoshinaga SK et al., 1999). It is constitutively expressed on B cells and 
induced in nonlymphoid tissues by the inflammatory cytokine TNF-α (Swallow MM 
et al., 1999). Other members of the B7 family are B7.H1 (PD-L1), B7-DC (PD-L2) 
and B7-H3 (Freeman GJ et al., 2000; Chapoval AI et al., 2001; Latchman Y et al., 
2001; Tamura H et al., 2001; Tseng SY et al., 2001). B7.H1 is expressed in peripheral 
tissues such as the heart and lung and its expression is induced by IFN−γ on 
monocytes, dendritic cells (DCs) and human keratinocytes. B7-DC is predominantly 
expressed on DCs. Both B7.H1 and B7-DC bind to their receptor, PD-1, on T cells. 
Ligation of PD-1 by B7.H1 or B7-DC shows an inhibitory effect on activated T cells 
(Nishimura H et al., 1999; Freeman GJ et al., 2000; Latchman Y et al., 2001). The 
receptor for B7-H3 is still unknown. Soluble B7.H3 enhances IFN-γ production on 
activated T cells (Chapoval AI et al., 2001). Other adhesion or costimulatory 
molecules pairs, such as CD40L/CD40, CD2/CD58, OX40/OX40L, and LFA-
1/ICAM-1, participate in the cross-talk between Th cells and APC and also influence 
the outcome of the response (Kawabe T et al., 1994; Biancone L et al., 1996; Akiba H 
et al., 1999; Luksch CR et al., 1999; Smits HH et al., 2002). 
 
1.2.2.2 Dendritic cells 
Dendritic cells represent a heterogeneous cell population residing in most peripheral 
tissues, particularly at sites of interaction with the environment (skin and mucosa) 
where they represent 1%-2% of the total cell numbers (Banchereau J & Steinman RM, 
1998; Banchereau J et al., 2000). Dendritic cells take up antigens in peripheral tissues, 
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process them into proteolytic peptides, and load these peptides onto major 
histocompatibility complex (MHC) class I and II molecules. They then migrate to 
secondary lymphoid organs and become competent to present antigens to T 
lymphocytes, thus initiating antigen-specific immune responses. Dendritic cells are 
the most potent antigen presenting cells in the immune system.  
 
According to the cell surface markers they express, dendritic cells can be divided into 
2 major populations; “lymphoid” CD11c+CD8α+DEC205+CD11b- (also called DC1) 
and “myeloid” CD11c+CD8α-DEC205-CD11b+ (also called DC2) in mouse. It has 
been shown that subcutaneous injections of antigen-loaded CD8α+dendritic cells 
primed Th1 responses, whereas CD8α- dendritic cells primed Th2 responses 
(Maldonado-Lopez R et al., 1999). The selective induction of Th1 responses by 
CD8α+ dendritic cells is in accordance with their selective ability to produce IL-12 
(Moser M & Murphy KM, 2000; Shortman K & Liu YJ, 2002). Tissue-specific 
environmental factors may participate in the phenotypic differentiation of dendritic 
cells. In mouse, CD11c+ dendritic cells purified from Peyer’s patches or lung, but not 
spleen, produce IL-4 and IL-10 and preferentially induce in vitro Th2 polarization 
(Stumbles PA et al., 1998; Iwasaki A & Kelsall BL, 1999).  
 
1.2.3 Cytokine and transcription factors  
Among several factors that influence the differentiation of Th cells, cytokines and 
their transcription factors were believed to be the primary determinants. The cytokine 
IL-12 and IL-4, acting through signal transducer and activator of transcriptions 4 
(STAT4) and STAT6 respectively are key determinants of Th1 and Th2 development 
(Kaplan MH et al., 1996a &1996b; Shimoda K et al., 1996; Takeda K et al., 1996; 
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Thierfelder WE et al., 1996). Mice deficient for IFN-γ, IL-12 or their receptors, or the 
IL-12 receptor downstream signaling molecule Stat4, fail to develop a robust Th1 
immune response while mice deficient for IL-4, IL-4R or STAT6 have severely 
compromised Th2 development (Magram J et al., 1996; Piccotti JR et al., 1998; 
Gessner A & Rollinghoff M, 2000; Wurster AL et al., 2000; Zhang Y et al., 2001). 
 
1.2.3.1 Th1 development 
Naïve Th cells activated under Th1-inducing conditions (in the presence of IL-12 and 
IFN-γ, and antibody against IL-4) are exposed to IFN-γ signaling during T-cell 
receptor engagement, leading to the activation of STAT1. Activation of STAT1 up 
regulates the expression of the Th1 cell-specific transcription factor T-bet (Lighvani 
AA et al., 2001). T-bet is a potent transactivator of the IFN-γ gene and is recently 
demonstrated to be the master regulator of Th1 lineage commitment (Szabo SJ et al., 
2000 & 2002). The expression of T-bet is followed by secretion of IFN-γ and up 
regulation of the IL-12Rβ2 chain, which further augments the IFN-γ and IL-12 signals 
(Szabo SJ et al., 1997; Mullen AC et al., 2001). The function of T-bet in the Th1 cell 
development in vitro is confirmed in T-bet deficient mice in vivo. T-bet-/- mice 
developed spontaneous airway hyperresponsiveness, airway inflammation and airway 
remodeling, features of acute and chronic asthma that resembled human asthma, and 
these pathological changes could be adoptively transferred with T-bet-/- Th cells 
(Finotto S et al., 2002). In terminally differentiated Th1 cells, reiteration of IFN-γ 
expression can occur through two experimentally distinct pathways-TCR ligation or 
cytokine (IL-12 and IL-18) stimulation. IL-18 has been demonstrated to synergize 
with IL-12 in enhancing IFN-γ production by Th1 cells (Robinson D et al., 1997; 
Murphy KM & Reiner SL, 2002). Other members of the IL-12 cytokine family such 
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as IL-23 and IL-27 can also play an instructive role in Th1 development (Oppmann B 
et al., 2000; Pflanz S et al., 2002). Unlike IFN-γ, which activated the STAT1, IL-12 
and IL-10 induced IFN-γ production was depended strongly on STAT4 (Jacobson NG 
et al., 1995).  
 
1.2.3.2 Th2 development 
In contrast, when naïve Th cell is stimulated under Th2-inducing conditions (in the 
presence of IL-4 and antibodies against IL-12 or IFN-γ), the IL-4 signaling factor 
STAT6 is activated, which translocates into the nucleus and rapidly induces (either 
directly or indirectly) the expression of GATA-3 (Ouyang W et al., 1998; Kurata H et 
al., 1999). GATA-3 is a Th2 cell-specific transcription factor and is a master regulator 
of the Th2 differentiation pathway (Zhang DH et al., 1997; Zheng W & Flavell RA, 
1997; Ouyang W et al., 1998). The expression of GATA-3 is followed by the 
induction of the transcription factor c-Maf, also preferentially expressed in Th2 cells, 
that is a potent and specific activator for IL-4 gene (Ho IC et al., 1996; Kim JI et al., 
1999). In synergy with other transcription factors or coactivators such as NFAT and 
NIP45, c-Maf and GATA-3 control the expression of IL-4 that further reinforces the 
IL-4R/Stat6 signal (Ho IC et al., 1996). Although GATA-3 is recognized to be the 
most dominant factor regulating Th2 cytokines, it mainly controls transcription of IL-
5 and IL-13 and to a lesser extent of IL-4 (Zhang DH et al., 1997; Lee HJ et al., 1998; 
Kishikawa H et al., 2001). The most important transcription factor for IL-4 is c-Maf. 
Unlike T-bet and GATA-3, c-Maf expression is not regulated by cytokine but rather 
by signaling through the TCR-CD4 complex. Functions of c-Maf are confirmed by in 
vivo studies. Over expression of c-Maf leads to a spontaneous Th2 phenotype and to 
an increased IgE levels (Ho IC et al., 1998). In addition to IL-4, IL-6 plays an 
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instructive role in Th2 differentiation by inducing early IL-4 production in Th cells 
(Rincon M et al., 1997). Furthermore, a member of IL-1R family, T1/ST2, was 
recently found to be selectively expressed on Th2 cells (Lohning M et al., 1998). 
Cross-linking of T1/ST2 was shown to enhance Th2 cytokine production, just as the 
IL-18 enhanced Th1 cytokine production (Meisel C et al., 2001). 
 
1.3. House dust mite allergens 
The discovery of house dust mite as a causative factor in inducing allergic diseases 
has led to the identification and cloning of many mite allergens as well as cloning of 
allergen genes. The first major allergen described was Der p 1 from 
Dermatophagoides pteronyssinus (Chapman MD & Platts-Mills TA, 1980). Der p 1 
was also the first allergen identified by cDNA cloning (Thomas WR & Chua KY, 
1988). To date, more than 30 different IgE binding bands have been recognized by 
Western blotting from different species of house dust mites. As summarised in table I, 
the house dust mite allergens can be grouped into 19 groups with the IgE binding 
reactivity varying from 10-100%. Allergens with high IgE binding frequencies (group 
1, 2, 3, 5, 9, 10, 11, 14) will be discussed in detail. 
 
cDNA sequences of the group 1 allergens revealed that they were cysteine protease 
and had 222 or 223 residues with a calculated MW of 25,000. The group 1 allergens, 
like other cysteine proteases, have a 19-residue signal peptide and a 79-residue 
proenzyme sequence (Chua KY et al., 1988; Dilworth RJ et al., 1991; Smith W et al., 
1999). Der p1 and Der f 1 show a sequence identity of 80%. The sequence of Eur m 1 
from Euroglypghus maynei has also been determined. It showed 84% and 86% 
sequence identity to Der p 1 and Der f 1 respectively. Recently the group 1 allergen 
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from the Blomia tropicalis was also identified. Blo t 1 showed sequence identity of 
34% to Der p 1 and had IgE reactivity in 65-90% of asthmatic subjects (Cheong N et 
al., 2003; Mora C et al., 2003). The presence of IgE cross-reactivity was 
demonstrated between Der p 1 and Der f 1 (Heymann PW et al., 1986; Lind P et al., 
1988), whereas Der p 1 and Blo t 1 showed low IgE cross-reactivity (Cheong N et al., 
2003). The sequence of all group 1 allergens contained an N-glycosylation site from 
residues 53-55, which is consistent with the presence of carbohydrates in purified 
natural allergen (Chapman MD & Platts-Mills TA 1980). Sequence polymorphism for 
the group 1 gene was reported (Chua KY et al., 1993, Smith WA et al., 2001). The 
biological function of Der p 1 in allergic diseases was demonstrated in few studies. 
Der p 1 was shown to have the ability to cleave CD23 (Hewitt CR et al., 1995; Schulz 
O et al., 1995) and CD25 (Schulz O et al., 1998) from cell surface. Both CD23 and 
CD25 were important in the regulation of IgE response. The proteolytic activity of 
Der p 1 was also shown to enhance cellular infiltration of lungs and IgE production in 
mice (Gough L et al., 1999 & 2003). Dendritic cells matured in the presence of 
proteolytically active Der p 1 produce less IL-12 and direct CD4+ T cells to produce 
less IFN-γ and more IL-4 (Ghaemmaghami AM et al., 2002). Furthermore Der p1 can 
loose the tight junctions in the respiratory epithelium and can induce the inflammatory 
cytokine release from epithelial cell cultures (King C et al., 1998; Wan H et al., 2000)  
 
The group 2 allergens were recognized as major allergen due to their high IgE binding 
activity (Lind P et al., 1984; Lind P 1985; Yasueda H et al., 1986; Abe T & Ishii A, 
1987; Heymann PW et al., 1989). cDNA sequences of Der p2 (Chua KY et al., 1990) 
and Der f 2 (Trudinger M et al., 1991; Yuuki T et al., 1991) showed that the allergens 
had 129 residues, with a calculated MW of 14,000 and without any N-glycosylation 
sites. Der p 2 and Der f 2 shared 88% sequence identity and there was high IgE cross-
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reactivity between the two allergens (Yasueda H et al., 1989). The Eur m 2 (Smith W 
et al., 1999) has 82% sequence identity to both Der p 2 and Der f 2. Group 2 allergens 
from the storage mites Lepidoglyphus destructor (Varela J et al., 1994; Schmidt M et 
al., 1995), Glycophagus domesticus (Gafvelin G et al., 2001) and Tyrophagus 
putrescentiae have also been identified. Although Lep d 2, Tyr p 2 and Cly d 2 do 
cross react among themselves, the cross-reactivity with Der p 2 is minimal (Gafvelin 
G et al., 2001). The Group 2 allergens (Der p 2, Der f 2, Lep d 2, etc.) exhibit a 35% 
sequence identity to a human epididymal gene product (HE1), suggesting that they 
may play a role in mite reproduction (Thomas WR & Chua KY 1995). The tertiary 
structure of Der p 2 (Mueller GA et al., 1998) and Der f 2 (Ichikawa S et al., 1998) 
was analyzed by NMR and shown a protein consisting of β-sheets folded into a single 
immunoglobulin domain. It has structure similarity to the third and fourth domain of 
the transglutaminase coagulation factor XIII. Recently the crystal structure of Der p 2 
and Der f 2 were solved (Derewenda U et al., 2002; Roeber D et al., 2003). It reveals 
that Der p 2 has relatively close structural similarity to human Rho-specific guanine 
dissociation inhibitor (RhoGDI). Furthermore the architecture of Der p 2 strongly 
suggests that the Der p 2 molecule has evolved to bind lipid-like molecules. This is in 
agreement with the finding that Der p 2 amino acid sequence shows homology to 
mammalian secretory epididymal protein HE1, which is known to bind cholesterol 
with high affinity (Naureckiene S et al., 2000). Sequence polymorphism of Der p 2 
and Der f 2 were also reported (Yuuki T et al., 1990; Smith WA et al., 2001). 
Variants of Der p 2 showed different extent of T cell activation and IgE binding 
(Hales BJ et al., 2002). The concentrations of group 2 in house dust were similar to 
group 1 (Custovic A et al., 1996; Yasueda H et al., 1996). 
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cDNA of Der p3 revealed that it had a pre-pro region of 29 amino acids and a mature 
protein of 233 residues with a calculated MW of 25,000 and contained the catalytic 
and substrate-binding sites of trypsin. (Smith WA et al., 1994) Although there is no 
N-glycosylation site, the native (Stewart GA et al., 1992) and recombinant Der p 3 
migrate as a 30,000 MW protein. The Der f 3 cDNA (Nishiyama C et al., 1995) had 
81% sequence identity with Der p 3. Eur m 3 had 81% identity to Der p 3 and Der f 3. 
Blo t 3 showed 47% sequence identity to Der p 3, Der f 3 and Eur m 3 (Cheong N et 
al., 2003). Der p 3 and Der f 3 also had polymorphic residues (Nishiyama C et al., 
1995; Smith WA & Thomas WR, 1996a & 1996b). The proteolytic activity of Der p 3 
has been demonstrated to cleave the complements C3 and C5 and generate 
anaphylatoxins C3a and C5a (Maruo K et al., 1997). Group 9 allergen was only found 
in native form from Dermatophagoides pteronyssinus. Der p 9 is a serine protease 
with a collagenolytic activity distinguishable from Der p 3 and Der p 6 (King C et al., 
1996). It migrated as a 28,000 MW band in SDS-PAGE and had a MW of 24,000 by 
mass spectroscopy. It reacted positive with human IgE in 90% of sera from patients 
with allergy (King C et al., 1996). The cDNA clone has not been identified. 
 
Full-length cDNA of Der p 5 revealed a 132-residue polypeptide with a putative 
leader sequence of the first 19 residues (Lin KL et al., 1994). The mature protein had 
a calculated MW of 15,000 and had no N-glycosylation sites or cysteins. The native 
Der p 5 has been purified (O’Neill GM et al., 1994) and N-terminal sequencing has 
shown that the native Der p5 has 112 residues beginning at aspartate designated as 
residue 2 in the study of Lin et al. Der p5 showed an IgE reactivity of 40% (Tovey ER 
et al., 1989), however Blo t 5 of B. tropicalis appeared to be a very important allergen 
as it reacted with 70% of sera (Arruda LK et al., 1995). Blo t 5 had 43% sequence 
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identity to Der p5 and little cross-reactivity (Kuo IC et al., 2003). One Der p 5 
isoform was reported with a single amino acid variation of alanine to aspartate at 
position 61 (Lin KL et al., 1994). Native Blo t 5 was purified recently and the 2-D 
electrophoresis showed that there were multiple isoforms reacting with sera IgE of 
asthmatic patients (Yi FC et al., 2004). 
 
The group 10 and 11 proteins were both structural proteins in mites. Tropomyosins 
from dust mite were designated as group 10 allergens. cDNA of Der f 10 encoded a 
284-amino acid molecule with a MW of 33,000 (Aki T et al., 1995). Der p 10 
(Asturias JA et al., 1998), Der f 10, Blo t 10 (Yi FC et al., 2002), and Lep d 10 
(Saarne T et al., 2003) share up to 96% sequence identity with each other. High IgE 
cross-reactivity was demonstrated between Blo t 10 and Der p 10 (Yi FC et al., 2002). 
The IgE reactivity to group 10 allergens varied from 13% to 95%. In addition, mite 
tropomyosins showed 75% identity to other arthropod tropomyosins and 60% identity 
to mammalian tropomyosins. The IgE cross-reactivity of mite tropomyosin with 
tropomyosins from other invertebrate is well documented (van Ree R et al., 1996a & 
1996b; Santos AB et al., 1999; Asturias JA et al., 1999). Tropomyosin, therefore, is 
considered as a pan-allergen.  
 
A partial cDNA clone encodes a 98,000 MW paramyosin from D. farinae has been 
reported as group 11 allergen. It bound IgE at high frequency with strong reactivity 
(Tsai LC et al., 1998; Tsai L et al., 1999). The Blo t 11 was reported as an 875-
residue polypeptide with a MW of 102,000 (Ramos JD et al., 2001). Affinity purified 
nBlo t 11 was susceptible to degradation with the major degraded product resolved at 
66 kD and showed IgE reactivity to 50% allergic sera (Ramos JD et al., 2003). Der p 
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11 was recently cloned and showed IgE reactivity to 41-66% in patients with allergy 
(Lee CS et al., 2004). 
 
The group 14 HDM allergen, a highly degradable high molecular weight allergen was 
identified as a vitellogenin or apolipophorin-like protein (Fujikawa A et al., 1996; 
Epton MJ et al., 1999) and responsible for several IgE binding bands on Western 
blotting to crude mite extract. Two different truncated allergens called Mag1 (Aki T et 
al., 1994) and Mag 3 (Fujikawa A et al., 1996), with 341 and 349 residues 
respectively, were identified in D farinae. Antibodies against Mag 3 recognized a 177 
kD allergen called M-177 (Fujikawa A et al., 1996 & 1998). 
 
Modified from Thomas WR et al. (2002) 
 
 
Table 1.1  Summary of denominated HDM allergens 
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1.4. Atopic dermatitis 
 
Atopic dermatitis (AD) is a common inflammatory skin disease characterized by 
recurrent episodes of itching and a chronic relapsing course. The concept of “atopy” 
(derived from the Greek atopia, meaning “different” or “out of place”) was originally 
proposed in 1923 to include asthma and allergic rhinitis, but AD was added to the 
group of atopic disorder in 1933 on the basis of association of this form of eczema 
with asthma and allergic rhinitis. In fact, AD is most often the first manifestation of 
this atopic triad (Spergel JM & Paller AS, 2003). 
 
1.4.1 Epidemiology  
1.4.1.1 Natural History  
The atopic march is the natural history of atopic manifestations, characterized by a 
typical sequence of progression of clinical signs of atopic disease, with some signs 
becoming more prominent while others subside. In general, the clinical signs of AD 
predate the development of asthma and allergic rhinitis, suggesting that AD is an 
“entry point” for subsequent allergic disease. Over the past two decades, it has been 
clearly shown that the skin is much more than just a covering and protecting coat. 
Indeed, it represents an integral component of the immune system. The concept that 
the skin acts as an immunologic organ was first suggested by Fichtelius et al 
(Fichtelius KE et al., 1971). They suggest that lympho-epithelial micro-organs in the 
skin of neonates localizing at the orifices of the body, reflect educational lymphoid 
environments in which systemic immunity to exogenous antigens is formed and 
therefore the skin may be considered as a “first-level lymphoid organ” compare to the 
primary lymphoid tissue thymus. Several studies provide evidence for the atopic 
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march from AD to the development of allergic rhinitis and asthma (ISAAC steering 
committee et al., 1998a; Gustafsson D et al., 2000; Rhodes HL et al., 2001 & 2002; 
Lau S et al., 2002; Ohshima Y et al., 2002;). These results also demonstrated that the 
severity of AD was a risk factor for subsequent development of asthma and allergic 
rhinitis. Approximately 60% of patients experience the development of signs of AD 
before their first birthday, and another 30% of patients experience the development by 
age 5 years (Kay J et al., 1994). Although the natural course of AD is highly variable, 
many cases resolve before age 2 years, and in the remaining patients improvement at 
puberty is common.  
 
1.4.1.2 Prevalence 
The occurrence of AD and atopic respiratory diseases began around 1960. Before this 
time, the lifetime prevalence of atopic dermatitis in community surveys of 
schoolchildren in European countries was a small percentage, but two-digit 





Table 1.3 summarized the prevalence surveys of AD in children born after 1980. The 
current lifetime prevalence of AD is around 20% in the Denmark, 18% in 
Table 1.2 Trends in the lifetime prevalence of atopic dermatitis in children born between 1960 
and 1993 
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Scandinavia, 10-20% in the Northwest Europe and is as common in the United States 
as it is in Western Europe. Studies from other continents indicated that the prevalence 
of AD in the Southern hemisphere and in some Asian countries is similar to 
Scandinavia, whereas surveys from Mediterranean and Eastern European countries 















The difference in the prevalence of AD in different country may be due to different 
questionnaires used in the survey and little is known about the prevalence of AD 
outside Northern Europe. Therefore the International Study of Asthma and Allergies 
in Childhood (ISAAC) was formed to standardize international comparisons of all 
atopic diseases and to maximize epidemiologic research. In this global questionnaire 
survey, parents of 256,410 children aged 6 to 7 years in 90 centers in 37 countries 
completed questionnaires on atopic eczema symptoms, whereas 458,623 13 to 14 
year-old schoolchildren in 56 countries throughout the world completed their own 
questionnaires in the classroom. The prevalence range for symptoms of atopic ezema 
was from less than 2% in Iran to over 16% in Japan and Sweden in the 6 to 7 year age 
range and less than 1% in Albania to over 17% in Nigeria for the 13 to 14 year age 
range. High prevalence values for atopic ezema symptoms (above 15%) were found in 
urban Africa, the Baltics, Australasia and Northern and Western Europe at both ages. 
Table 1.3. Prevalence surveys of atopic dermatitis in children born after 1980 
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Low prevalence values (under 5%) were present in China, Eastern Europe and Central 
Asia. In addition, it appeared that low prevalence was observed in low latitudes and 
high prevalence at high latitudes (Williams H et al., 1999). 
 
1.4.1.3 Risk factors  
Studies in twins have suggested that genetic factors play a role in the AD (Schultz 
Larsen F, 1993). Many investigations on environmental influences have identified that 
parental history with atopy or ezema is one of the strongest risk factors. Maternal 
atopy is a greater risk of atopic disorder in offspring than paternal atopy (Schultz 
Larsen F, 2000). There was a slight female preponderance for symptoms of atopic 
ezema with an overall female: male ratio of 1.3:1.0 among 6 to 7 and 13 to 14 year-
old children. (Schultz Larsen F et al., 1996 and Williams H et al., 1999) In addition, 
investigators also found greater prevalence in wealthier families (Freeman GL & 
Johnson S 1964; Gergen PJ et al., 1987; Suarez-Varela MM et al., 1999; Bergmann 
RL et al., 2000). 
 
Family structure is another factor that has received attention in a number of studies. 
Several studies demonstrated that the prevalence of AD was inversely related to the 
number of siblings and was related more strongly to the number of older siblings 
(Strachan DP 1989; Olesen AB et al., 1997; Xu B et al., 1999; Harris JM et al., 2001). 
Data also showed an inverse relation of positive skin prick tests to common 
aeroallergens to the number of siblings (von Mutius E, 1994; Braback L et al., 1995). 
The hygiene hypothesis was first described by Strachan DP in 1989. He proposed that 
“infection in early childhood transmitted by unhygienic contact with older siblings” 
may prevent atopic diseases. The most consistent evidence of an inverse relationship 
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between infection and atopy comes from studies on hepatitis A infection. The 
prevalence of antibodies to hepatitis A virus was significantly higher in nonatopic 
than in atopic subjects. (Matricardi PM et al., 2000) The authors suggested that the 
orofecal and foodborne microbes might be better candidates than airborne respiratory 
infections for the protective effect from atopy and that inadequate stimulation of the 
gut associated lymphoid tissue by microbes enhances the risk of atopy. Therefore, 
studies were performed to compare differences of fecal bacteria in infants between 
atopic and nonatopic infants and results showed that immunogenic properties of the 
flora broadly correspond to differences between atopic and nonatopic infants 
(Bjorksten B et al., 1999). Another study revealed a lower prevalence of atopy in 
children attending Steiner schools in comparison with the prevalence in children of 
the same age at two neighboring schools (Alm JS et al., 1999). However, not all 
studies in this area confirm the hygiene hypothesis. Some studies of specific 
infections (measles, pertussis, tuberculosis) and vaccination against these diseases 
offer weak or no support for a link between infection/immunization and a reduced risk 
of allergy. (Strachan DP, 2000). Wide variations in the prevalence have been 
identified within countries inhabited by similar ethnic groups, suggesting that 
environmental factors determine expression of AD (Williams H et al., 1999). 
Furthermore results of comparative studies in former East and West Germany have 
confirmed that lifestyle and environment play a major part in expression of AD 
(Schafer T et al., 2000). 
 
1.4.2 Environmental triggers of atopic dermatitis 
1.4.2.1 Allergens  
1.4.2.1.1 Aeroallergens 
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House Dust Mite 
House dust mite allergy has the largest body of scientific and clinical data linking 
aeroallergens and atopic diseases. Positive prick skin testing and patch testing to dust 
mite antigen in patients with AD had been shown (Mitchell EB et al., 1982; Platts-
Mills TAE et al., 1983; Clark RA & Adinoff AD, 1989). In contrast, patients with 
respiratory allergy and healthy volunteers rarely had positive allergen patch tests. 
Further studies demonstrated that house dust mite inhalation challenge caused a flare 
up of the skin lesions in AD patients. This was more prominent in AD patients who 
already suffered from an IgE-mediated allergic inflammation in the lung (Tupker RA 
et al., 1996; Brinkman L et al., 1997). Laboratory data supported the role for inhalants 
with the finding that IgE antibody to specific inhalant allergens in most patients with 
AD. Indeed, a recent study showed that 95% of sera from AD patients had IgE to 
house dust mite compared with 42% of asthmatic subjects (Scalabrin DM et al., 
1999). The degree of sensitization to aeroallergens is directly associated with severity 
of AD (Schafer T et al., 1999). Der p mite specific T cell clones can be isolated from 
skin lesions or patch-tested site with a predominant Th2 phenotype (van der Heijden 
FL et al., 1991; Mudde GC et al., 1992; Sager N et al., 1992). In an environmental 
epidemiologic survey, homes of patients with moderate-to-severe AD showed a 
higher dust mite concentration (Beck HI & Korsgaard J, 1989). Several studies 
demonstrated that house dust mite allergen avoidance could improve the clinical 





Pollen were the first aeroallergen reported in association with AD. In 1950s, Tuft 
reported that patients with AD pruitus and eczematoid developed skin lesions after 
intranasal inhalation challenge with either Alternaria or ragweed pollen but not 
placebo challenges (Tuft L 1949). In addition, patients with seasonal exacerbation of 
AD showed resolution of symptoms in a pollen-free environment or during their off-
season sensitization (Wuthrich B 1989). Since then, investigators have shown positive 
skin prick tests and patch tests to common pollen in patients with seasonal distribution 
of AD (Bruynzeel-Koomen CA & Bruynzeel PL, 1988; Rasanen L et al., 1992). 
Pollen allergen-specific T cells lines could be obtained from skin lesion of patients 
with AD and they showed a Th2-like cytokine profiles (Ramb-Lindhauer C et al., 
1991; van Reijsen FC et al., 1992). 
 
Animal Dander and Cockroach Allergens 
Animal dander and cockroach allergens have been studied in association with asthma 
and allergic rhinitis. Although less information was reported about these allergens 
group with AD, studies demonstrated that patients with AD showed positive skin and 
patch testing to animal dander and cockroach, indicating the possible relevance of 
these allergens in atopic dermatitis. Positive skin tests to dander correlated with the 
dander identified in patients’ living environments. T cell proliferation and an increase 
in antigen-processing cells have been seen in skin lesions in patients sensitive to cat 
dander and other aeroallergens (Buckley CC et al., 1992). 
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1.4.2.1.2 Food allergens 
The relation of food and AD was first reported in the medical literature at 1909 
(Smith HL 1909). Further studies demonstrated that dietary manipulation results in 
dramatic improvement in a subset of patients with AD, especially in young infants 
and children (Atherton DJ et al., 1978; Sampson HA & Ho DG. 1997; Sampson HA 
1999). Other studies also indicate that AD can be at least partially prevented by 
prophylactically eliminating the more highly allergenic foods from the diets of infants 
and breast-feeding mothers (Sigrus N et al., 1992; Zeiger R S & Heller S, 1995). 
Laboratory studies have provided evidence for the role of food allergy in AD. Infants 
and young children with moderate to severe AD frequently have positive immediate 
skin tests or food specific-IgE (Sicherer SH & Sampson HA, 1999). Using oral food 
challenge, investigators further demonstrated that approximately 40% of infants and 
young children with moderate to severe AD had food allergy (Sampson HA, 1983; 
Burks AW et al., 1988; Sicherer SH et al., 2000). Following a positive food challenge 
or chronic ingestion of a known food allergen, increased mediator release has been 
observed in patients. These included increased plasma histamine levels (Sampson HA 
& Jolie PL, 1984), increased spontaneous histamine release from basophils and 
mononuclear cells (Sampson HA et al., 1989) and eosinophil activation (Magnarin M 
et al., 1995). In addition, food allergen-specific T cells with Th2 like cytokine profile 
have been cloned from lesional skin and normal skin of patients with AD (van Reijsen 
FC et al., 1998; Reekers R et al., 1999). Skin-homing receptors, CLA (cutaneous 
lymphocyte antigen), are increased on T cells from casein-allergic patients with AD 
as compared with controls. These studies provide strong scientific evidence that food 
allergens play a role in the pathogenesis of AD in young children. Among suspected 
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food allergens tested, egg, milk, peanut, fish and tree nuts accounted for the majority 
of positive food challenges; and egg sensitivity was the most prevalent food allergen 
(Sampson HA et al., 1989; Sampson HA, 1999). 
 
1.4.2.2 Microorganisms 
Aside from food and inhalant allergens, fungi and bacterial skin infections can 
exacerbate AD. The most extensively studied and widely recognized microorganism 
known to trigger AD is Staphylococcus aureus. S. aureus is found in more than 90% 
of AD skin lesions (Leyden JJ et al., 1974; Lever R et al., 1988). Recent studies 
suggest that S. aureus secretes a group of toxins known to act as superantigens that 
stimulate marked activation of T cells and therefore exacerbate or maintain skin 
inflammation in AD. Some evidence support a role for superantigen in AD. First, 
superantigens (such as enterotoxins A and B and TSST-1) secreting S. aureus was 
cultured from the skin of more than half of AD patients (Nickoloff BJ & Naidu Y, 
1994; Bunikowski R et al., 1999; Nomura I et al., 1999). Skin-homing CLA+ T cells 
from these patients revealed a superantigenic stimulation with expansion of T cell 
receptor Vβ (Strickland I et al., 1999; Bunikowski R et al., 2000). Second, most AD 
patients make specific IgE antibodies directed against the staphylococcal toxins found 
in the skin. In those patients who had increased IgE levels to specific allergens, a 
correlation between the presence of anti-superantigens IgE and the severity of AD 
was found (Nickoloff BJ & Naidu Y, 1994; Nomura I et al., 1999; Bunikowski R et 
al., 2000). In a humanized murine model of AD, S aureus superantigen plus allergen 
was shown to have an additive effect in inducing cutaneous inflammation (Herz U et 
al., 1998). Third, when applied the superantigen staphylococcal enterotoxin B (SEB) 
to the skin, changes of erythema and indurations could be induced as well as the 
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selective expansion of SEB specific T cells (Strange P et al., 1996; Skov L et al., 
2000). It was proposed that staphylococcus superantigens secreted on the surface of 
the skin could penetrate the inflamed skin and stimulate epidermal macrophages or 
LCs to produce IL-1, TNF-α, and IL-12 (Leung DYM et al., 1995). Local production 
of IL-1 and TNF-α induces the expression of E-selection on vascular endothelium (de 
Vries IJ et al., 1998), allowing an initial influx of CLA+ memory and effecter cells. 
IL-12 increases CLA expression on those T cells activated by allergen or superantigen 
and increases the efficiency of T-cell recruitment to the skin. These mechanisms 
would amplify the initial cutaneous inflammation in AD and create conditions 
favoring staphylococcal skin colonization. 
 
Various species of yeast organisms, such as Candida albicans, Trichophytan, and 
Malassezia furfur (also known as Pityrosporum ovale or P orbiculare) have been 
implicated as causal factors in the pathogenesis of AD. A 3-fold increased in 
frequency of Trichophyton rubrum skin infections was found among patients with AD 
as compared with nonatopic control subjects (Jones HE et al., 1973). Increased level 
of IgE antibodies against M. furfur was commonly found in patients with AD 
(Wessels MW et al., 1991) and most frequently in patients with dermatitis on head 
and neck especially in older children and adults (Kieffer M et al., 1990). Positive 
allergen patch test reactions to M. furfur have also been demonstrated (Rokugo M et 
al., 1990). The potential importance of M furfur is further supported by the reduction 
of AD skin severity in patients with positive IgE to M. furfur after treatment with 
antifungal agents such as ketoconazole (Back O et al., 1995; Kolmer HL et al., 1996). 
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Mold allergens also have been implicated as causal factors in the patients with AD. 
Approximately 10% of adults and 25% of children of patients with AD had positive 
skin tests to Alternaria, Aspergillus and Penicillium (Kesten BM. 1954). Inhalation 
challenge with mold extract induced or exacerbated the eczematous lesions and 
symptoms of dermatitis (Tuft L. 1950). Patch testing with fungi has shown allergen-
specific development of typical eczematous lesion with increased expression of 
Langerhans’ and dendritic cells in biopsies of lesions (Buckley CC et al., 1992). 
 
1.4.2.3 Autoantigen 
Since 1920s several investigators had demonstrated that human skin dander could 
trigger immediate hypersensitivity reactions in the skin of patients with severe AD. 
Recently, it was demonstrated that the majority of sera from patients with severe AD 
contained IgE antibodies directed against human proteins (Valenta R et al., 2000). 
One of these IgE-reactive autoantigen has been cloned from a human epithelial cDNA 
expression library and designated Hom s 1, which is a 55 kDa cytoplasmic protein in 
skin keratinocytes (Valenta R et al., 1998). Another autoantigen that was recognized 
by the sera from AD patients on IgE immunoblot was designed as dense fine speckles 
70 kDa (DFS70) (Ochs RL et al., 2000). These data suggest that, although IgE 
immune responses are initiated by environmental allergens, allergic inflammation can 
be maintained by human endogenous antigens, particularly in severe AD. 
 
1.4.2.4 Other environmental triggers 
Other environmental factors including climate (extreme temperature and humidity), 
chemical irritants (e.g. detergents, bleaches), physical irritants (e.g. scratching, 
sweating) and psychosocial stresses (e.g. emotional stress, sleep disturbance) 
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frequently act as triggers that cause exacerbations of disease, but they are not the 
primary causes of the underlying disease. 
 
1.4.3 Immunopathogenesis of atopic dermatitis 
The histological features of AD depend on the acuity of the skin lesion (Mihm MC et 
al., 1976; Leung DYM et al., 1983). Uninvolved or clinically normal appearing skin 
of patients with AD is histologically abnormal and demonstrates mild hyperkeratosis 
and a sparse perivascular cellular infiltrate consisting primarily of T lymphocytes. 
Acute lesions are characterized by marked intercellular edema (spongiosis) of the 
epidermis and a sparse epidermal infiltrate consisting primarily of T lymphocytes. In 
the dermis, there is a marked perivenular inflammatory cell infiltrate consisting 
predominantly of T lymphocytes and occasional monocyte-macrophages. The 
lymphocytic infiltrate consists predominantly of T lymphocyte bearing CD3, CD4 and 
CD45RO (Leung DYM et al., 1983; Bos JD et al., 1989). Basically, all T cells 
infiltrating into the skin lesion express high levels of cutaneous lymphocyte antigen 
(CLA), which functions as a skin homing receptor for T lymphocytes. Eosinophils, 
basophils, and neutrophils are rarely present in the acute lesion. Mast cells, in various 
stages of degranulation, are present in normal numbers. In chronic lichenified lesions, 
the epidermis is hyperplastic with elongation of the rete ridges, prominent 
hyperkeratosis, and minimal spongiosis. There are an increased number of IgE-
bearing Langerhans’ cells in the epidermis, and macrophages dominate the dermal 
mononuclear cell infiltrate. The mast cells are increased in number but are generally 
fully granulated. Increased numbers of eosinophils are observed in chronic AD skin 
lesions. Eosinophil-derived extracellular major basic protein (MBP) can be detected 
by immunofluorescence in a fibrillar pattern associated with the distribution of elastic 
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fibers throughout the upper dermis (Leiferman KM et al., 1985). Extracellular MBP 
deposition is much more prominent in the involved areas than the uninvolved areas of 
skins. Although the role of eosinophils in the pathogenesis of AD is not completely 
understood, it is believed to contribute to tissue injury in AD through the production 
of reactive oxygen intermediates and release of cytotoxic granules. Eosinophil 
cationic protein is elevated in AD sera and correlates with disease severity, providing 
further evidence for eosinophil activation and involvement in AD (Kagi MK et al., 
1992). 
 
1.4.3.1 Skin homing T cell and atopic dermatitis 
There are overwhelming evidences that abnormal T cell functions contribute to the 
pathogenesis of AD. Skin represents a functionally distinct immune compartment and 
chronic inflammation of the skin is generally associated with tissue infiltration by T 
cells with abnormal cytokine production (Bos JD& Kapsenberg ML, 1993; Leung 
DYM et al., 1983). As mentioned, the great majority of these T cells homing to the 
skin are of the CD45RO+ memory/effector phenotype and they express the selective 
skin-homing receptor CLA (Picker LJ et al., 1990). CLA consists of a sialyl Lewis-x 
carbohydrate and corresponds to a post-translational modification of the P-selectin 
glycoprotein ligand 1 (PSGL-1) (Fuhlbrigge RC et al., 1997). CLA binds to its 
vascular counter-receptor, E-selection (CD62E), which is expressed on inflamed 
superficial dermal postcapillary venules and endothelial cells (Picker LJ et al., 1991). 
The chemokine CTACK (CCL27), which is produced primarily by keratinocytes, and 
its receptor CRP-2/CCR10, are demonstrated to play a role in the preferential 
attraction of CLA+ T cells to the skin (Morales J et al., 1999; Hormey B et al., 2000). 
In peripheral blood CLA+CD45RO+ T cells represent a subset of 10-25% of the 
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circulating CD4 and CD8 T cells (Picker LJ et al., 1990; Santamaria Babi LF et al., 
1995a; Akdis M et al., 1997). Patients with AD have an increased number of activated 
CLA+ T cells in their circulation than patients with allergic asthma (Santamaria Babi 
LF et al., 1995b). Freshly isolated CLA+CD45RO+ T cells from patients of AD, but 
not from normal controls, show significantly higher expression of CD25, CD40-
ligand and HLA-DR (Akdis M et al., 1997). This indicates that peripheral blood skin-
homing memory/effector T cells are in an activated state in patients afflicted with AD. 
Both CD4+ and CD8+ CLA+ T cells in AD contain and spontaneously release high 
amounts of preformed IL-5 and IL-13 but they have only very little IL-4 and IFN-γ in 
their cytoplasm. IL-5 and IL-13 can functionally prolong eosinophil survival and 
induce IgE synthesis (Akdis M et al., 1997 & 1999). 
 
1.4.3.2 Biphasic cytokine expression pattern in atopic dermatitis skin lesions 
Recent studies indicate that Th2 and Th1-type cytokines contribute to the 
pathogenesis of skin inflammation in AD, depending on the stages of skin 
inflammation (Hamid Q et al., 1994; Hamid Q et al., 1996). As compared with 
normal skin, uninvolved skin of patients with AD has an increased number of cells 
expressing IL-4 and IL-13, but not IL-5, IL-12, or IFN-γ mRNA. Acute and chronic 
skin lesions, when compared with normal skin or uninvolved skin of patients with 
AD, have significantly greater numbers of cells expressing IL-4, IL-5, and IL-13 
mRNA. However, acute AD does not contain cells that express IFN- γ or IL-12 
mRNA. Chronic skin lesions of AD have significantly fewer IL-4 and IL-13 mRNA-
expressing cells but increased numbers of IL-5, IL-12 and IFN- γ mRNA-expressing 
cells as compared with acute AD. These data indicate that acute T-cell infiltration in 
AD is associated with a predominance of Th2-like cytokines (IL-4 and IL-13), 
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whereas maintenance of chronic inflammation is associated with an increase of Th1 
and Th2 cytokines (IL-5, IL-12, IFN-γ) accompanied by the infiltration of eosinophils 
and macrophages. The increased expression of IL-12 by eosinophils and macrophages 
is believed to initiate the switch of Th1 cell development in chronic AD (Grewe M et 
al., 1998). 
The biphasic pattern of T-cell activation has been well demonstrated in studies on 
skin biopsies of atopic patch test reaction sites (Tsicopoulos A et al., 1994; Grewe M 
et al., 1994; Thepen T et al., 1996). Increased expression of IL-4 mRNA and protein 
is observed 24 hours after allergen application, after that IL-4 expression declines to 
basal level. In contrast, IFN- γ mRNA expression is not detected in 24-hour patch test 
lesions but is strongly over-expressed at the 48- to 72- hour time points. 
 
1.4.3.3 Mechanism of chronic skin inflammation 
Dysregulated apoptosis of eosinophils, monocyte-macrophage, T cells and 
keratinocytes leads to the pathology of chronic skin inflammation in AD. IL-5 
secreted by CLA+ T cells of both CD4+ and CD8+ subsets extended the lifespan of 
freshly isolated eosinophils in vitro (Akdis M et al., 1999). Increased IL-5 expression 
during the transition from acute to chronic AD likely contributes to the prolongation 
of eosinophil survival and function. In addition, different lifespan of CLA+ T cells is 
also shown in AD patients. In the peripheral blood of AD patients, both CD4+ and 
CD8+ subsets of CLA+CD45RO+ T cells expressed upregulated Fas receptor and Fas 
ligand and underwent spontaneous activation-induced cell death (Akdis M et al., 
2000). In contrast, infiltrating T cells in the skin of AD patients expressed both Fas 
receptor and Fas ligand; however, they did not show any signs of apoptosis. The 
 36
contribution of apoptotic keratinocytes to the chronic skin inflammation will be 
discussed later. 
 
1.4.3.4 Other cells involved in immunopathogenesis of AD 
1.4.3.4.1 Dendritic cells 
Dendritic cells are potent antigen-presenting cells that can prime naive T cells, and are 
thus responsible for the primary immune response. Two types of dendritic cells are 
found in increased numbers in the skin of AD, Langerhans’ cells (LCs) and 
inflammatory dendritic epidermal cells (IDECs). LCs are the only cells in the 
epidermis that constitutively express MHC class II. Epidermal LCs seems to be 
maintained by a stable precursor population in the dermis under steady-state 
conditions. With inflammation, however, blood-borne LC precursors are actively 
attracted to the epidermis under the influence of the CCR2 chemokine receptor 
(Merad M et al., 2002). IDECs are a distinct DC population that mainly found in 
inflammatory skin diseases (Wollenberg A et al., 2002). In the lesional skin of AD, 
the number of IDECs exceeds the number of LCs, whereas normal skin does not 
contain IDECs (Kerschenlohr K et al., 2003). IDECs can be distinguished from LCs 
on the basis of the surface density of the high affinity receptors for IgE, FcεRI, and 
the CD11b: LCs are CD1a+++CD11b-FcεRI+ and IDECs are CD1a+CD11b+++ 
FcεRI+++. IDECs express CD11a, CD11b and CD11c additionally. The presence of 
IgE bearing dendritic cells in the skin is one of the hallmarks of AD. The classic 
tetrameric FcεRI, consisting of one α-chain, one β-chain and two disulfide linked γ-
chain, is constitutively expressed on mast cells and basophils. By contrast, a trimeric 
form of FcεRI (αγ2) is variably expressed on LCs, IDECs, DCs, and monocytes. In 
agreement with the increased number of DCs on skin of AD patients, the FcεRI 
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expression on DCs is positively associated with the atopic status of the individual. 
Recently, the γ-chain of FcεRI was found to be differentially expressed on DCs of 
atopic and nonatopic individuals. It has been proposed that enhanced expression of 
FcεRI on DCs from atopic donors was driven by the enhanced expression of γ-chain 
of FcεRI and was preserved by increased IgE levels (Novak N et al., 2003). In 
addition, LCs of atopic patients, bearing IgE on the surface, presented antigen more 
efficiently than LCs of the nonatopic individuals (Mudde GC et al., 1990). 
Furthermore, it had been shown recently that LCs activated by FcεRI drive naïve T 
cells into IL-4 producing T cells of the Th2 phenotype. In contrast, FcεRI-activated 
IDECs, like DCs, primed naïve T cells into IFN-γ producing T cells of the Th1 
phenotype and release IL-12 and IL-18 in vitro, which together might lead to the 
switch of the initial Th2 immune response to a Th1 immune response in vivo (Novak 
N et al., 2003). In addition to the antigen presenting function of dendritc cells, FcεRI 
activation on DCs leads to the release of chemokines, such as monocyte 
chemoattractant protein 1 (MCP-1), IL-16, thymus and activation-regulated 
chemokine (TARC), and macrophage activation-chemokine (MAC), which may be 
responsible for the recruitment of other pro-inflammatory cells into the skin (Reich K 
et al., 2002; Eglite S et al., 2003; Kerschenlohr K et al., 2003). 
 
1.4.3.4.2 Monocytes 
FcεRI expression is increased not only on DCs but also on monocytes of AD patients. 
Recently, it is believed that the FcεRI-bearing monocytes in the peripheral blood may 
be the source of subtypes of IgE-bearing DCs in the dermal lesions of patients with 
AD, which are recruited in the acute phase or during exacerbation of the disease into 
the inflammatory skin by chemokines, cytokines, and other mediators. Cross-linking 
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of FcεRI on monocytes induced the secretion of IL-10 (Novak N et al., 2001). IL-10 
acts to regulate the balance between Th1 and Th2 functional responses accounting for 
many atopic features, including increased IL-4, IL-5, and IL-6 production by T cells; 
increased IgE synthesis; decreased IFN-γ production; and impaired cell-mediated 
immune responses. Furthermore, monocytes of AD patients display increased levels 
of cAMP-phosphodiesterase (Holden CA et al., 1986), which contributes to excessive 
production of prostaglandin E2 (PGE2). Increased monocyte PGE2 production 
inhibits Th1 responses, accentuating IL-4 secretion by Th2 cells (Hanifin JM & Chan 
SC, 1995). In chronic lesions, however, monocytes are stimulated by IFN-γ and act in 
concert with eosinophils to produce IL-12 that promotes conversion to the Th1 
phenotype during the chronic stage of the disease. 
 
1.4.3.4.3 Keratinocytes 
Keratinocytes are not only the targets of inflammation in AD, but also contribute to 
the initiation and maintenance of inflammation as well. Both inflammation and 
mechanical trauma cause the release of a range of keratinocyte-derived cytokines and 
chemokines (Giustizieri ML et al., 2001). These chemokines and cytokines 
contributed to the pathogenesis of AD. In the presence of IL-1α and IFN-γ, 
keratinocytes of AD patients showed an elevated production of GM-CSF (Pastore S et 
al., 1997 & 1998). Keratinocytes of AD patients also released high amounts of 
proinflammatory cytokines TNF-α and IL-1β. In addition, chemokines released by 
keratinocytes contribute to AD pathogenesis. For example, CCL5 (RANTES), CCL17 
(TARC) and CCL20 (liver and activation-regulated chemokine, LARC) play 
important roles in the recruitment of CLA+ memory T cells into AD skins 
(Vestergaard C et al., 2000; Nakayama T et al., 2001). In response to TNF-α and 
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IFN-γ, keratinocytes of patients with AD over-express soluble epidermal growth 
factors, which induce the release of CCL2 (monocyte chemoattractant protein 1, 
MCP-1), RANTES, CXCL10 (Interferon activated gene 10, IP-10), and IL-8 (Pastore 
S et al.,1997; Mascia F et al., 2003). More importantly, thymic stromal lymphopoetin 
(TSLP), an IL-7-like cytokine, was found in high amount in the epidermal skin of 
chronic lesional skin of AD patient. TSLP activates CD11c+ DCs to produce CCL17 
and CCL22 (macrophage-derived chemokine, MDC), which directly attract Th2 cells. 
In addition, TSLP is involved in the activation and emigration of LCs from the 
epidermis to the lymph node. It also plays a role in the recruitment of LC precursors 
into the dermis. TSLP-activated DCs primed naive T cells to produce high amount of 
IL-5, IL-13 and TNF-α, moderate levels of IL-4 and none or very low levels of IL-10 
and IFN-γ (Soumelis V et al., 2002). Beside the cytokines and chemokines, a 
deficiency in the synthesis of antimicrobial peptides needed for innate immune 
responses against microbes was found in the keratinocytes of AD patients recently 
(Ong PY et al., 2002; Nomura I et al., 2003). T-cell-induced keratinocyte apoptosis is 
a key pathogenetic mechanism in AD. IFN-γ released from activated T cells 
upregulated Fas receptors on keratinocytes and made them susceptible to apoptosis 
(Trautmann A et al., 2000). Furthermore, the apoptotic keratinocytes release 
chemotactic factors and recruit more T cells into the epidermis, which themselves 
enhance the amounts of IFN-γ and Fas, as well as the apoptosis of keratinocytes 
(Klunker S et al., 2003). 
 
1.4.3.4.4 Eosinophils/Mast cells  
The deposition of eosinophil-derived extracellular major basic protein was found 
extensively in the skins of patients with AD (Leiferman KM et al., 1985). It had also 
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been reported that the increased levels of circulating eosinophils and eosinophil 
granule proteins were seen in AD patients and the concentration of eosinophil granule 
proteins correlated with the disease severity (Leiferman KM, 2001). Recent study 
reveled that peripheral blood eosinophils of AD patients showed a delayed 
programmed cell death (Wedi B et al., 1997) and might contributed to chronic skin 
inflammation. Another potentially important role for eosinophils in AD was the 
finding that human eosinophils could produce biologically active IL-12 (Grewe M et 
al., 1998). This IL-12 may be critical in switching the Th2 cytokines profile in acute 
lesions to a mixed Th1 and Th2 cytokines profiles in chronic lesions. 
Mast cells are increased in number in chronic lesional skins of AD patients. They 
express FcεRI which binds IgE with high affinity. Crosslinking of IgE on surface of 
mast cells induced cell degranulation and initiated the immediate-type 
hypersensitivity. In addition, mast cells release IL-4 and IL-13 that may enhance the 
Th2 cell development and IgE production. Mast cells are important target cells of 
neuropeptides (will be discussed later) and may play important roles in linking the 
immune system and nerve system. 
 
1.4.3.5 Skin Barrier and atopic dermatitis 
In addition to the immunological abnormality, recent studies showed that the 
impairment of the epidermal skin barrier also contributed to the pathogenesis of AD. 
The extent of the barrier abnormality appears to correlate with the state of dermatitis 
as well as the degree of inflammation in lesional skin (Agner T, 1992; Seidenari S & 
Giusti G, 1995; Denda M et al., 1996). Even the noninvolved skin of patients with 
AD is characterized by severe dryness and an impairment of the barrier function of 
the stratum corneum, as reflected by increased transepidermal water loss. The altered 
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lipid composition of the stratum corneum is a basic defect of AD. As compared with 
normal controls of the same age, the skins of patients with atopic epidermis displayed 
a decrease in total lipids, phospholipids, and sterol esters, as well as an increase in 
free fatty acids and sterols (Mustakallio KK et al., 1967; Barth J et al., 1989). 
Ceramides that account for up to 50 % of stratum corneum lipids by weight (Robson 
KJ et al., 1994; Schmuth M et al., 2000) were shown to serve as the major water-
retaining molecules in the epidermis and regarded critical for barrier function. A 
significant decrease in ceramides has been reported in stratum corneum of both 
lesional and nonlesional skins in patients of AD (Melnik B et al., 1988; Imokawa G et 
al., 1991; Yamamoto A et al., 1991). Reduced levels of ceramides were shown to be 
the results of increased expression of sphinogomyelin deacylase, which destroyed 
ceramides in AD (Murata Y et al., 1996; Hara J et al., 2000; Higuchi K et al., 2000). 
In addition, bacterial flora from both lesional and nonlesional skins of AD patients 
secreted more ceramidase than that from either lesional psoriasis or normal subjects 
(Ohnishi Y et al., 1999). Altogether, the abnormality of epidermal lipid may lead to 
the increase in the permeability to allergens and irritants that cause the enhancement 
of disease severity. 
 
1.4.3.6 Neuroimmunologic factors 
The finding that stress causes exacerbations of AD leads researchers to investigate the 
contribution of nervous system and its interaction with immune system. It has been 
shown that stress can alter levels of circulating lymphocyte subsets and eosinophils in 
patients with AD (Schmid-Ott G et al., 2001). The interaction between peripheral 
nerves and the immune system is mediated by different types of neuromediators 
released by cutaneous nerve fibers which activate specific receptors on target cells in 
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the skin such as keratinocytes, mast cells, Langerhans’ cells, microvascular 
endothelial cells, fibroblasts and infiltrating immune cells (Scholzen T et al., 1998). 
Neuropeptides (NPs) are neurotransmitters and neuromodulators that comprise a 
variety of peptides. NPs are found in both the central and peripheral nervous systems, 
including nerves in the skin. The most common cutaneous NPs are substance P (SP), 
calcitonin gene-related peptide (CGRP), and vasoactive intestinal peptide (VIP). 
Increased levels of nerve growth factor and SP can be found in the plasma of patients 
with AD and the levels correlate positively with the disease activity (Toyoda M et al., 
2002). In addition SP-positive nerve fibers are seen close to mast cells (Giannetti A et 
al., 1999). It was shown that skin mast cells in response to SP stimulation released 
TNF-α, histamine, prostaglandin D2 and leukotriene B4 (Furutani K et al., 1999). SP 
up-regulates the expression of ICAM-1 and VCAM-1 on human dermal 
microvascular endothelial cells (Quinlan KL et al., 1998 & 1999). This may enhance 
the recruitment of neutrophils and eosinophils into the skin. In keratinocytes, SP 
stimulates the production of proinflammatory cytokines IL-1 (Song IS et al., 2000). 
CGRP is one of the most prominent neuropeptides in the skin and is often associated 
with mast cells, Merkel cells, melanocytes, keratinocytes and Langerhans cells. It is 
capable of increasing keratinoctye proliferation and regulating cytokine production in 
human keratinocytes, and it exerts its effects predominantly on arterioles, resulting in 
vasodilatation (Brain SD & Williams TJ, 1989; Wimalawansa SJ, 1996). CGRP was 
shown to exert an inhibitory effect on the antigen-presenting capacity of LCs (Hosoi J 
et al., 1993). Increased levels of CGRP were found in AD skin and in dermal contacts 
with mast cells, and CGRP positive fibers were also increased in number (Jarvikallio 
A et al., 2003). 
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Neurofibers positive stained for VIP can also be found in close anatomic connection 
to mast cells and sweat glands (Harvima IT et al., 1993). An increase in the numbers 
of VIP-positive nerve fibers in skin lesions of patients with AD is observed (Al'abadie 
MS et al., 1995). An increased VIP levels in sera of AD patients (Umemoto N et al., 
2003) especially in the chronic lichenified lesions of AD (Anand P et al., 1991; 
Pincelli C et al., 1991; Giannetti A et al., 1992). Recently, it has been reported that 
VIP could be a Th2 cytokine (Delgado M & Ganea D, 2001). VIP mediates 
vasodilation by inducing nitric oxide synthesis (Williams TJ, 1982), keratinocyte 
proliferation and migration (Wollina U et al., 1997) and may be an important 
transmitter during neurogenic inflammation possibly by inducing histamine release 
from mast cells. 
 
1.5. Murine models of atopic dermatitis 
Experimental animal models enable the dissection of disease mechanisms. Among the 
experimental animals, mice have been studied most extensively and the mouse 
immune system is well-characterized. Mouse models have the synergistic benefits of 
genetic manipulation, easy accessibility, and the availability of immunologic reagents 
for characterization and experimental manipulation. Several mouse strains have been 
used to induce allergic responses to different allergens, including Balb/c (H-2d), 
DBA/2 (H-2d), C57BL/6 (H-2b), A/J (H-2a), SJL/J (H-2s). The Balb/c strain appears 
to be the high-responder for the development of Th2 immune responses against 
antigens (Corry DB et al., 1996; Morokata T et al., 1999a & 1999b; Wang J et al., 
2000). This strain responded to every antigen including OVA, birch pollen (Bet V), 
house dust mite (Der p), ragweed (Amb a), grass pollen (Phl p), cat (Fel d). To date, 
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animal model of AD has been successfully induced in mouse, cat and dog. The mouse 
AD model will be described in detail of the present study. 
 
1.5.1 Percutaneous sensitization mouse model 
Kondo H et al. reported the induction of Th2-dominant cytokine response through 
sensitization with mite allergens through barrier-disrupted skin (Kondo H et al., 
1998). In his model, skin barrier of Balb/c mice had disrupted by repeated application 
of adhesive cellophane tape to the shaved abdominal skin. Such manipulations disrupt 
cutaneous barrier function as demonstrated by the increased transepidermal water 
loss. Topical application of house dust mite allergens induced mRNA expression for 
IL-4 but not IL-2 and IFN-γ in the local draining lymph nodes. In parallel, IgE and 
IgG1, but not IgG2a, were up-regulated after sensitization. When sensitized mice 
were challenged with the same allergen at a distant site, eosinophils infiltration into 
the dermis had been found. These data indicated that environmental allergens could 
penetrate barrier-disrupted skin and elicit a Th2-dominant cytokine profile as is seen 
in atopic dermatitis. 
 
1.5.2 Epicutaneous sensitization (EC) mouse model 
Sensitization of mouse with OVA antigen through EC exposure had been shown to 
induce a Th2-like response with high IL-4 and IgE production in Balb/c mice (Wang 
LF et al., 1996). Further study compared the EC sensitization protocol with the 
conventional intraperitoneal injection of OVA and Al(OH)3, but not intraperitoneal 
immunization with OVA alone. The IgE and IgG1 antibody responses were more 
pronounced following the EC sensitization protocol and a significant elevation of total 
serum IgE levels was elicited. Local allergic dermatitis was induced by EC 
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sensitization and characterized by thickening and inflammation of the dermis and 
epidermis and the infiltration of the dermal layer with neutrophils, eosinophils, mast 
cells, and mononuclear cells, including CD3+ and CD4+ lymphocytes. In EC 
sensitized mice, a single allergen challenge by OVA aerosol induced eosinophilia in 
bronchoalveolar lavage fluid and mice developed airway hyper-responsiveness to 
methacholine (Spergel JM et al., 1998). The roles of IL-4, IL-5, IFN-γ in the 
pathogenesis of atopic dermatitis were evaluated by using the IL-4, IL-5 and IFN-γ 
knockout mice (Spergel JM et al., 1999). Balb/c IL-4-/- mice displayed normal 
thickening of the skin layers but had a drastic reduction in eosinophils and a 
significant increase of infiltrating T cells. These findings were associated with a 
reduction in eotaxin mRNA and an increase in mRNA for the T-cell chemokines 
macrophage inflammatory protein (MIP-2), MIP-1β, and RANTES. OVA-sensitized 
skin from C57BL/6 IL-5-/- mice had no detectable eosinophils but with decreased 
epidermal and dermal thickening compared with that from wild-type mice. Sensitized 
skin from BALB/c IFN-γ-/- mice was characterized by reduced dermal thickening. The 
authors concluded that Th2 and Th1 cytokines have important roles in the 
inflammation and hypertrophy of the skin in this model. Epicutaneous sensitization of 
mice with superantigen, SEB, was recently demonstrated to induce IgE production 
and mice developed allergic skin inflammation (Laouini D et al., 2003). 
 
1.5.3 NC/Nga mice 
NC mice originate from the Japanese fancy mice (Nishiki-Zezumi) and were 
established as an inbred strain in 1955. The NC/Nga strain has been reported to have 
some biological characteristics similar to those of the DBA/s strain, such as high 
susceptibility to radiographic irradiation and high susceptibility to anaphylactic shock 
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by OVA. The skin lesions, which were clinically and histologically very similar to 
human AD, spontaneously appeared on the face, neck, ears and dorsal skin of NC/Nga 
mice when they were raised in non-sterile (conventional) environments, but not under 
specific pathogen-free conditions. Plasma total IgE level in the conventional NC/Nga 
mice was markedly elevated from 8 weeks of age, correlating well with the clinical 
skin severity of dermatitis. Immunohistochemical examination of the skin lesion 
showed increased numbers of mast cells and CD4+ T cell containing IL-4 (Matsuda H 
et al., 1997). B cells of NC/Nga mice were highly sensitive to CD40L and/or IL-4 
induced JAK3 phosphorylation and produced more IgE than that of BALB/c mice. 
Thus, it is suggested that constitutive and enhanced JAK3 phosphorylation in B cells 
by CD40L and IL-4 may be attributable to the IgE hyperproduction in NC/Nga mice 
and patients with AD (Matsumoto M et al., 1999). T cells of NC/Nga mice were 
shown to respond poorly to IL-12 due to less tyrosine-phosphorylated STAT4 
(Matsumoto M et al., 2001). Overproduction of Th2-specific chemokines TARC by 
vessal keratinocytes and MDC by dermal DCs was found in the skin lesion. TARC 
and MDC may play a significant role in recruiting Th2-type lymphocytes to the AD-
like skin lesions (Vestergaard C et al., 1999). 
 
1.5.4 Humanized severe combine immunodeficiency (SCID) Model 
Herz et al. transferred atopic peripheral blood mononuclear cells (PBMC) into SCID 
mice and assessed the contribution of epidermally applied superantigens and house 
dust mite allergens for the development of cutaneous inflammation (Herz U et al., 
1998). Repeated epidermal administration of superantigens (SEB) resulted in acute 
inflammatory responses in the epidermis paralleled by mild dermal influx of human T 
lymphocytes. A similar but weak inflammatory response was also observed when 
 47
house dust mite antigen was administered repeatedly to the skin. When superantigen 
and house dust mite allergen were applied simultaneously to the skin, however, a 
marked and profound inflammatory response was detected in the epidermis and 
dermis. The histological features of this inflammatory response were similar to that 
observed in the patients with AD. This model provides initial evidence for a 
synergistic effect of epidermal exposure to allergens and superantigens. 
 
1.5.5 Systemic Immunization  
Among the AD mouse models reported to date, only one model was induced by 
intraperitoneal injection of recombinant glutathione-S-transferase (GST) antigen with 
Al(OH)3 (Hsu CH et al., 1996). Skin histopathology is characterized by an 
inflammatory infiltrate of mononuclear cells and eosinophils in the dermis and mild 
spongiosis in the epidermis. Numerous IgE-bearing cells can be detected in the 
dermis. These changes are accompanied by markedly elevated antigen-specific IgE 
responses. 
 
1.5.6 relB-/- mice 
RelB belongs to family of Rel/NF-κB. RelB-deficient mice (relB-/-) spontaneously 
showed histopathological changes, inflammatory infiltrates and cytokine expression 
patterns in skin similar to patients with AD. Skin lesions of relB-/- mice revealed 
hyperkeratosis and marked epidermal hyperplasia. Many CD4+ T cells and 
eosinophils mixed with lesser numbers of CD8+ T cells and neutrophils were present 
in the dermis. There was a moderate increase of MHC class II-positive dermal 
dendritic cells and dermal mast cells. Increased expression of Th2 cytokines 
correlated with increased mRNA levels of eotaxin and CCR3 in relB-/- skin. The 
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dermatitis did not develop in the offspring of relB-/- mice crossed with transgenic mice 
that lack peripheral T cells, demonstrating that the skin lesions were T cell dependent 
(Barton D et al., 2000). 
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Chapter 2  
Rationale and specific aims of the study 
 
2.1 Rationale of the study 
Allergic diseases such as asthma, allergic rhinitis (AR), and atopic dermatitis (AD) 
are common health problems afflicting a large number of general populations 
worldwide. The overall prevalence of allergic diseases and morbidity related to them 
has risen progressively during the past 20 years. Approximately 20-30% of the 
general population is affected and this constitutes a major source of suffering, 
disability and loss of productivity throughout the world. In Singapore, the 12 months 
prevalence of asthma and atopic eczema was 20.9% and 7.4% respectively in children 
of older age (13-14 years old) and 18.5% and 2.8% respectively in younger age (6-7 
years old) (ISAAC steering committee, 1998, Williams H et al., 1999).  
 
Exposure to sources of indoor allergens such as dust mite, cockroaches and animal 
dander is a risk factor for allergen sensitization and the development of allergic 
disease (Gelber LE et al, 1993; Nelson RP Jr et al, 1996; Platts-Mills TAE, 1997). 
House dust mites (HDM) and cockroaches are the most common indoor allergens that 
cause the allergic disease in the tropical and subtropical countries (Leung R et al., 
1997, Chapman MD et al., 1996; Tsai JJ et al., 1998; Chew FT et al., 1999, Santos 
AB et al., 1999). The question on the IgE cross-reactivity between mite and 
cockroach allergens has not been fully addressed. In recent years, the concept of 
panallergy had been indicated by several studies but the clinical impacts of such 
phenomenon remains unclear. With regards to IgE cross-reactivity between mite and 
cockroach allergens, tropomyosin, paramyosin and glutathione-S-transferase 
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(GST).have been suggested as possible candidates for panallergens (Aalberse RC et 
al., 2001). To date the IgE cross-reactivity of mite tropomyosin and paramyosin with 
other invertebrate is well documented (van Ree R et al., 1996a; 1996b; Asturias JA et 
al., 1999; Santos AB et al., 1999). However the IgE cross-reactivity of mite GSTs, 
(group 8 mite allergens, e,g Der p8 from Der p mites) with the cockroach GSTs 
(group 5 cockroach allergens, e,g. Bla g 5 from German cockroach) and parasite 
GSTs (e.g. Sj26 from S. japonicum) is unclear. Among these GSTs, Bla g 5 has been 
documented as a major cockroach allergen that showed up to 70 % reactivity with IgE 
in asthmatic sera (Arruda LK et al., 1997). As for the mite GSTs , Der p 8 is the most 
well documented mite GST to date, however although the IgE reactivity of Der p 8 
has been examined in the temperate countries (O’Neill GM et al.,1994; Pittner G et 
al., 2004), the clinical importance of Der p 8 in the tropical and subtropical countries 
has not been assessed. To date there is no reported study on the IgE cross-reactivity 
between mite and cockroach GSTs even though it is an important question of clinical 
relevance which deserves more studies especially in the domestic environments where 
both mites and cockroaches are highly prevalent. Therefore one of the aims of this 
study aims to address some aspects of these unresolved questions and the outcomes of 
the study may provide useful information for development of more precise diagnostic 
and therapeutic reagents for mite and cockroach allergy. 
It has been suggested that the nature of the allergic disease is dictated by the site of 
exposure to allergen, with the various diseases stemming from very similar cellular 
and molecular processes (Lichtenstein LM, 1993). According to this notion, allergen 
entering the upper airways will result in rhinitis or asthma whereas allergens entering 
the eye and skin will result in conjunctivitis and allergic dermatitis, respectively.  
However recent epidemiological studies provide some evidence to conceptualize the 
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phenomenon of “atopic march” (ISAAC steering committee et al.,1998; Gustafsson D 
et al., 2000; Rhodes HL et al.,2001 & 2002; Lau S et al.,2002; Ohshima Y et al., 
2002). The atopic march is the natural history of atopic manifestations, characterized 
by atypical sequence of progression of clinical signs of atopic disease. In general, the 
clinical signs of AD predate the development of asthma and allergic rhinitis, 
suggesting that AD is an entry point for subsequent allergic disease. Although this is 
an important concept that has been well received by researchers in allergy field, there 
is insufficient systematic studies and experimental evidence to further understand the 
phenomenon. In view of this, another major aim of this study is to perform proof-of-
concept studies on the phenomenon of “atopic march” and to elucidate the mechanism 
of such allergic responses induced through skin sensitization. Given the complexicity 
of the study, a good animal experimental model that enables the dissection of disease 
origin and mechanisms, therefore the major focus of the study was to establish a 
murine allergy model using epicutaneous patching approach. Mice have been used 
extensively for the establishment of disease models mainly due to the well 
characterization of their immune system and easy handling. Mouse models permit the 
synergistic benefits of genetic manipulation, accessibility, and availability of 
immunologic reagents for characterization and experimental manipulation. 
To date, the animal studies have demonstrated that the skin is not only a covering and 
protective coat but it is also an important site for the initiation of primary allergic 
sensitization to environmental irritants or allergens. The epicutaneous patching 
approach to induce sensitization has been reported using OVA as a model antigen 
(Wang LF et al., 1996). These animal studies revealed that sensitization through skin 
induced the development of not only atopic dermatitis but also asthma (Spergel et al., 
1998) and food allergy (Hsieh KY et al., 2003). In most of the murine allergy models, 
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OVA has been commonly used as a model sensitization antigen although it is not a 
relevant allergen to human and two studies demonstrated that OVA and mite allergen 
had different effect on the alveolar macrophages (Chen CL et al., 2003) and mast cells 
(Yu CK et al., 2003). In order to have a better understanding of the 
immunopathogenesis of human allergic diseases, it is necessary to use allergens that 
are clinical relevant. It is well documented that in human AD, aeroallergens, including 
house dust mite, pollen, mold, animal dander and cockroach allergens, are known as 
triggering factors of AD. The importance of dust mite allergens in the development of 
allergic disease is well document elsewhere. A recent study showed that 95% of sera 
from AD patients had IgE to house dust mite compared with 42% of asthmatic 
subjects (Scalabrin DM et al., 1999). The degree of sensitization to aeroallergens is 
directly associated with severity of AD (Schafer T et al., 1999). To date three AD 
animal models using mite allergens had been reported (Heishi M et al., 2003; 
Matsuoka H et al., 2003; Santa K et al., 2003). The major drawback of using crude 
mite extract to induce sensitization is that the subsequent studies on cellular and 
humural responses in the sensitized animals could be problematic due to multiple 
specificities induced by the mixture of antigens in the extract. In this study, 
recombinant house dust mite allergens Der p 2 and Der p 8 were used to perform 
epicutaneous sensitization in mice. Previous study had demonstrated that an allergic 
dermatitis model could be induced by intraperitoneal injection of Sj26, a glutathione 
S-transferase (GST) of Schistosoma japanicum (Hsu CH et al., 1996), whereas similar 
approach using major mite allergens was not successful. Thus it was thought that the 
parasite GST or GSTs in general may have some intrinsic properties to facilitate the 
induction of dermatitis. Der p 8, a GST homologue from Dermatophagoides 
pteronyssinus mite, was therefore chosen on the basis of this historic reason. 
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2.2 Specific aims of the study 
The specific aims of the study are: 
I. Cloning and expression of Der p 8 and characterization of its IgE reactivity 
a. Cloning , characterization and expression of Der p 8 cDNA  
b. Analysis of the human IgE reactivity to recombinant Der p 8 and its 
native counterpart in the sera of allergic patients from tropical and 
subtropical countries. 
c. Analysis the IgE cross-reactivity of Der p 8 to cockroach GST and 
parasite GST 
II. Establishment and characterization of a mouse model for allergic dermatitis / 
pulmonary inflammation using dust mite allergens by epicutaneous patching 
and to prove the concept of “ atopic march” using this model, 
a. Establishment of mouse model for allergic dermatitis using Der p 8 by 
epuicutaneous patching  
b. To assess the systemic immunological and pathophysiogical  effects of 
epicutaneous sensitization on lung tissues upon airway exposure to 
allergen 
c. Comparison of immune response induced by allergenic and 
nonallergenic protein through epicutantous patching. 




Characterization of glutathione S-transferase (GST) from dust mite, Der p 8 and 
its IgE cross-reactivity with cockroach GST 
 
3.1 Introduction 
Immunoglobulin E-mediated Type I hypersensitivity forms the basis for allergic 
diseases which affect more than 25% of the population. Exposure to sources of indoor 
allergens such as dust mite, cockroaches and animal dander is a risk factor for 
allergen sensitisation and the development of allergic disease (Gelber LE et al., 1993; 
Nelson RP Jr et al., 1996; Platts-Mills TAE et al., 1997). House dust mite has been 
recognized as a major cause of allergic disease such as asthma, allergic rhiniits and 
atopic dermatitis. Since the first cloning of the cDNA of major house dust mite 
allergen- Der p 1 from Dermatophagoides pteronyssinus (Der p) (Chua KY et al., 
1988), 19 groups of dust mite allergen have been identified (Thomas WR et al., 
2002). Sequence polymorphisms and isoforms have been reported (Lin KL et al., 
1994; Smith WA et al., 1996a; 1996b; Yuuki T et al., 1997; Thomas WR et al., 1997; 
Smith WA et al., 2001). The unique roles for the polymorphisms in T and B cell 
epitope binding have also reported (Smith WA et al., 2001; Hales BJ et al., 2002).  
 
Another risk factor associated with asthma and allergy in these regions is cockroach 
allergens (Arruda LK et al, 2001). The most commonly found domiciliary cockroach 
species are Blattella germanica (German cockroach) and Periplaneta americana 
(American cockroach), with predominance of the latter in the subtropics such as 
Taiwan tropical countries such as Brazil, Singapore and Malaysia (Chew FT et al., 
1999; Tsai JJ et al.,1998; Santos AB et al., 1999; Chapman MD et al., 1996). Several 
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allergens from both species had been cloned and IgE cross reactivity has been 
described. For example, the group 1 cockroach allergens, Bla g 1 and Per a 1, are the 
major cross reactive cockroach allergens reported (Melen E et al., 1999; Wu CH et 
al., 1998), and tropomyosin from American, Per a 7 and German cockroach, Bla g 7 
are also allergenically cross reactive (Asturias JA et al., 1999; Jeong KY et al., 2003). 
 
Recombinant allergen produced in either prokaryocyte or eukaryocyte systems 
provide a useful tool for immunologic studies, potentially for diagnosis and therapy 
for allergic disease. To date, recombinant allergens have been widely expressed in 
Escherichia coli, yeast, insects and mammalian cell systems with the resultant IgE 
reactivity being lower or similar to their native counterparts. The E. coli expression 
system is the easiest system to work with; however some of the E. coli-expressed 
recombinant allergens achieve low yield and low IgE reactivity due to reduced 
solubility and possibly due to improper protein folding. Many allergens with good 
biological activity and allergenicity have been expressed in Pichia pastoris with high 
yield (De Vouge MW et al., 1996; Smith PM et al., 1996; Vailes LD et al., 1998; Best 
EA et al., 2000; Yasuhara T et al., 2001; van Oort E et al., 2002) including the mite 
allergen Der p 1 which was difficult to express in E. coli. As compared to insect and 
mammalian cell expression systems, P. pastoris does not require complex media or 
growth conditions and has the eukaryotic post-translational modification pathway 
(Bretthauer RK et al., 1999).   
 
Among those cloned allergens, the group 8 allergen of Der p was shown to be a 
homologue of glutathione-S-transferase (GST) and reacted with IgE in 40% of sera 
from mite allergic patients (O’Neill GM et al., 1994). It has 27% sequence identity 
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with a major allergen of cockroach, Bla g 5 which binds IgE of 70% of cockroach-
allergic asthmatic patients (Arruda LK et al., 1997). In addition, Der p 8 has 33% 
sequence identity with another IgE-eliciting GST from Schistosoma japanicum (Sj26). 
The IgE cross reactivity among these GST allergens had been suggested but the 
question has not been addressed experimentally. 
 
In this study, I isolated native Der p 8 from the crude mite extract and found the 
presence of multiple isoforms. One of the isoforms was identified from lambda gt11 
Der p cDNA library. This isoform was expressed in Pichia pastoris and E. coli to 
obtain the recombinant protein. The IgE reactivity of recombinant Der p 8 was 
compared to its native counterpart by ELISA utilizing the sera from Der p mite 
sensitised subjects. In addition, I also examined the IgE cross-reactivity between Der 






3.2 Materials and Methods 
 
3.2.1 Cloning of Der p 8 gene 
The λ phage DNA was purified from the Dermatophagoides pteronyssinus λ gt11 
cDNA library (Chua KY et al., 1988) using Wizard® Lambda Preps DNA purification 
system (Promega, Madison, WI, USA). To obtain the complete coding region of the 
Der p 8 gene, polymerase chain reaction (PCR) was performed using pfu DNA 
polymerase. According to the published Der p 8 cDNA (O’Neill GM et al., 1994), 
primers were designed as 5’-GCGGATCCATGAGCCAACCAATCCTA-3’ (anti-
sense) and 5’-GCGGATCCTCAGGCATATGAAGCATT-3’ (sense). The cDNA was 
cloned into the pGEX-2T vector and nucleotide sequencing was analyzed using the 
ABI 377 DNA Sequencer (Applied Biosystems, USA).  
 
3.2.2 Expression of recombinant Der p 8 and recombinant Sj26 
Recombinant Der p 8 was expressed both in eukaryotic and prokaryotic expression 
system. Plasmid DNA of pGEX-2T-Der p 8 was purified using Wizard® plus SV 
Minipreps DNA purification system (Promega) and was used as a template for PCR 
amplification. To express the recombinant Der p 8 in yeast, Pichia pastoris expression 
system was used. The primers used for PCR amplification of Der p 8 cDNA were 5’-
GCCTCGAGAAAAGAATGAGCCAACCAATCCTA-3’ (anti-sense) and 5’-
GCGAATTCTCAGGCATATGAAGCATT-3’ (sense). The cDNA was cloned into 
the pPIC9 vector (Invitrogen Corporation, California). The pPIC9-Der p 8 construct 
was linearlized with Bgl II and transformed into the P. pastoris strain GS115 by 
lithium chloride transformation method as described in the manual of Pichia 
expression kit (version A). The colonies with His+MutS phenotype (slow growth) were 
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picked for screening of protein expression. For large-scale protein expression, a single 
colony from the positive clone was picked and inoculated into 4ml of BMGY medium 
and grew at 30°C. Twenty-four hours later the small culture was further diluted into 
two liters and cultured at 30°C with vigorous shaking (250rpm) until OD600 = 6.0.  
After that, cells were centrifuged and transferred to 400 ml of BMMY medium for 
methanol-induced expression. After 48h, the supernatant was harvested. To express 
the recombinant Der p 8 in E. coli, the pQExpress system (QIAgen) was used. The 
primers used for PCR amplification of Der p 8 cDNA were 5’-
AGCCAACCAATCCTAGGATAT-3’ (anti-sense) and 5’-
GCAGATCTGGCATATGAAGCATTCCATTA-3’ (sense). Subsequently, they were 
cloned into the pQE60 vector and further transformed into M15 host cell. The protein 
expression was induced by IPTG. The recombinant Der p 8 was purified from the E. 
coli lysate (10mM Tris, 300mM NaCl, pH 8.0) using glutathione agarose beads 
(Sigma Aldrich, Saint Louis, MO, USA). Recombinant Sj26 was obtained by passing 
the lysate of IPTG induced E. coli culture containing the pGEX-2T vector through 
glutathione agarose beads (Sigma Aldrich, Saint Louis, MO, USA) and eluted with 
10mM of reduced glutathione.  
 
 3.2.3 Purification of native Der p 8 and native Der p 2 
Dry Dermatophagoides pteronyssinus mites (Commonwealth Serum Laboratories, 
Parkville, Australia) were grounded by mortar and pestle in 10mM Tris, 300mM NaCl 
buffer in the presence of 1mM PMSF for 30 minutes on ice and further stirred 
overnight at 4°C. The crude mite extract was obtained after spinning at 14,000g for 20 
min. Native Der p 8 was affinity purified by glutathione agarose beads (Sigma). 
Native Der p 2 was also purified by affinity chromatography. Anti-Der p 2 
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monoclonal antibody C2 was coupled to cynogen bromide-activated Sepharose 4B 
(Pharmacia, Uppsala, Sweden) according to the manufacturer’s instruction. The crude 
mite extract was applied to affinity chromatography column and the unbound 
materials were washed with TBS. The column was eluted with 0.1 M glycine, 0.15 M 
NaCl, pH 2.6 and neutralized with 1 M Tris-Cl, pH 8.8. The purified native Der p 2 
was changed to PBS immediately after elution by dialysis and stored in -20°C. 
 
3.2.4 Cockroach allergens  
Crude extract of Periplaneta americana that was used for ELISA and absorption 
studies was a gift kindly provided by Dr. Wu CH from Department of Medical 
Research, Taichung Veterans General Hospital, Taichung, Taiwan. Cockroach GST 
of Periplaneta americana was affinity purified from 20 ml of whole body extract 
(1:20 w/v, Greer laboratories, Lenoir, NC) using glutathione agarose beads. To 
prevent the interference of 50% glycerine in the commercial extract, the extract was 
diluted 20 times in TBS before loading into the column. The unbound materials were 




Sera for testing IgE reactivity to Der p 8 was obtained from: (1) 55 asthmatic 
Taiwanese children (aged 7-15 years) who had undergone immunotherapy with Der p 
extract in the Allergy Clinic of the Department of Paediatrics, National Taiwan 
University Hospital, Taipei, Taiwan, (2) 20 Der p mite allergic Singaporeans (aged 
20-50 years) and (3) 17 patients with allergic asthma (aged 1-44 years) visiting the 
Asthma Clinic at the University Hospital, University of Malaysia. All the subjects 
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showed positive skin tests to Der p crude mite extract. For the negative control, sera 
from 8 cord blood samples and 2 adults showing no IgE reactivity to Der p crude mite 
extract were included. 
 
3.2.6 2D electrophoresis and Western blotting 
Isoelectric focusing was performed using 7cm-long immobilized DrySstrip™ with 
linear pH ranging from 3-10 on IPGphor™ isoelectric focusing system (Amersham 
Biosciences Corp. Piscataway, NJ) according to the manufacturer’s instruction. 
Briefly, 2µg of native Der p 8 was added to 125 µl of the rehydration solution (8M 
urea, 2% CHAPS, 20mM DTT) and loaded into the strip holder followed by placing 
the IPG strip. Gel rehydration was performed at 30 volt for 18h. Isolectric focusing 
was performed at 50mA/strip, 20°C as follows: step 1: 500 volt for 250Vhr, step 2: 
1000 volt for 500Vhr and step 3: 8000 volt for 20,000Vhr. After equilibration, the 
second dimension electrophoresis was performed using 12.5% SDS-PAGE. For 
Western blotting, proteins were transferred onto Hybond-C nitrocellulose membrane 
(Amersham Biosciences Corp.). The isoforms of Der p 8 were identified by 
polyclonal anti-Der p 8 mouse sera (generated by injecting recombinant Der p 8 into 
Balb/c mice) followed by biotinylated anti-mouse immunoglobulin (Sigma) and 
ExtrAvidin-Peroxidase® (Sigma). The result was developed using the SuperSignal 
chemiluminescence substrate (Pierce, Rockford, IL, USA).    
 
3.2.7 MALDI-TOF mass spectrometry 
MALDI-TOF mass spectrometry was performed as previously described (Ramos JD 
et al, 2003). In short, 2 ng dialyzed protein was digested overnight at 37°C with 20 µl 
of tryptic digestion buffer (0.02 mg/ml trypsin in 25 mM ammonium bicarbonate, pH 
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8.5) and was then passed through a C18 ZipTip (Millipore, MA, USA). One 
microliter of trypsin-digested sample was loaded onto MALDI-TOF sample plate 
along with 1 µl of matrix solution (10mg/ml a-cyano-4-hydroxycinnamic acid, 0.1% 
TFA, 50% acetonitrile). The sample was allowed to dry under ambient conditions. 
Mass analysis was carried out using the PerSeptive Biosystems Voyager-DE STR 
MALDI-TOF mass spectrometer (Framingham, MA, USA). Peptide mapping was 
performed by comparison with the deduced amino acid sequence of the Der p 8 
cDNA gene. 
 
3.2.8 Determination of antigen specific IgE by ELISA   
Costar high binding plates (Costar, Cambridge, USA) were coated with 50 µl of rDer 
p 8 (5µg/ml), Sj26 (5µg/ml), nDer p 8 (2µg/ml), nDer p 2 (2µg/ml) or cockroach 
extract (50µg/ml) diluted in coating buffer (0.1 M NaHCO3, pH 8.2). After overnight 
incubation at 4°C, plates were washed three times and blocked with 1% BSA-PBS 
buffer for 2h at room temperature. Serum samples diluting in blocking buffer were 
added into the plates and further incubated at 4°C overnight. After 3 washes, 50 µl of 
biotinylated anti-human IgE mAb (250ng/ml) (Southern Biotech, Birmingham, AL) 
diluted in 1% BSA-PBS/0.05% Tweev-20 was added for 1h. After another 3 washes, 
ExtrAvidin-alkaline phosphatase (Sigma, St Louis)(1:2000) was then added and 
incubated for 1h at room temperature. The colour reaction was developed with the 
addition of phosphatase substrate p-nitrophenyl phosphate, Disodium (Sigma, St 
Louis) after further 3 washes. Plates were read in a microplate autoreader at 
wavelength of 405 nm. For quantification purpose, internal standard was included in 
each plate by coating the wells with anti-human IgE (Pharmingen) and adding the 2 
times serial diluted partial purified human myeloma IgE (Chemicon, Temecula, CA) 
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instead of adding human sera. Readings of absorbance were referenced to these 
standards to get the relative concentration of Der p 8-specific IgE.  
 
3.2.9 Inhibition study 
Inhibition study was performed using ELISA. Diluted sera were incubated with 100 
µg/ml, 1 µg/ml or 0 µg/ml of cockroach extract or 1 µg/ml of GST of Periplaneta 
americana for 12-16 hours before adding to the nDer p8 coated plates. ELISA was 
performed as described above. The percentage of inhibition was calculated as (1-
OD405nm with inhibitor/OD405nm without inhibitor)×100. 
 
3.2.10 Statistic analysis 
Student’s t-Test was used to compare the IgE titer between native and recombinant 





3.3.1 Sequence analysis of cDNA clone coding for Der p 8 
An isoform of Der p 8 cDNA was identified from the Dermatophagoides 
pteronyssinus cDNA lambda gt11 expression library by PCR amplification. In 
comparison with the nucleotide sequence of the previously published clone (O’Neill 
GM et al., 1994), eleven nucleotide differences were found. These nucleotide changes 
resulted in six polymorphic amino acid residues located at positions 46(E→Q), 
106(E→K), 149(I→V), 160(N→Y), 167(H→R) and 184 (R→K) (Fig 3.1). The six 
polymorphic residues contributed to the change of theoretical isoelectric point from 
6.3 to 8.5. The calculated molecular weight was 25704.69 daltons. This isoform 
showed 26% and 35% sequence identity to Bla g 5 and Sj26 (Fig 3.2)  
 
3.3.2 SDS-PAGE analysis of native and recombinant Der p 8  
Recombinant Der p 8 was produced in both eukaryotic, Pichia pastoris and 
prokaryotic, E. coli, expression system. In this yeast expression system, twenty-four 
hours after the methanol induction, significant amounts of Der p 8 protein could be 
detected in the culture supernatant and continued increase in protein production was 
observed for up to 72 hours (Fig 3.3A). The yeast expressed recombinant Der p 8 
(yrDer p 8) showed three bands when the protein was analysed by SDS-PAGE (as 
indicated by arrow). These three bands were further analysed by N-terminal amino 
acid sequencing and the data demonstrated that they have identical sequences starting 
from the first amino acid methylene of the deduced sequence from cDNA.  Native 
Der p 8 (nDer p 8) was obtained from the crude mite extract by affinity purification 
using glutathione agarose beads. The yield of native Der p 8 was 0.1 milligram per 
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gram of dry mites. The nDer p 8 showed a single band on SDS-PAGE, which had the 
mobility similar to the lower band of the yrDer p 8. In contrast, the E.coli expressed 
recombinant Der p 8 (erDer p 8) moved faster than nDer p 8 on SDS-PAGE (Fig 
3.3B).  
 
3.3.3 Presence of isoforms in native Der p 8 
A number of GST isoenzymes from the crude mite extract had been isolated by 
glutathione affinity purification. To determine whether all mite GSTs were related to 
Der p 8 and evaluate the number of isoforms existing, two-dimensional 
electrophoresis was performed. The results showed that there were at least 8 isoforms 
in the native protein that could be recognized by anti-Der p 8 mouse sera that had 
been generated by immunizing mice with the recombinant Der p 8 (Fig 3.4). The 
isoelectric points (pI) of these Der p 8 isoforms ranged from 5 to 10. There was an 
isoform at the isoelectric point similar to that of the recombinant Der p 8 described in 
this paper (as indicated by arrow). The native protein was further analysed by 
MALDI-TOF mass spectrometry. Four tryptic peptides from the native protein were 
found to match with the amino acid sequences deduced from the cDNA clone. A total 
of 44 amino acids were identified from the four peptides with sequences from 34-44, 
71-83, 170-183 and 189-194 (Fig 3.1). The results confirmed that the native GST 
proteins purified from crude mite extract by glutathione affinity purification indeed 
were Der p 8 allergens. 
 
3.3.4 Comparison of IgE reactivity to recombinant Der p 8 and native Der p 8 
The IgE reactivity to the recombinant and native Der p 8 was determined by ELISA. 
Among the 55 Taiwanese sera tested, IgE reactivity to nDer p 8, yrDer p 8, erDer p 8 
 65
were 96%, 84% and 55% respectively. The level of nDer p 8-specific IgE (mean: 
615.37 ng/ml) was significantly higher than that of yrDer p 8-specific IgE (mean: 
95.61 ng/ml; p<0.05). The level of erDer p 8-specifc IgE was 264.35 ng/ml (mean 
value) (Fig 3.5A). Twenty-four subjects had positive IgE to all the three forms of Der 
p 8. Five subjects showed positive IgE reactivity only to nDer p 8 and another three 
showed positive only to recombinant Der p 8 (Fig 3.5B). There was poor correlation 
between the level of nDer p 8 and yrDer p 8 specific IgE (r =0.037, p =0.788) (Fig 
3.6A), whereas the level of erDer p 8 specific IgE showed low but positive correlation 
to that of nDer p 8 specific IgE (r =0.304, p <0.05) (Fig 3.6B). In addition, two 
recombinant Der p 8 showed good correlation in IgE titer (r =0.734, p <0.01) (Fig 
3.6C). Although the tested sera showed high frequency of IgE reactivity to nDer p 8, 
the titer was much lower than that of nDer p 2-specific IgE (Fig 3.7A). However, 
there was good correlation between the level of nDer p2 and nDerp 8 specific IgE 
(r=0.602, p <0.01) (Fig 3.7B). There was also high frequency of IgE reactivity to 
nDer p 8 in the tropics, with fifteen of twenty (75%) Singaporeans and eleven of 
seventeen (65%) Malaysians having detectable IgE to nDer p 8. In addition, the two 
asthmatic patient groups, Taiwanese and Malaysian, showed no difference in the level 
of nDer p 8-specific IgE. The level was slightly lower in the mite sensitized 
Singaporean (Fig 3.8).      
 
3.3.5 Presence of IgE cross-reactivity between Der p 8 and cockroach GST 
The IgE cross-reactivity between mite GST and cockroach GST was next examined. 
The American cockroach GST was chosen in these experiments as this species of 
cockroach is predominant in the tropics and subtropics and a high level sensitization 
in allergic subjects has been observed.   Firstly, sera of positive IgE to Der p 8 were 
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selected and tested for the IgE reactivity to extract of Periplaneta americana. 68% 
and 85% of selected sera from Taiwan (n=22) and Singapore (n=7) respectively 
showed positive IgE to cockroach extract, however, the titers of cockroach specific 
IgE were much lower than that of nDer p 8 specific IgE (Fig 3.9A). Six sera showing 
positive IgE to both cockroach extract and nDer p 8 were then selected for inhibition 
studies. Sera preabsorbed with 100 µg/ml cockroach extract inhibited 16-68% of IgE 
reactivity to nDer p 8 in five of the test sera (Fig 3.9B). One serum showed almost no 
inhibition. The results indicated that the presence of cross-reactive IgE specific to Der 
p 8 and crude cockroach allergen extract. Subsequently, GST of Periplaneta 
americana was purified from the whole body extract (Fig 3.9C) for inhibition studies. 
Because of the limited amount of purified cockroach GST obtained, only one subject 
showing high cross-reactive IgE to cockroach extract was selected for inhibition 
study. Data showed that cockroach GST inhibited 47% of IgE reactivity to nDer p 8 
(Fig 3.9D). 
 
3.3.6 Comparison of IgE reactivity to erDer p 8 and Sj26 
GST of Schistosoma spp. was demonstrated to be another GST that could elicit IgE in 
human. Therefore IgE reactivity to Sj26 was also included in this study. The results 
showed that only 11 (20%) subjects had IgE to Sj26 protein and the titer was very low 
as compared to that of erDer p 8. In addition, there was no significant correlation of 
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(1): sequence of Der P8 published by O’Neill GM (pI 6.3) 
(2): sequence of Der p8 cloned from the Der p library (pI 8.5)  
 
 
Figure 3.1: Nucleotides and amino acid sequences alignment of two Der p 8 
isoforms. Sequence (1) is the original published sequence. Sequence (2) is the clone I 
have isolated in this study. Four tryptic peptides of native protein that match with the 












Der p 8         -MSQPILGYWDIRGYAQPIRLLLTYSGVDFVDKRYQIGPAPDFDRSQWLNEKFNLGLDFP 59 
Sj26            -MS-PILGYWKIKGLVQPTRLLLEYLEEKYEEHLYERD-----EGDKWRNKKFELGLEFP 53 
Bla g 5         MAPSYKLTYCPVKALGEPIRFLLSYGEKDFEDYRFQEG--------DWPN--LKPSMPFG 50 
                  .   * *  ::.  :* *:** *   .: :  :: .        .* *  :: .: *  
 
Der p 8         NLPYYIDGDMKMTQTFAILRYLGRKYKLNGSNDHEEIRISMAEQQTKDMMAAMIRVCYDA 119 
Sj26            NLPYYIDGDVKLTQSMAIIRYIADKHNMLGGCPKERAEISMLEGAVLDIRYGVSRIAYSK 113 
Bla g 5         KTPVLEIDGKQTHQSVAISRYLGKQFGLSGKDDWENLEIDMIVDTISDFRAAIANYHYDA 110 
                : *    .. :  *:.** **:. :. : *    *. .*.*      *:  .: .  *.  
 
Der p 8         N----CDKLKPDYLKSLPDCLKLMSKFVGEH-AFVAFANISYVDFYLYEYLCRVKVMVPE 174 
Sj26            D----FETLKVDFLSKLPEMLKMFEDRLCHK-TYLNGDHVTHPDFMLYDALDVVLYMDPM 168 
Bla g 5         DENSKQKKWDPLKKETIPYYTKKFDEVVKANGGYLAAGKLTWADFYFVAILDYLNHMAKE 170 
                :     .. .    ..:*   * :.. :  :  ::   :::  ** :   *  :  *    
 
Der p 8         VFGQ-FENLKKYVERMESLPRVSDYIKKQQPKTFNAPTSKWNASYA------- 219 
Sj26            CLDA-FPKLVCFKKRIEAIPQIDKYLK--SSKYIAWPLQGWQATFGGGDHPPK 218 
Bla g 5         DLVANQPNLKALREKVLGLPAIKAWVAKRPPTDL------------------- 204 










Figure 3.2. Sequence alignment of dust mite GST (Der p 8), cockroach GST (Bla 
g 5) and parasite GST (Sj26). The numbers indicated the amino acid position of the 
corresponding proteins. Identical (*), conserved (:) and semi-conserved (.) residues 































Figure 3.3: SDS-PAGE analysis of recombinant and native Der p 8. (A) SDS-
PAGE showing the kinetics of P. pastoris expressed recombinant Der p 8. (B) The 
mobility of, yrDer p 8, nDer p 8 and erDer p 8 on SDS-PAGE.   
 












































Figure 3.4 Characterization of nDer p 8 by two-dimensional electrophoresis. The 
native Der p 8 was separated by 2D electrophoresis and stained with Coomassie blue 
(upper panel) or transferred to Hybond C membrane and blotted with polyclonal anti-




























     
 
Figure 3.5: Comparison of erDer p 8, yrDer p 8 and nDer p 8 specific IgE among 
the Taiwanese sera. (A) Box plot showing the relative IgE titers as determined by 
ELISA. The mean values are indicated with dash line. (B) The profiles of IgE 
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Fig 3.6. Correlation of IgE titer of recombinant Der p 8 and native Der p 8. (A) 
Correlation of yrDer p 8- and nDer p 8-specific IgE. (B) Correlation of erDer p 8- and 





























Figure 3.7: Comparison of nDer p 2 and nDer p 8 specific IgE titer in Taiwanese 
sera. (A) Box plot showing the titer of nDer p 2 and nDer p 8 specific IgE in 
Taiwanese sera (n=55). The mean values were indicated with dashed line. (B) 
Correlation of the titre of nDer p 2- and nDer p 8-specific IgE. The cutoff values 
(dashed line) were determined by the mean plus 3 fold of standard deviation of Der p 
8 or Der p2 specific IgE of control sera. In panel A and B, IgE titers were determined 
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Figure 3.8. Comparison of nDer p 8 specific IgE titer among Taiwanese, 
Malaysian and Singaporean. Box plot showing the nDer p 8 specific IgE level. The 
















































Figure 3.9: Presence of cross-reactive IgE between nDer p 8 and cockroach GST. 
(A) Correlation of the titre of nDer p 8- and cockroach extract-specific IgE. Twenty-
two nDer p 8 positive sera were selected for testing of cockroach extract-specific IgE. 
The cutoff values (dashed line) were determined by the mean plus 3 fold of standard 
deviation of cockroach extract specific IgE of control sera.  (B) Absorption assay 
showed various extent of IgE cross-reactivity between Der p 8 and cockroaches. Sera 
were pre-absorbed with 100 or 1µg/ml of cockroach extract before determining the 
titer of nDer p 8 specific IgE. (C) SDS-PAGE analysis of purified cockroach GST (M: 
molecular weight marker). (D) Inhibition of IgE reactivity to nDer p 8 by cockroach 
GST. Sera were pre-absorbed with 100 or 1µg/ml of cockroach extract or 1µg/ml 




















































































Figure 3.10. Comparison of Sj26 and nDer p 8 specific IgE titer in Taiwanese 
sera. (A) Box plot showing the relative IgE titers as determined by ELISA. The mean 
values were indicated with dashed line. (B) Correlation of the titre of nDer p 8- and 
Sj26-specific IgE. The cutoff values (dashed line) were determined by the mean plus 
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Der p 8 was cloned by O’Neill et al in 1994 and has been reported to belong to the mu 
class of the glutathione-S-transferase superfamily. Here I report the isolation of a Der 
p 8 isoform consisting of 6 polymorphic residues with a theoretical isoelectric point of 
8.5. This pI is quite different from the original clone that had a theoretical isoelectric 
point of 6.3. The presence of basic Der p 8 in mite was demonstrated by two-
dimensional electrophoresis that showed a wide distribution of pI from 5-10 for native 
Der p 8. There was indeed an isoform with a pI of 8.5 identical to the cloned Der p 8 
isoform, strongly supporting the true existence of the Der p 8 clone rather that the 
result of a technical artifact.  
 
Post-translational modification by glycosylation is the feature of yeast expression 
systems. It has been shown that Der p 1 and Der f 1 proteins expressed in P. pastoris 
are heterogenously glycosylated (Vailes LD et al., 1998; Best EA et al., 2000; 
Yasuhara T et al., 2001; van Oort E et al., 2002). This glycosylation is likely to occur 
in our expressed yrDer p 8. The yrDer p 8 showed three bands on SDS-PAGE 
analysis but showed the same N-terminal amino acid sequences indicating the 
presence different isoforms of glycosylated Der p 8. In fact, there is one putative N-
glycosylation site in the Der p 8 sequences.  
 
GST is widely distributed in nature, being found in almost all species of 
microorganisms, plants and animals (Hayes JD et al., 1995). Essentially all eukaryotic 
species appear to posses multiple isoenzymes, therefore the presence of multiple 
isoforms of Der p 8 is not unexpected. Our data showed that there are at least 8 
isoforms of Der p 8-related mite GST. The isoforms of Birch pollen allergen Bet v 1 
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(Ferreira F et al., 1996) and mite allergen Der p 2 (Hales BJ et al., 2002), which 
consist of up to10 and 8 isoforms respectively, have been extensively studied in terms 
of IgE binding and T cell responses. These studies revealed that each isoform showed 
differences not only in the extent of IgE binding activity but also in T cell activation. 
More interestingly, isoforms of Der p 2 could induce different cytokine production 
patterns in allergic subjects. As GST is a big supergene family, multiple isoenzymes 
may be present in the mite. From the study of mammalian GST, sequence identity 
between the families can be less than 30%. Therefore the sequence identity among the 
isoforms of mite GST may be varied. Further study to investigate the IgE binding to 
Der p 8 isoforms is warranted to clarify whether all mite GSTs are allergenic.  
 
In this study, 84% of mite sensitized subjects showed positive IgE activity to yrDer p 
8. This percentage was higher than the previous study by O’Neill which showed 
positive IgE reactivity in the sera of 40% of mite allergic patients and was also much 
higher than the recently reported showing that Der p 8 reacted with IgE of only 10% 
of mite allergic patients (Pittner G et al., 2004). In O’Neill’s study, the IgE reactivity 
was performed using plaque immunoassay of λ phage clones containing Der p 8 gene, 
whereas the study here used the yeast expressed recombinant Der p 8 protein. The 
eukaryotic system-expressed Der p 8 might have better protein conformation than the 
prokaryotic expressing system used by O’Neill. This was further demonstrated in our 
study showing erDer p 8 reacted with only 55% of sera IgE of mite sensitized patients 
and therefore suggested that yrDer p 8 was a better material for diagnostic purpose 
than the erDer p 8. Another reason for this might also be due to conformation 
difference of the isoforms. The six amino acid differences between the two isoforms 
might result in a change of IgE epitopes. As mentioned, different IgE reactivity to 
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different isoforms of allergens was reported (Hales BJ et al., 2002, Ferreira F et al., 
1996). The presence of multiple isoforms in native Der p 8 could explain why the 
frequency of IgE reactivity to nDer p 8 was higher than that of rDer p 8 as the rDer p 
8 used represented only one of the iosforms. The low frequency in Pittner’s study 
might be due to different patient selection. The IgE reactivity to the minor mite 
allergen Der p 5, Der p 7 and Der p 10 were 18%, 27%, 6% respectivitely in Pittner’s 
study. These percentages were much lower than data published by others showing that 
IgE reactivity to Der p 5, Der p 7, Der p 10 was above 50% (Thomas WR et al., 
2002). Although nDer p 8 showed extremely high frequency of IgE binding (96%) to 
the Taiwanese sera, it is probably not to be a major allergen as the titer of nDer p 8 
specific IgE was much lower than that of nDer p 2 specific IgE. It should be noted 
that the Taiwanese sera used in this study were of subjects that had undergone 
immunotherapy using D. pteronyssines crude mite extract. It has been suggested that 
immunotherapy could actively boost the frequency and titer of IgE to Der p 5 (Kuo IC 
et al., 2003). To determine whether the high frequency of IgE reactivity to Der p 8 is 
due to natural sensitization or boosted by immunotherapy, a panel of sera from 
allergic Singaporeans and Malaysians asthmatic patients who had never undergone 
immunotherapy were then tested. The frequency of IgE reactivity to native Der p 8 
was 65% and 75% for Singaporeans and Malaysians, respectively. The reduction in 
the frequency was expected, as Blomia tropicalis instead of Dermatophagoides 
pteronyssinus was the most important mite species in tropical countries. However, 
there was no difference in the Der p 8-specific IgE titers between immunotherapy and 
nonimmunotherapy groups. Taken together, the results confirmed that sera obtained 
from mite sensitive subjects living in tropical and subtropical countries showed high 
frequency of IgE reactivity with Der p 8 but the IgE titres were generally low.  
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Numerous allergens of mites have been cloned and sequenced, revealing different 
extents of sequence identity between allergen homologues. This sequence identity 
raises the issue of IgE cross-reactivity. In general, homologues of allergens in the 
same genus that share high amino acid sequence identity have a higher potential for 
IgE cross-reactivity, for example, Der p 1 and Der f 1, Der p 2 and Der f 2 (Heymann 
PW et al., 1986; Lind P et al., 1988; Yasueda H et al., 1989). Lower cross-reactivity 
was demonstrated between Pyroglyphidae and Glyciphagidae, for example Der p 1 
and Blo t 1 (Cheong N et al., 2003), Der p 2, Gly d2 and Lep d 2 (Gafvelin G et al., 
2001), and Der p 5 and Blo t 5 (Kuo IC et al., 2003). There was less than 45% 
sequence identity between members of each group. In addition, the concept of 
panallergy that involved arthropods and other invertebrates had been discussed 
extensively, highly conserved proteins such as tropomyosin and paramyosin of 
shrimp, snail, cockroach and schistosomes, have been found to be allergenic (Panzani 
RC et al., 2001). Patients infected with S. mansoni and O. volvulus produced cross-
reactive IgE antibody to paramyosin (Steel C et al., 1990). The IgE cross-reactivity of 
mite tropomyosin with other invertebrate was especially well documented (Santos AB 
et al., 1999; Asturias JA et al., 1999; van Ree R et al., 1996a; 1996b). IgE cross 
reactivity to GST from different organisms including mites had been postulated by 
Aalberse and colleages (Aalberse RC et al., 2001), but there was no experimental 
evidence to support such notion. The high frequency of IgE reactivity to Der p 8 
shown by the allergic sera tested prompted us to examine the possiblility of IgE cross-
reactivity between GSTs from mite and cockroach. This study was rationalized by the 
observation that mites and cockroaches are the most important source of indoor 
allergens associated with asthma in these regions (Chew FT et al., 1999; Tsai JJ et al., 
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1998; Lin YC et al., 2002). Our results showed moderate cross-reactivity between Der 
p 8 and American cockroach, to both the crude extract and purified American 
cockroach GST. Six sera preabsorbed with 100 µg/ml cockroach extract inhibited 16-
68% of IgE reactivity to nDer p 8 in five of the test sera (Fig 3.3B) and one serum 
showed almost no inhibition suggesting that not all IgE to Der p 8 were cross reactive 
to its homologue in cockroach. More sera need to be tested to further understand the 
extent of IgE cross reactive between mite and cockroach GST. It has previously been 
suggested that P. americana extracts could not inhibit IgE antibody binding to Bla g 5 
using RIA assay, suggesting that there was no significant IgE cross-reactivity between 
GSTs from these two species (Arruda LK et al., 1997). Our data revealed that GST(s) 
in American cockroach is/are allergenic. Therefore the question of IgE cross-
reactivity between cockroach GSTs should be readdressed by using purified native 
GSTs from both species and recombinant Bla g 5. More quantitative information 
including the relative affinity of such IgE cross reactivity may help to throw some 
light in verification of the clinical impacts of such cross-reactive IgE. 
 
GST of Schistosoma spp. was demonstrated to be another GST that could elicit IgE in 
human. However, our data showed poor correlation of IgE titers between Sj26 and 
erDer p 8, interestingly, the sera that showed high IgE titer to Der p 8 tended to have 
lower IgE titer to Sj26 (Fig 3.10). Others have also reported inverse correlation 
between allergen specific IgE/atopy and helminth infection (Araujo MI et al., 2000; 
Medeiros M Jr et al., 2004). In addition, a large panel of skin prick test performed in 
our laboratory showing that only <1% of mite sensitized patients showed positive IgE 
to Sj26 (data not shown), further indicating that the extent of IgE cross-reactivity 
between Der p 8 and Sj26, if present, would be very limited.  
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In summary, both native Der p 8, which exists in multiple isoforms, and recombinant 
Der p 8 showed a high frequency but relatively low titer of IgE binding in the dust 
mite allergic subjects studied and inclusion of Der p 8 isoforms for diagnostic and 
therapeutic purposes may be necessary. The present results have also demonstrated 
the presence of cross-reactive IgE between Der p 8 and GST in P. americana 
cockroach suggesting that the GST in mites and cockroach may be considered a 
panallergen. The unresolved question of which GST is the primary sensitizing 
allergen in an environment where both mites and cockroaches are equally prevalent 




Mite allergen induces atopic dermatitis and allergic asthma with concomitant 
neurogenic inflammation in mouse 
 
4.1 Introduction 
Atopic dermatitis (AD) is a common chronic relapsing inflammatory skin disease 
afflicting up to 10-15% of the population in industrialized countries (Rudikoff D et 
al., 1998). Both clinical and epidemiological studies indicate that AD is closely 
associated with respiratory allergies, also known as the atopic triad (atopic eczema, 
rhinitis and asthma), usually manifesting with eczema in early life followed by the 
development of respiratory allergies later on (Hanifin JM et al., 1980). The 
pathogenesis of AD is multifactorial, and genetically determined immunological 
aberrations are thought to play a central role in the pathogenesis of chronic AD. The 
mechanisms involved in disease development are not well understood. In addition, 
there is some evidence that T-cell responses to inhalant allergens such as house dust 
mite allergens and pollens or food allergens are crucial to the propagation of AD 
(Werfel T et al., 1998). Recent studies indicate that both Th2 (IL-4, IL-5, IL-13) and 
Th1 (IFN-γ) type cytokines contribute to the pathogenesis of skin inflammation in AD 
and the biphasic cytokine expression pattern is therefore proposed (Grewe M et al., 
1994; Thepen T et al., 1996; Grewe M et al.,1998; Spergel JM et al., 1999). 
 
It is known that exacerbation of AD can be provoked by stress associated and 
abnormal local expression of neuropeptides (Anand P et al., 1991). Inflammatory 
changes mediated by sensory nerves have been reported in the skin and other tissues 
(Baluk P., 1997). Increasing evidence reveals that the neuropeptides release by 
sensory nerves such as c-fibers in the skin are capable of activating specific cutaneous 
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target cells locating in close proximity to the activated nerve fibers thereby inducing a 
range of inflammatory activities (Baraniuk J et al., 1990; Ansel JC et al., 1996). For 
example, mast cell degranulation can be induced by neuropeptides such as Substance 
P (SP) from cutaneous nerve (Ebertz JM et al., 1987; Sugiura H et al., 1992; Toyoda 
M et al., 1998). In addition, it has been shown that SP can induce keratinocytes and 
mast cells to produce IL-1 and TNF- respectively (Brown J et al., 1990; Ansel JC et 
al., 1993). 
 
Given the complexity of the immunopathogenesis of AD, a good animal model of this 
disease would provide important insights into the underlying mechanisms. A murine 
model is a convenient research tool as the murine immune system is well 
characterized and the research reagents are readily available. To date several murine 
models have been reported for human AD (Hsu CH et al., 1996; Gijbels MJ et al 
1996., Matsuda H et al., 1997; Xing Z et al., 1997; Spergel JM et al., 1998; Herz U et 
al., 1998; Barton D et al., 2000), however, most of them are not induced by specific 
protein antigens, and unsuitable for the studies on disease mechanisms. There have 
been two reports on murine AD models involving the use of protein antigens (Hsu CH 
et al., 1996; Spergel JM et al., 1998). However, in these models, the protein antigens 
used are not relevant to human AD. Since numerous recent studies have suggested 
that house dust mite allergens played a direct pathophysiologic role in AD (Mudde 
GC et al., 1990; Maeda K et al., 1992; Yamada N., 1995; Jung K et al., 1997; Kimura 
M et al., 1998), the utilization of house dust mite allergen to establish a murine model 
for AD is a logical and more desirable choice. 
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4.2 Materials and Methods 
4.2.1 Mice and antigens 
6-8 weeks old female BALB/cJ mice from the Sembawang Laboratory Animals 
Center, National University of Singapore, were used in the experiments. Recombinant 
Der p 8, recombinant OVA expressed in Pichia pastoris and OVA (Sigma-Aldrich, St 
Louis, MO, USA) were used as a sensitizing antigen. 
 
4.2.2 Expression of OVA in Pichia pastoris 
cDNA of OVA was amplified from the pBR322-OVA (a gift provide by Thomas 
WR) by PCR. The primer used were 5’-
GCCTCGAGAAAAGAGGCTCCATCGGTGCAGCA-3’ (sense) and 5’-
GCTCTACATTAAGGGGAAACACATCTGC-3’ (anti-sense). The cDNA was then 
cloned into pPICZαA vector (Invitrogen). The pPICZαA-OVA construct was 
linearized with Pme I (Promega) and further transformed into P. pastoris strain KM71 
by lithium chloride transformation method as described in the manual of Pichia 
expression kit (version A). The Zeocin resistant colonies were selected for protein 
expression screening. The method for large scale OVA expression was the same as 
the Der p 8 expression as described in Chapter 3 (section 3.2.2.) 
 
4.2.3 Antibodies 
Rat and hamster monoclonal antibodies (mAbs) were used for immunofluorescence, 
FACScan analysis and magnetic cell sorting (MACS). They were anti-DEC205 
(NLDC-145, Serotec Ltd, UK), biotin-conjugated anti-CD3ε (145-2C11), anti-
CD8α (53-6.7), FITC-conjugated anti-CD4 (RM4.5), APC-conjugated IFN-γ (XMG-
2.1), PE-conjugated anti-CD4 (RM4.5), anti-CD8α (53-6.7), anti-IL-4 (BVD4-1D11), 
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IL-10 (JES5-16E3). Cy-chrome™-conjugated streptavidin, FITC-conjugated 
streptavidin, streptavidin microbeads were used in conjunction with the biotin-
conjugated antibodies for fluorescence studies and cell sorting. mAbs used in cytokine 
ELISA were rat antibodies to mouse IL-4 (BVD4-1D11), IL-5 (TRFK5), IL-10 
(JES052A5) (R&D), IL-13 (38213) (R&D), IFN-γ (R4-6A2) and biotin-conjugated rat 
antibodies to mouse IL-4 (BVD6-24G2), IL-5 (TRFK4), IFN-γ (XMG1.2). 
Biotinylated polyclonal Abs, IL-10 and IL-13 (both from R&D systems, Minneapolis, 
MN, USA) were used as detection antibodies in ELISA. Recombinant mouse IL-4, 
IL-5, IL-10 (R&D systems), IL-13 (R&D systems) and IFN-γ were used as standards 
in sandwich ELISA. For the detection of antigen specific immunoglobulins in mouse 
sera, the rat antibodies to mouse Igκ light chain (187.1) and biotin-conjugated rat 
antibodies to mouse IgG1 (LO-MG1-2, Serotec), IgG2a (LO-MG2a-7, Serotec), IgE 
(LO-ME-3, Serotec) were used. Rat antibody to mouse IgE (R35-72) and biotin-
conjugated rat antibody to mouse IgE (R35-118) were used to detect the amount of 
total IgE in mouse sera. The purified mouse IgG1 (107.3), IgG2a (G155-178) and IgE 
(IgE-3) were used as standard in sandwich ELISA. Rabbit polyclonal anti-substance P 
and anti-calcitonin gene related peptides (CGRP) were purchased from DiaSorin Inc 
(Stillwater, MN). For stimulation of T cell in vitro, low endotoxin and azide free rat 
anti-mouse CD3ε (145-2C11) and CD28 (37.51) mAbs were used. All mAbs and 
reagents were purchased from PharMingen (San Diago, CA) unless specified 
otherwise. 
 
4.2.4 Mice sensitization and challenge protocols  
Epicutaneous sensitization of mice was performed as described by Wang et al (Wang 
LF et al., 1996) and Spergel et al. (Spergel JM et al., 1998). Briefly, 50µg or 100µg 
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of Der p 8 or OVA in 100µl of PBS or PBS alone was applied to 1cm2 gauze, which 
was patched to the skin with a transparent dressing (Smith Nephew) and further 
secured with an elastic bandage (3M). The patch was applied for 4 days and then 
removed. 17 days later, an identical patching was repeated at the same site. This 
procedure was repeated twice over a period of 50 days. To investigate the airway 
inflammation and airway hyperresponsiveness, patched mice were challenged with 10 
µg of Der p 8 intratracheally at day 49. To test the antibodies production in some 
cases, mice received another patch at day 63. Two weeks after the fourth patching, 
mice were further challenged by inhalation with 1mg of Der p 8 for 6 times with 2 
days intervals. Inhalation challenge was performed by generating the Der p 8 aerosol 
by an ultrasonic nebulizer (model Uterine 99, DeVilbiss Health Care, Sommerset, PA) 
with 0.1 mg/ml of Der p 8 in PBS. The mice were kept unrestrained in a desiccator 
chamber with continues flow of aerosol for 30 minutes. Sera were collected weekly 
during the whole experimental procedure. 
 
4.2.5 Detection of antigen specific mouse immunoglobulin responses 
The amounts of antigen specific IgE, IgG1, and IgG2a were determined by ELISA. 
OVA or Der p 8 was diluted in 0.1 M NaHCO3, pH 8.2 to a concentration of 5 µg/ml. 
Costar high binding 96-well ELISA plates were coated with 50µl of the protein 
solution at 4°C for overnight. After washing, plates were blocked with 1% BSA in 
PBS containing 0.05% Tween-20 at room temperature for 2 hours. Sera were added 
and incubated for overnight at 4°C. Plates were washed and incubated with biotin-
conjugated monoclonal rat anti-mouse IgE, IgG1 or IgG2a for 1 hour, followed by 
addition of ExtrAvidin-alkaline phophatase. Signal was developed by addition of p-
Nitrophenylphosphate substrate and the optical density was measured at OD405nm. 
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ELISA unit was defined as the OD405nm reading corresponding to the signal generated 
with 1 ng/ml of IgE, IgG1, or IgG2a in a sandwich ELISA reacting with anti-mouse 
Igκ as the capture antibody in the same plate. 
 
4.2.6 Preparation of single cell suspension 
Spleens or lymph nodes were removed from mice and placed in Petri dishes in the 
presence of 10 ml of 1× Hanks balanced salt solution (HBSS) (Sigma). Single cell 
suspension was made by disrupting the tissues using two frosted-slides. Red blood 
cells were lyses by adding 1 ml of RBC lysis buffer (10mM Tris, 0.83% NH4Cl, 
pH8.2-8.4) for 90 seconds. The cells were then washed three times with 1XHBSS and 
cell number was determined using hematocytometer. The cells were resuspended in 
complete RPMI-1640 medium (as described below) for further use. 
 
4.2.7 Short-term T cell culture in vitro 
Cells were cultured with RPMI-1640 supplemented with 10% heat-inactivated bovine 
calf serum (StemCell Technologles, Vancouver, BC, Canada), 2mM L-glutamine, 
antibiotics (100U/ml penicillin and 100µg/ml streptomycin), 1mM sodium pyruvate 
(Hyclone Laboratories, Logan, UT), and 5.5×10-2 mM 2-mercaptoethanol (Life 
technology, Grand Island, NY). The splenocytes were cultured in 24-well (4×106 
cell/well) or 6-well (2×107 cell/well) plates in the presence of Der p 8 (10 µg/ml) for 
10 days. Recombinant mouse IL-2 (Pharmingen) was added to the cultured cells on 
day 3 and day 6 to a final concentration of 10 U/ml. To determine the cytokine 
production in the freshly isolated splenocytes, 100 µl of splenocytes (4×106 cells/ml) 
were added into the 96-well U bottom plate (Nunc, Roskilde, Denmark) followed by 
100µl of Der p 8 (20 µg/ml) diluted in culture medium. To determine the cytokine 
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production from the short-termed cultured T cells, 50 µl of T cells (2×106 cells/ml) 
collected after the Ficoll-Paque centrifugation and 50 µl of antigen presenting cells 
(6×106 cells/ml) were added into the 96-well U bottom plate followed by 100µl of 
Der p 8 (20 µg/ml). 
 
4.2.8 Preparation of antigen presenting cells  
Mitomycin C treated splenocytes of naïve mice were used as antigen presenting cells. 
Mitomycin C (Roche Diagnostics GmbH, Mannheim, Germany) was dissolved in 
PBS at a concentration of (0.5mg/ml). Splenocytes were washed twice with 1×HBSS 
and suspended in PBS to a concentration of 5×107 cells/ml. Mitomycin C was added 
to a final concentration of 50µg/ml and the tube was wrap with aluminum foil. The 
tube was incubated in 37°C water bath for 20min. After that, cells were washed 3 
times with large volume of 1×HBSS and suspended in RPMI-1640 medium. 
 
4.2.9 Separation of dead cells from short-term cultured splenocytes by Ficoll-
Paque centrifugation  
Ten days after the primary cell culture with antigen, the cells were collected and 
suspended in 5 ml of 1×HBSS. This cell suspension was transferred to a 15 ml tube. 
Three milliliters of Ficoll-Paque (Amersham Biosciences Corp. Piscataway, NJ) was 
added carefully to the bottom of the tube without disturbing the interface of two 
layers. The cells were then centrifuged for 20 min at 800×g. After that, live cells were 
collected from the interface, washed 3 times with 1×HBSS and suspended in culture 
medium. 
 
4.2.10 Measurement of cell proliferation by [3H]-Thymidine incorporation 
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4×105 cells/well of splecnocytes in 96 well U bottom plate were stimulated in the 
absence or presence of 1 or 10 µg/ml of Der p 8 for 5 days. 1µCi of [3H]-thymidine 
(NEN Life Science, Boston, MA) was added to each well for the last 18 hour. Cells 
were then harvested to a glass filter (Skatron instruments AS, Lier, Norway). After 
adding the scintillation fluid (Amersham Biosciences Corp.), incorporation of [3H]-
thymidine was measured by the liquid scintillation counter (Beckman Coulter, Inc. 
Fullerton, CA). 
 
4.2.11 Purification of CD4+ and CD8+ T cells by AutoMACS 
After removing dead cells from cultured splenocytes, pooled cells of two mice were 
separated into two parts and stained with biotinylated anti-CD4 or biotinylated anti-
CD8 mAb in staining buffer (0.5%BSA/2mM EDTA/PBS, pH7.2) for 10 mins at 4°C. 
The cells were then washed with staining buffer and streptavidin-microbeads were 
added and incubated at 4°C for another 10min. The stained cells were washed twice 
and suspended in staining buffer. Cell separation was performed using AutoMACS 
(Miltenyi Biotec GmbH, Gladbach, Germany) by running the “double positive 
selection” program. The purity of CD4+ and CD8+ T cells was checked by flow 
cytometry and both showed more than 95% pure.  
 
4.2.12 Stimulation of T cells by anti-CD3 and anti-CD28 mAbs 
Thirty microliters of rat ant-mouse CD3ε mAb at a concentration of 10 µg/ml was 
added to each well of 96- well U-bottom plate (Nunc). The plate was incubated at 
37°C for two hours. After that, each well was washed twice with 100µl of PBS. One 
hundred microliters of cell suspension (1×106 cells/ml) and 100µl of rat anti-mouse 
CD28 mAb (2 µg/ml) were added to each well. 
 91
 
4.2.13 Cytokine ELISA  
The 96-well high-binding plate (Costar) was coated with 50 µl of purified rat anti-
mouse IL-4, IL-5, IL-10, IL-13 or IFN-γ diluted in coating buffer (0.1M NaHCO3, 
pH8.2) to a concentration of 2 µg/ml and incubated at 4°C overnight. After washing 
the plate with 0.05% Tween/PBS, 100 µl of blocking buffer (1%BSA (Sigma)/PBS) 
was added to each well and incubated at room temperature for 2 hours. The plate was 
washed again. Fifty microliters of cultured supernatants were added to wells and the 
plate was incubated again at 4°C overnight. For quantification purpose, fifty 
microliters of recombinant mouse IL-4, IL-5, IL-10, IL-13 or IFN-γ prepared in two-
fold serial dilution in blocking buffer were included in each plate. The next day, plate 
was washed and fifty microliters of biotinylated anti-mouse IL-4, IL-5, IFN-γ mAbs 
(2 µg/ml) or biotinlyated anti-mouse IL-10 (400 ng/ml), IL-13 (200 ng/ml) polyclonal 
Abs diluted in blocking buffer were added to each well. The plate was incubated at 
room temperature for 1 hour followed by washing with 0.05% Tween/PBS. Fifty 
microliters of ExtraAvidin®-alkaline phosphatase (Sigma, St Louis) (1:2000) diluted 
in blocking buffer were added and incubated at room temperature for additional 1 
hour. The colour reaction was developed with the addition of 50 µl of phosphatase 
substrate p-nitrophenyl phosphate, Disodium (Sigma, St Louis). Plates were read in a 
microplate autoreader at wavelength of 405 nm.  
 
4.2.14 Intracellular staining 
The 24-well plate was coated with 200 µl/well of anti-CD3 mAb (10µg/ml) diluted in 
PBS and incubated at 37°C for 2 hours. The well was then washed twice with 1 ml 
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PBS. One mililiter of cell suspension (2×106 cells/ml) was added to each well in the 
presence of 2 µg/ml of rat anti-mouse CD28 mAb and 3µM of monensin (Sigma, St. 
Louis, MO) and cultured for 10 hours. After staining of surface marker with anti-
CD3, anti-CD4 or anti-CD8 monoclonal antibodies, cells were fixed and 
permeabilized with 0.1% saponin(Sigma) /4% paraformaldehyde (BDH Laboratory 
supplies, England) for 30 min at room temperature. After washing the cells with 0.1% 
saponin/1%BSA/PBS, the cells were further stained with anti-IL-4, IL-10 or IFN-γ 
mAbs for another 30 min. The cells were then washed twice with 0.1% 
saponin/1%BSA/PBS and resuspend in 1% paraformaldehyde/PBS. Flow cytometry 
was performed using FACScalibur (Becton Dickson Immunocytometry Systems, San 
Jose, CA) 
  
4.2.15 Histocytochemistry and Immunocytochemistry 
For histological examination, specimens were obtained from the patched skins at day 
50 after sensitization and fixed in 10% buffered neutral formalin immediately. The 
fixed tissues underwent automatic tissue processing procedure using Citadel™ Tissue 
Processor (Shandon Lipshaw, Pittsburgh, PA). The program was set as following: 1.5 
hr in 70% ethanol, 1.5 hr in 75 % ethanol, 1.5 hr in 95% ethanol I, 1.5 hr in 95% 
ethanol II, 1.5 hr in absolute ethanol I, 1.5 hr in absolute ethanol II, 1.5 hr in absolute 
ethanol III, 1.5 hr in xylene I, 1 hr in xylene II, 1 hr in xylene III, 1hr in paraffin I, 1 
hr in paraffin II. After embedding in the paraffin, sections of 4µm were prepared 
using microtone (Leica Microsystems, Wetzlar, Germany) and stained with Harris 
hematoxylin and eosin. Mast cells were stained with toluidine blue or chloroacetate 
esterase. For immunofluorescence staining, the skins obtained from the patched area 
were embedded in Tissue-Teck O.C.T. compound, snap-frozen in liquid nitrogen and 
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10µm sections were prepared. The sections were fixed with ice-cold acetone for 10 
mins and were air-dried. These sections were further incubated with 5% normal 
mouse serum before the first antibodies were applied. The fluorescence was viewed 
under the Zeiss laser scanning confocal microscope. For staining of neuropeptides, 
mice were perfused with 4% paraformaldehyde, embedded in Tissue-Teck O.C.T. 
compound (Sakura Finetek U.S.A., Inc., Torrance, CA) and 20µm sections were 
prepared. Sections were stained by an avidin-biotin complex method (Vector 
Laboratories, Inc., Burlingame, CA) and counterstained by methylene green.  
 
4.2.16 Non-invasive measurement of airway responsiveness 
The airway responsiveness was assessed in conscious, unrestrained mice by the 
whole-body plethysmography (model PLY3211, Buxco Electronics Inc., Troy, New 
York, USA) as described previously (Hamelmann et al., 1997b). This system 
calculates a dimensionless parameter known as enhanced pause (Penh) reflecting the 
changes in waveform of the chamber pressure, measured with a transducer (model 
TRD5100) connecting to preamplifier modules (model MAX2270) and analyzed by 
BioSystem XA software (model SFT 1410, all from Buxco Electronics). 
Measurements were made of respiratory rate, tidal volume, pause (PEF/PIF), and 
Penh ((Te/RT-1) x PEF/PIF), where PEF = peak expiratory flow (ml/s), PIF = peak 
inspiratory flow (ml/s), Te = expiratory time, and RT = relaxation time). 
Measurements of methacholine responsiveness were obtained by exposing mice to an 
aerosol of PBS (baseline readings) and followed by cumulatively increased doses (2.5 
to 40 mg/ml) of aerosolized methacholine. The aerosol was generated by a portable 
ultrasonic nebulizer (model 5500D, DeVilbiss Health Care, Sommerset, PA) and 
drawn through the chamber for 3 minutes with the Bias Flow Supply (model 
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PLY1040). The signals were recorded for subsequent 5 minutes. The interval between 
each dose was 1 minute. This whole-body plethysmographic method for measurement 
of airway hyperresponsiveness has been validated by direct comparison with the 
conventional invasive measurement (Hamelmann et al., 1997a). 
 
4.2.17 Collection of bronchoalveolar lavage and cytospin preparation for 
differential cell counts 
Mice were anesthetized with intraperitoneal injection with a lethal dose of a mixture 
containing 1.25 mg/ml midazolam, 2.5 mg/ml fluanisone and 0.079 mg/ml fentanyl 
citrate. The trachea was cannulated by tracheotomy (20G cannula) and lung was 
lavaged with 0.8 ml of ice-cold Hank’s balanced salt solution (HBSS) without 
calcium and magnesium for four times. Cells were centrifuged at 1,200 rpm for 10 
min and resuspended in PBS with 1% BSA. Cytospin was prepared by centrifugation 
of 1 x 105 cells in 100 µl at 600 rpm for 10 minutes using Cytospin® 3 (Shandon 
Lipshaw) (Cytospin, Runcorn, Cheshire, U.K.). The cells were stained with the Liu 
stain (Liu, 1953). Cells were identified and differentiated into macrophages, 
lymphocytes, neutrophils, and eosinophils based on standard hematological 
characteristics under the light microscope. For each slide, 500 cells were counted and 
the percentage of each cell type was calculated. 
 
4.2.18 Data analysis 
All the data were represented as mean±SEM. Mast cells in the dermatitis layers were 
quantified from 20 oil-immersion files (1000×). All the results were analyzed by two-




4.3.1 Epicutaneous sensitization of Der p 8 induced specific cellular and humoral 
immune response in mice   
The immune responses to Der p 8 were evaluated after three patches of 50µg of Der p 
8. Der p 8-specific IgG1 and IgE were detected in low titer in few sensitized mice; 
however, IgG2a was not detected in all mice. Furthermore, the sensitized mice 
showed elevated level in total serum IgE (Fig 4.1A). Though some of the sensitized 
mice did not produce detectable specific antibodies to Der p 8, spleen cells from these 
mice were able to proliferate in the presence of 1 µg/ml or 10 µg/ml of Der p 8 in 
vitro (Fig 4.1B) indicating that the mice had been primed by Der p 8 protein. 
Furthermore, when the patched mice were inhalation challenged with Der p 8, 
antibodies production was significantly boosted. All the Der p 8 patched mice 
produced significant levels of Der p 8 specific IgE and IgG1 after aerosol challenge. 
A negligible amount of IgG1 and IgG2a antibodies were induced in the PBS patched 
mice after receiving 6 inhalation challenges with Der p 8 (Fig 4.2). These results 
demonstrated that mice were indeed responded to Der p 8 in vivo by epicutaneous 
patching though some of them had undetectable antibodies.  
 
4.3.2 Comparison of antibody responses between OVA and Der p 8 sensitized 
mice 
Immunization of mice with antigen through epicutaneous patching was first described 
using OVA as patching antigen, however OVA is not a clinically relevant inhalant 
allergen to human. In the present study, antibody production was compared between 
mice receiving three patchings with 100 µg OVA or Der p 8. Three out of five mice 
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and five out of five mice showed positive IgG1 antibody to Der p 8 and OVA 
respectively. The titer of Der p 8 specific IgG1 was higher than OVA specific IgG1. 
Five mice showed OVA specific IgG2a antibody however the titers were relatively 
low. Only one out of five Der p 8 sensitized mice had positive IgG2a antibody. 
Furthermore, OVA appeared to be a stronger IgE inducer than Der p 8 in mice. All the 
OVA sensitized mice produced OVA specific IgE, whereas only one Der p 8 
sensitized mouse produced specific IgE to Der p 8 (Fig 4.3).  
 
4.3.3 OVA induced mild pathological changes in the skin 
In comparison with the histology of the PBS-patched control skin (Fig 4.4A), it was 
obvious that OVA, serving as a positive control antigen in my study, could induce 
pathological changes. Fifty days after the first sensitization, a slight epidermal 
hyperplasia and mild spongiosis in the epidermis of the OVA-patched skin were 
observed. Cellular infiltration including polymorphonuclear cells and mononuclear 
cells could be observed in the dermis layer (Fig 4.4B). Extremely high number of 
eosinophils and neutrophils infiltrated into the subcutaneous layers, and these cells 
were also found in much reduced number in the dermis layer (Fig 4.4C). The number 
of mononuclear cells infiltrating the epidermis and dermis layer was significantly less 
than that observed in the Der p 8-treated skin (Fig 4.5).  
 
4.3.4 Der p 8 induced severe dermatitis  
Twenty-nine days after the first sensitization, mild cellular infiltration and 
pathological changes could be observed in Der p 8 patched skin and the 
histopathology was more prominent after three patches. Histological examination 
showed features of dermatitis with epidermal hyperplasia and spongiosis in skin 
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patched with Der p 8 (Fig. 4.5A). A significant lichenification and excoriation could 
be observed in the thickened skin (Fig. 4.5B). Eosinophilia and neutrophilia were seen 
in the dermis and subcutaneous layers (Fig. 4.5C). The most dominant cell type 
infiltrating into the epidermis and dermis layers of the affected skin was the 
mononuclear cell, and most of these were CD4+ and CD8+ T lymphocytes. In 
addition, numerous CD8+-positive dendritic cells were found at the junctions of 
dermis and epidermis of the skin (Fig. 4.6).  
 
4.3.5 Evaluation of the immune response induced by native OVA (OVA) and 
recombinant OVA (rOVA) 
It has been reported that bacteria and fungi may induce or exacerbate atopic dermatitis 
(Herz U et al., 1998; Nomura I et al., 1999; Bunikowski R et al., 2000). The Der p 8 
used in my experiment was the recombinant protein expressed in yeast expression 
system whereas the OVA used was the natural product purchased from a commercial 
company. To rule out the possibility that the prominent histopathology seen in Der p 8 
patched skin might be due to the enhancing effect of yeast component; recombinant 
OVA was produced in the Pichia expression system. This yeast expressed 
recombinant OVA (rOVA) was glycosylated and heterogeneous (Fig 4.7 Lane 1) and 
the polyclonal anti-OVA mouse sera recognized only the less glycosylated bands on 
Westernblot analysis (Fig 4.7 Lane 3). The antibody responses of native OVA 
(nOVA) and rOVA patched mice were compared and the results revealed that all mice 
produced OVA-specific IgG1 (Fig 4.8A) and IgE (Fig 4.8C). In addition, nOVA 
patched mice showed a slight higher nOVA specific IgE than rOVA patched mice 
(Fig 4.8C). The frequency and titer of antigen-specific IgG2a were similar in both 
nOVA and rOVA patched mice (Fig 4.8B). These two forms of OVA induced highly 
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similar histopathology in the patched skins (Fig 4.9). These results indicated that the 
differences in the histopathology of OVA and Der p 8 patched skins were mainly due 
to the unique characteristics of the respective patching protein , the possible 
contaiminating yeast components may not have contributed to the enhanced severity 
of the skin inflammation seen in Der p 8 patched mice. 
 
4.3.6 Th2 skewed cytokine profiles induced by epicutaneous sensitization of Der 
p 8 
 To evaluate the immune responses induced in the Der p 8 patched mice, freshly 
isolated splenocytes were stimulated with Der p 8 allergen in vitro. The supernatant 
were collected at 48 hour and 72 hour and subjected to cytokine ELISA tests. A clear 
Th2 cytokine profile was observed. As compared to the control patched mice, Der p 8 
patched mice produced significantly higher IL-4 (200±28 pg/ml vs. 28±11 pg/ml, 
p<0.001) and IL-5 (121±24 pg/ml vs. 7±8 pg/ml, p<0.001) at both time points (Fig. 
4.10). Although slight decrease in the IFN-γ production in Der p 8 patched mice was 
shown at 72 hour, the difference was insignificant. In the splenocyte cultures from 
Der p 8 patched mice, a higher production of IL-4 (200±28 pg/ml) than IFN-γ 
(125.5±11.9 pg/ml) was observed at 72 h after Der p 8 stimulation (p<0.05). 
The Th2 skewed cytokines profiles were much pronounced when the Der p 8 specific 
T cells were enriched from a short-term cultured splenocyte in vitro. The cytokine 
profiles of the enriched T cells were analyzed again after stimulation with Der p 8. T 
cells of PBS patched mice showed a negligible amount of cytokines in the cultured 
supernatant indicating that these cells were not Der p 8 specific cells, as they didn’t 
respond to Der p 8 stimulation. In contrast, the cells of Der p 8 patched mice produced 
prominent amount of IL-4 (559±83 pg/ml, 72 hour) and IL-5 (196±32 pg/ml, 72 hour) 
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upon Der p 8 stimulation. Although significant amount of IFN-γ (106±41 pg/ml, 72 
hour) was produced, the quantity was lower than IL-4 (p<0.01) (Fig. 4.11). 
 
4.3.7 Cytokines profiles of T- subsets  
The phenotype of the short-term cultured T cells was analyzed by flow cytometry.  I 
observed that there was statistically  significant increase in the ratio of CD8+/CD4+ 
cells in the Der p 8 patched mice (0.24 and 0.18 for Der p 8 and PBS patched mice 
respectively, p<0.01) (Fig 4.12). This prompted us to analyze the cytokine profiles of 
T cell subsets by intracellular cytokine staining. As shown in Fig 4.13, there were 
significant increments in the percentages of IL-4 (4.3%±2.2% vs. 0.8%±0.3%, 
p<0.01), and IFN-γ (2.4%±0.2% vs. 1.9%±0.8%, p<0.05) producing cells in the CD4+ 
subset of Der p 8 patched mice. Interestingly, similar results were shown in the CD8+ 
subset (IL-4: 1.6%±0.8% (Der p 8) vs. 0.9%±1.0% (PBS), p=0.08; IFN-γ: 
12.7%±5.1% vs. 3.6%±1.5%, p<0.01). These results were further confirmed by 
cytokine ELISA. The cultured T cells were sorted into CD4+ and CD8+ subsets by 
AutoMACS. Purified cells were stimulated by anti-CD3 and anti-CD28 mAbs. As 
compared to PBS patched mice, CD4+ T cells of Der p 8 patched mice produced 
dramatically high levels of IL-4 (25289±2730 pg/ml) as well as IL-5 (993±61 pg/ml). 
Although significant amount of IFN-γ was produced by CD4+ T cells of Der p 8 
patched mice (1217±68 pg/ml and 420±25 pg/ml for Der p 8 and PBS respectively, 
p<0.01), it was twenty-fold lower than that of IL-4 (Fig 4.14). Similar cytokine 
production profiles were also shown in the CD8+ T cells (Fig 4.15). Significant 
amount of IL-4 and IL-5 were detected from the supernatant of purified CD8+ T cells 
from Der p 8 patched mice. These amounts were much lower than that of CD4+ 
subset. It is known that CD8+ T cells are the main IFN-γ producing cells, in the 
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current study, CD8+ T cells of allergen-patched mice produced much higher IFN- γ 
than the CD4+ T cells.  
In addition to IL-4, IL-5 and IFN-γ, IL-10 and IL-13 were also examined. As 
compared to PBS patched mice, levels of IL-13 and IL-10 were increased in the 
supernatant of primary cultured splenocytes (SP), short term cultured T cells (T) and 
both CD4+ and CD8+ T cells (Fig 4.16). The intracellular staining further 
demonstrated that the percentages of IL-10 producing cells were increased in both 
CD4+ (2.5%±0.6% (Der p 8) vs. 0.6%±0.2% (PBS), p<0.01) and CD8+ (1.5%±0.6% 
(Der p 8) vs. 0.5%±0.3% (PBS), p<0.01) T cells of Der p 8 patched mice (Fig 4.17). 
 
4.3.8 A systemic type 2-immune response induced by epicutaneous sensitization 
of Der p 8 
In the mice patched with 50 µg of Der p 8, although the level of Der p 8 specific IgE 
was low, these mice showed elevated serum total IgE (Fig 4.1 & 4.2). Instead of 
stimulating the cells with Der p 8, therefore, cells from draining lymph nodes of 
patched mice were stimulated with anti-CD3 and CD28. The supernatants were 
collected for cytokine ELISA. Significant differences in the amount of IL-4 and IL-5 
were observed in the 24 hour culture supernatant. Der p 8 patched mice showed 
higher production of IL-4 (151±15 pg/ml vs.98±9 pg/ml, p<0.01) and IL-5 (87±12 
pg/ml vs. 55±9 pg/ml., p<0.05) than control mice. There was no difference in the 
amount of IFN-γ (376±100 pg/ml and 437±64 pg/ml for PBS and Der p 8 patched 
mice respectively). However, forty-eight hours after stimulation, reduced amount of 
IFN-γ production was detected in the culture supernatants of Der p 8 patched mice 
(3552±251 pg/ml vs. 5550±583 pg/ml, p<0.01). At the same time point, the amount of 
IL-4 and IL-5 remained high in Der p 8 patched mice (IL-4 [727±64 pg/ml vs. 510±44 
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pg/ml, p<0.05]) and (IL-5 [311±28 pg/ml vs.227±31 pg/ml, p=0.056]) as compared to 
the control mice (Fig. 4.18). These results indicated that patching with Der p 8 could 
somehow systemically inhibit the level of Th1 cytokine and on the other hand 
enhance the levels of Th2 cytokines. 
 
4.3.9 Epicutaneous sensitization induced airway inflammation 
EC sensitized mice were challenged with PBS or Der p 8 intratracheally. Der p 8 itself 
did not show irritant effect to the lungs as the cell counts in the BAL fluid (Fig 4.19 
A) and the Penh value (Fig 4.19B) showed no difference between the PBS patched 
mice receiving intratracheal challenge of PBS (PBS/PBS) or Der p 8 (PBS/Der p 8). 
In contrast, an allergic airway inflammation was developed in the Der p 8 patched 
mice receiving intratracheal challenge with Der p 8 (Der p 8/Der p 8). The process 
was characterized by the increased percentage of infiltrated lymphocytes (from 7% to 
22%, p<0.05), eosinophils (from 0.5% to 8%, p<0.05) and neutrophils (from 11% to 
39%) in the BAL (Fig 4.19A). In addition, the mice developed airway hyper-
reactivity upon methacholine challenge (Fig 4.19B).  
 
4.3.10 Interaction between neuropeptides and immune target cells 
The number of mast cells was investigated by staining the skin sections with toluidine 
blue. In comparison to PBS patched mice, Der p 8 patched mice showed a significant 
increment in the number of mast cells (203.7±11.4 vs. 157.4±10.5, p<0.01, n=9) and 
degranulated mast cells (37.8±5.5 vs. 11.4±2.1, p<0.01) in the dermis layer (Table I & 
Fig 4.20). The specificity of mast cells staining was further confirmed by enzymatic 
method, i.e. chloroacetate esterase staining. As shown in Fig 4.21, cells positively 
stained with toluidine blue also showed positive to chloroacetate esterase staining on 
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serial sections. The interaction between the nerves and immune systems in the 
dermatitis lesions was then investigated. The presence of neuropeptides CGRP and 
Substance P were confirmed by immunohistochemical staining of the inflamed skin in 
mice treated with Der p 8 and these were undetectable in the control mice (Fig 
4.22A). Numerous nerve fibers ramified into the dermis and appeared to be in close 
proximity with a number of granular cells that are most likely the mast cells in the 





































Figure 4.1. Total IgE and T cell responses in mice sensitized with Der p 8 by 
epicutaneous patching. (A) The kinetic profiles of total IgE. Mice were sensitized by 
patching with 50 µg of Der p 8 or PBS. Sera were collected weekly. Data was present 
as mean±SD (n=5). (B) Der p 8 specific T cell proliferative response.  Splenocytes 
from PBS or Der p 8 sensitized mice were cultured in absence or presence of 1 or 10 
µg/ml of Der p 8 for 5 days. [3H]-Thymidine was added 18 hours before harvesting. 
Stimulatory index expresses as arithmetic mean of the count per minute (cpm) of 





















































































Figure 4.2. Specific antibody responses in mice sensitized with Der p 8 by 
epicutaneous and inhalation routes. Mice were subjected to four courses of 
epicutaneous patching with 50 µg of Der p 8 (mouse 1-4) or PBS (mouse 5 & 6). Two 
weeks after the last patching all mice receive six aerosol inhalation of Der p 8 with 
two days intervals. Sera were collected weekly before (wk -1), at the day of (wk 0) 
and after (wk 1, wk2, wk3) the first aerosol challenge. Titers of Der p 8-specific IgE, 
IgG1 and IgG2a were determined by ELISA. One antibody production unit denotes 





























































































Figure 4.3. Comparison of specific antibodies response in mice epicutaneously 
sensitized with Der p 8 or OVA. Mice were epicutaneously sensitized three courses 
of 100 µg Der p 8, OVA or PBS alone. One week after the last patching, sera were 
collected for specific IgG1, IgG2a and IgE determination by ELISA. The solid line 
represents the background value of PBS patched mice. Antibody production unit was 

























































































Figure 4.4. Skin histopathology induced by OVA. Histology of PBS (A) and OVA 
(B) treated skin (magnification, 200×). (C) Higher magnification (400×) showing the 























































Figure 4.5. Skin histopathology induced by Der p 8. (A) Histology of PBS and Der 
p 8 patched skin. (B) Der p 8-patched skin showing hyperplasia, spongiosis (single 
arrow) and lichenification (double arrow). (C) Der p 8 patched skin showing the 
infiltration of mononuclear cells, eosinophils and neutrophils. (D) Histology of PBS 















































Figure 4.6. Der p 8 sensitization induced infiltration of T cells and dendritic cells. 
Skin sections were stained with FITC labeled α-CD3, PE labeled α-CD4, PE labeled 
α-CD8 and biotinylated α-DEC205 plus Streptavidin PE as indicated. The green color 
indicated CD3+ or DEC205+ cells. The single positive CD4+ or CD8+ cells are 
indicated by red color. The double positive cells are indicated by orange to yellow 
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Figure 4.7. Expression of recombinant OVA in Pichia pastoris. Recombinant OVA 
was resolved on Comassie blue stained SDS-PAGE gel (lane 1). Western blot analysis 
of recombinant OVA (lane 3) and native OVA (native 4) was performed using anti-
OVA sera. Lane 2 represents the BioRad low range marker. 
 







































Figure 4.8. Comparison of specific antibody responses in mice sensitized with 
recombinant OVA or native OVA by epicutaneous route. Mice were patched 3 
courses of 100µg of recombinant OVA (rOVA), native OVA (OVA) or PBS alone. 
One week after the last patch, sera were collected and determined for specific titers of 
IgG1 (A), IgG2a (B) and IgE (C) by ELISA. The solid line represents the background 
value of PBS patched mice.One antibody production unit denotes one nanogram of 


































































































Figure 4.9. Skin histopathological features in mice sensitized with recombinant 
OVA or native OVA by epicutaneous route. Skin sections of rOVA-treated (left) 










































Figure 4.10. Production of Th2-skewed cytokines by splenocytes in mice 
sensitized with Der p 8 by epicutaneous route. Splenocytes of PBS and Der p 8 
patched mice were stimulated with 10 µg/ml Der p 8. Forty-eight and seventy-two 
hours later, culture supernatants were collected and analyzed for IL-4, IL-5 and IFN-γ 






























































































Figure 4.11. Production of Th2-skewed by cultured T cells of Der p 8 patched 
mice. Splenocytes of PBS and Der p 8 patched mice were stimulated with Der p 8 for 
10 days in vitro. Viable cells were restimulated with Der p 8 in the presence of 
antigen presenting cells for 48 or 72 hours. Culture supernatants were collected and 






















































































Figure 4.12. Increment of CD8+ T cells in the cultured T cells of Der p 8 patched 
mice. Splencytes of PBS and Der p 8 patched mice were stimulated with Der p 8 in 
vitro for 10 days. Dead cells were removed by Ficoll-Paque centrifugation. Viable 
cells were stained with anti-CD3, anti-CD4 and anti-CD8 mAbs. CD4+ and CD8+ T 
cell subsets were analyzed by flow cytometry. The CD8+/CD4+ ratio expresses the 
percentage of CD8+ T cells over the percentage of CD4+ T cells. The solid line 































































Figure 4.13. Intracellular cytokine staining of CD4+ and CD8+ T cells subsets. 
Splenocytes of PBS and Der p 8 patched mice were stimulated in vitro with Der p 8 
for 10 days. Viable cells were then stimulated with anti-CD3 and anti-CD28 in the 
presence of monensin for 10 hours. T cells subsets expressing IL-4 and IFN-g were 
analyzed by flow cytometry. Mean percentages (n=12) of CD3+CD4+ or CD3+CD8+ 

























































Figure 4.14. Cytokine production by CD4+ T cells. Splenocytes of PBS and Der p 8 
patched mice were stimulated in vitro with Der p 8 for 10 days. CD4+ T cells were 
sorted by AutoMACS and were stimulated with anti-CD3 and anti-CD28 mAbs for 24 
hours. Culture supernatants were collected for IL-4, IL-5 and IFN-γ analysis. The 

























































































Figure 4.15. Cytokine production by CD8+ T cells. Splenocytes of PBS and Der p 8 
patched mice were stimulated in vitro with Der p 8 for 10 days. CD8+ T cells were 
sorted by AutoMACS and were stimulated with anti-CD3 and anti-CD28 mAbs for 24 
hours. Culture supernatants were collected for IL-4, IL-5 and IFN-γ analysis. The 






































































































Figure 4.16. Production of IL-10 and IL-13 in Der p 8 patched mice. Splenocytes 
of PBS and Der p 8 patched mice were stimulated with Der p 8 for 3 days and the 
culture supernatants (SP) were assayed for IL-13 (A) and IL-10 (C). Viable secondary 
bulk T cells from 10-day splenocyte culture were re-stimulated with Der p 8 in the 
presence of APC for 72 hours and the culture supernatants (T) were assayed for IL-13 
(A) and IL-10 (C). AutoMACS sorted CD4+ and CD8+ T cells from 10-day 
splenocyte culture were re-stimulated with anti-CD3 and anti-CD28 mAbs for 24 
hours and the culture supernatants were assayed for IL-13 (B) and IL-10 (D). Data are 





























































































Figure 4.17. Intracellular IL-10 staining CD4+ and CD8+ T cell subsets. 
Splenocytes of PBS and Der p 8 patched mice were stimulated in vitro with Der p 8 
for 10 days. Viable cells were then stimulated with anti-CD3 and anti-CD28 in the 
presence of monensin for 10 hours. T cells subsets expressing IL-10 were analyzed by 
flow cytometry. Mean percentages of CD3+CD4+ or CD3+CD8+ subsets expressing 
IL-10 are shown (n=12). double positive cells. Data was presented as the mean value 





















































Figure 4.18. Systemic enhancement of Th2 cytokines in mice sensitized with Der 
p 8 by epicutaneous route. Freshly prepared viable lymph node cells from PBS and 
Der p 8 patched mice were stimulated with anti-CD3 and anti-CD28 mAbs for 24 h or 
48 h. Culture supernatants were collected and analyzed for IL-4, IL-5 and IFN-γ 


























































































Figure 4.19. Induction of airway inflammation and hyperresponsiveness in Der p 
8 patched mice after intratracheal challenge with Der p 8. Patched mice were 
challenged intratrachelly with PBS or Der p 8 at day 49. (A) Differential cell counts in 
the BAL fluid.  BAL fluid was obtained 48 hours after challenge. The percentages of 
BAL cell types were derived from the number of each cell type over 500 cells 
examined at 1000X magnification. Results are expressed as mean±SEM (n=4). (B) 

























































Table 4.1. Quantification of the mast cells of the Der p 8 and PBS sensitized skin sites 





Mean values are cells from 20 HPFs (±SEM). Each group consists of 9 mice. 
 
 Dermis Subcutaneous 
 Intact Degranulated Intact Degranulated
 


























































Figure 4.20. Histocytochemical staining of mast cells (I). Toluidine blue staining of 
mast cells in PBS and Der p 8 patched skin (A) and degranulated mast cells (indicated 
by arrow) in Der p 8 patched skin (B).  
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Figure 4.21. Histocytochemical staining of mast cells (II). Serial sections were 
stained with toluidine blue or for chloroacetate esterase. All toluidine blue-stained 
cells (left panel) showed positive staining for chloroacetate esterase (right panel) as 





















































Figure 4.22. Immunohistochemical staining of neuropeptides. (A) The presence of 
immunoreactive nerve fibers ramified from the dermis to the epidermis of the skin of 
Der p 8 sensitized mice. (B) Numerous granular cells (probably mast cells) were seen 
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This study demonstrates that localized epicutaneous patching of the skin with a house 
dust allergen can induce local and systemic allergic sensitization in mice. Der p 8 
sensitization resulted in histopathological changes in the patched skin and 
subsequently developed airway inflammation, with characteristic features similar to 
those of atopic dermatitis and allergic asthma in humans. Furthermore, this model 
underscores the pivotal role of Th2-polarised immunity in cutaneous and airway 
allergic inflammation. 
 
The Der p 8-induced murine AD model has several features that resemble human AD, 
such as epidermal hyperplasia and lichenification, and the presence of severe 
spongiosis and intracellular edema in the epidermis and dermis of the inflamed skin. 
Also, numerous eosinophils and neutrophils were found in the dermis and a small 
number of eosinophils migrated into the epidermis. For comparison, epicutaneous 
sensitization was also performed with OVA antigen and the pathology of the inflamed 
skin was similarly investigated. There were significant differences in the skin 
pathology between the OVA- and Der p 8-patched mice. The OVA-patched mice 
induced much less pronounced epidermal hyperplasia and spongiosis. In addition, the 
eosinophil was the major infiltrating cell type found in the OVA patched skin. In 
contrast, the main infiltrating cell type in the dermis and epidermis of the Der p 8-
patched mice was lymphocytes, and there were substantially less infiltrating 
eosinophils. The comparison of histopathology between OVA and rOVA patched skin 
further confirmed that the prominent histopathology shown in Der p 8 patched skin 
was not due to the contamination of yeast product during the preparation of 
recombinant protein. It also implied that allergen might possess some unique feature 
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that is absent in OVA. Recently two studies demonstrated that OVA and mite allergen 
had different effect on the alveolar macrophages and mast cells. Alveolar 
macrophages stimulated with Der f mite extract, but not OVA, showed activation of 
NF-κB, up-regulation of IL-6, TNF-α, and nitric oxide. In addition, Der f-stimulated 
alveolar macrophages expressed enhanced levels of co-stimulatory B7 molecules, 
supported T cell proliferation, and Th2 cell development (Chen CL et al., 2003). 
Furthermore Der f, but not OVA, could rapidly activate mast cells in mice and the 
supernatant of Der f stimulated mast cells attained the chemo-attractant property for 
monocytes and T lymphocytes (Yu CK et al., 2003). These differential effects of 
OVA and mite allergen on immune responses may help to explain why Der p 8 
induces more prominent pathology on patched skin than OVA. This further warrants 
the need to use an allergen instead of OVA to induce allergic disease model, as the 
allergen induced animal model may show higher resemblance to human allergic 
diseases.  
 
An inflammatory T-cell infiltrate is one of the main histological characteristics of 
atopic dermatitis and increasing evidence suggests that T cells play a key role in the 
generation of AD (Herz U et al., 1998). It has also been suggested that Th2 cells and 
Th2 cytokines released play a pathological role in AD (Yamaguchi Y et al., 1991; Bos 
JD et al., 1992; Weller P., 1992; Del Prete G et al., 1993; Hamid Q et al., 1996; Akdis 
M et al., 1997). In the present study, there was heavy infiltration of mononuclear 
cells, which were predominantly T-lymphocytes, both CD4+ and CD8+ (Fig. 4.6). My 
preliminary results showed that the cultured cutaneous T cells from the inflamed skin 
produced significant levels of IL-4 and IL-10, as well as high levels of IL-5 and IL-
13. The presence of these Th2-like cytokines as well as the eosinophilia of the 
 128
inflamed skin strongly suggests that a Th2-mediated allergic inflammation has been 
elicited and has contributed directly to the pathophysiology of the affected skin.  
 
In addition to T cells, the Der p 8 patched skin showed a prominent increase in the 
number of Langerhans’ cells/dendritic cells. Langerhans’ cells (LCs) and dermal 
dendritic cells (DDCs) are potent antigen-capturing and presenting cells, and play an 
important role in the pathogenesis of AD (Leung DYM et al., 1987; Fokkens WJ et 
al., 1990). Increased numbers of LCs have been found in epidermis and dermis of 
skin biopsy from AD patients (Leung DYM et al., 1987). In addition, IgE-bearing 
LCs from AD patients are capable of stimulating specific T cell responses to house 
dust mite allergens, both in-vivo and in-vitro (Mudde GC et al., 1990). It has been 
reported that DDCs are rapidly recruited from blood into the inflamed skin. These 
DDCs could serve as an immediate source of antigen-presenting cells to CLA+ T cells 
in the inflamed skin. Although the precise role of these DDCs remains speculative, it 
is tempting to hypothesize that DDCs have a role in the development of systemic 
allergy sensitization and in the manifestation of asthma, as demonstrated in this 
murine model. 
 
Atopic dermatitis is usually associated with the developing of the allergen-specific 
IgE and/or elevated levels of total IgE. All the Der p 8 patched mice showed elevated 
total IgE even though only some of these mice had detectable Der p 8 specific IgE in 
sera but when these mice were challenged with the aerosolized Der p 8, allergen-
specific IgE was boosted and detected in all Der 8-patched mice, but not in PBS-
patched controls, a week after Der p 8 challenge. Therefore the undetectable low 
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levels of Der p 8-specific IgE in some of the mice as described earlier is probably due 
to the IgE detection limit of the ELISA system  
 
A strong Th2-skewed cytokine profile was observed in mice patched with mite 
allergen. First, reduced IFN-γ but enhanced IL-4 and IL-5 were observed systemically 
in the Der p 8 patched mice. As the T cells of Der p 8 patched mice were stimulated 
non-specifically with anti-CD3 and anti-CD28 Abs, an increased production of IL-4 
and IL-5 but a decreased level of IFN-γ production were observed (Fig 4.18). Second, 
Der p 8 specific T cells showed a strong Th2 cytokine profile. Splenocytes of Der p 8 
patched mice released significant amounts of IL-4, IL-5 and IL-13 when stimulated in 
vitro with Der p 8 (Fig 4.10 & 4.16). In contrast, low or negligible amount of IL-4 and 
IL-5 were detected in the supernatant of splenocytes in control mice (Fig 4.10). Th2-
skewed cytokine profile was further highlighted when the Der p 8 specific T cells 
were enriched after short-term cultured in vitro and these cells produced 5-fold higher 
IL-4 than IFN-γ (Fig 4.11). Third, CD4+ T cells of Der p 8 patched mice released 20-
fold higher IL-4 than IFN-γ (Fig 4.14). Interestingly, other than CD4+ T cells, a subset 
of CD8+ T cells expressing IL-4, IL-5 and IL-13 were also being induced in these 
mice (Fig 4.15 & 4.16). The induction of Th2 cytokines producing CD8+ T cells by 
patching is a novel observation that has not been reported in other animal models for 
atopic dermatitis. In human, a pathological role for CD8+ T cells in AD has been 
suggested (Ishii N et al., 1998) and the frequency of IL-4+CD8+ T cells correlated 
with the level of serum IgE in allergic patients. These CD8+ T cells also enhanced IgE 
production in vitro (Meissner N et al., 1997). Recently, it was reported that 
CD8+CLA+ T cells induced IgE production by B cells, mainly through IL-13 secretion 
(Hamid Q et al., 1996; Akdis M et al., 1997), and these T cells secreted IL-5 that 
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enhanced eosinophil survival by delaying eosinophil apoptosis (Yamaguchi Y et al., 
1991., Weller P., 1992). In addition, these CD8+ T cells responded to superantigen 
stimulation suggesting that they play an important role in pathogenesis of AD (Akdis 
M et al., 1999). The crucial role of IL-13 in the induction of Th2 response through 
epicutaneous sensitization was addressed earlier (Herrick CA et al., 2000; 2003). It 
was shown that the induction of Th2 response by inhalation or intraperitoneal 
injection of OVA was dependent on IL-4. In contrast, IL-13 but not IL-4 played an 
important role in the induction of Th2 response in mice sensitized epicutaneously with 
OVA. It is to be noted that these studies use lung inflammation as the final readout 
parameter, therefore the direct role of IL-13 in the pathogenesis of AD in the 
epicutaneous sensitized mice was not addressed, thus this observation warrants further 
investigation. The role of IL-10 in inflammatory diseases is controversial (Asadullah 
K et al., 2003). Recent study using epicutaneous sensitization with OVA on the tape-
stripped skin of IL-10-/- mice showed that skin infiltration of eosinophils and 
expression of eotaxin, IL-4 and IL-5 mRNA levels were severely diminished. On the 
other hand, they found that IL-10 produced by both DC and T cells participate in the 
process of shifting Th2 response to Th1 response (Laouini D et al., 2003). 
 
In the present study, significant amount of IFN-γ was also produced in the cultured T 
cells of Der p 8 patched mice as compared to the control mice. Intracellular cytokine 
staining showing that it was different population that producing IFN-γ and IL-4. This 
indicated that some type 1 cytokine producing cells were also induced through 
patching with allergen. In atopic dermatitis, IFN-γ producing cells were shown in 
increasing number in chronic lesion and were shown to play an important role in the 
pathogenesis of AD. For example, IFN-γ induced the apoptosis of keratinocytes from 
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the AD skin (Trautmann A et al., 2000). Apoptotic keratinocytes released chemokines 
that may recruit more T cells infiltrated into the skin (Klunker S et al., 2003). In 
addition, IFN-γ was demonstrated to play an important role in inducing the dermal 
thickening (Spergel JM et al., 1999). 
 
It is well established that degranulation of mast cells in AD skin release a number of 
products that have profound effects on the pathogenesis of atopic skin (Katayama I et 
al., 1992; Klein LM et al., 1989). Mast cell degranulation can be induced by 
neuropeptides such as substance P released by cutaneous nerves (Ebertz JM et al., 
1987). This interaction between cutaneous target cells and neuropeptides contributes 
to the neurogenic inflammation seen in AD. Der p 8 patched mice showed an increase 
in the number of mast cells and degranulated mast cells in the dermis layers of the 
inflamed skin. In addition, increased innervations of neuropeptides CGRP and 
substance P were observed in the inflamed skin and interactions between nerve fibers 
and mast cells were seen. To the best of my knowledge, this is the first animal model 
that shows the phenomenon of neurogenic inflammation associated with AD. 
Understanding these interactions can facilitate the development of more specific 
treatments for a wide range of chronic neuroinflammatory skin diseases, and the 
current animal model will serve as an excellent research tool for such studies. 
 
When exposed to allergen intratracheally, the EC sensitized mice developed allergen-
specific airway inflammation and hyper reactivity. These were characterized by the 
increased infiltrating cells including mononuclear cells, neutrophils and eosinophils. 
This shift from skin towards respiratory manifestations closely resembles the clinical 
course of atopic subjects who develop atopic dermatitis in infancy (age between 6 
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months to 1 year) and subsequently develop respiratory symptoms before the age of 
five. Sensitization to inhalant allergens occurs very early in life with the induction of 
allergen-specific cutaneous memory T cells with Th2-polarised pattern of cytokine 
production. It has been speculated that some genetically determined elements causing 
an epidermal barrier dysfunction could predispose an atopic individual to allergen 
sensitization very early in life (Ogawa H and Yoshiike T., 1993; Taieb A., 1999). The 
synergy of such epidermal barrier breakdown and other immunological abnormalities 
could lead to the propagation and enhancement of allergic inflammation associated 
with the pathogenesis of atopic dermatitis and allergic asthma. Taken together, the 
data derived from this animal model support the notion that skin is not only a target 
site for atopic disease, but it is also an important site for the initiation of primary 
allergic sensitization to environmental irritants or allergens. The present findings also 
support the notion that primary prevention of allergic diseases should start very early 
in life and the problems associated with skin permeability should be addressed for the 
high-risk atopic babies. 
 
In addition to OVA, few allergen-induced allergic dermatitis models were reported so 
far. However, in these reported studies crude extract instead of single allergen was 
used to sensitize mice. These include the use of Der p extract (Heishi M et al., 2003), 
Der f extract (Matsuoka H et al., 2003; Santa K et al., 2003) and natural rubber latex 
(Lehto M et al., 2003). This study is probably the first report describing a AD model 
induced by a single mite allergen with the exception of OVA The establishment of 
AD animal model with single relevant protein provides a means to investigate 
antigen-specific immune response related to immunopathogenesis of AD. 
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Chapter 5  
Comparison of responses induced by epicutaneous patching with  
allergenic and nonallergenic proteins 
 
5.1 Introduction 
Epicutaneous patching with proteins such as OVA, mite allergens or latex allergens 
has been shown to induce Th2-skewed humoral and cellular immune responses 
coupled by development of local allergic dermatitis in mice (Wang LF et al., 1996, 
Spergel JM et al., 1998; Lehto M et al, 2003, Matsuoka H et al., 2003). However skin 
sensitization with hapten or highly reactive chemicals was shown to induce a 
dermatitis that primarily involved in the IFN-γ producing Th1 and Tc1 cells 
(Sinigaglia F et al., 1985; Kapsenberg ML et al., 1992; Cavani A et al., 1998). The 
research question to be addressed in this chapter is to determine whether the type of 
immune responses induced by epicutaneous patching is antigen dependent. The 
experimental strategy used was to perform comparative in vivo and in vitro studies 
using a well characterized highly allergenic major mite allergen from Der p mites, Der 
p2 and a non–allergenic fungal protein designated as Fve.  
 
Der p 2, a major mite allergen of Dermatophagoides pteronyssinus, consists of 129 
amino acid residues and with a calculated MW of 14,000 (Chua KY et al., 1990). It 
has been shown that more than 80% of allergic patients reacted with Der p 2 (Lind P 
1985; Heymann PW et al., 1989). Fve is a fungal immunomodulatroy protein isolated 
from the edible mushroom Flammulina velutipes (Ko JL et al., 1995). It is a simple 
protein consisting of 114 amino acid residues with a molecular mass of 14kDa, and its 
cDNA has been cloned (Ko JL et al., 1997). Fve was shown to stimulate the 
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proliferation of human peripheral blood mononuclear cells (PBMC), induce 
expression of ICAM-1 and enhance production of IFN- through p38 mitogen-
activated protein kinase signaling pathway in human T cells (Ko JL et al., 1995; 
Wang PH et al., 2004). Intraperitoneal injection of Fve appeared to modify immune 
responses in mice and inhibited anaphylactic responses (Ko JL et al., 1995). 
Furthermore, oral administration of Fve inhibited the development of food-allergic 
reactions in mice (Hsieh KY et al., 2003). Fve is a mitogenic protein exhibits similar 
properties as Con A and PHA targeting primarily at naïve but antigen-specific T cells 
resulting in high levels production of IFN-. Furthermore it has been demonstrated 
Fve exhibits Th1 adjuvant properties (probably via its mitogenic effects on target 
cells) that can be exploited to drive Th1-skewed responses. Fve protein is also a 
potent immunogen that capable of eliciting strong antigen specific humoral and 
cellular responses (Soew SV 2004).  
 
The in vivo studies involved the use of highly purified recombinant Der p2 and native 
Fve proteins as epicutaneous patching antigen to induce immune responses in mice, 
followed by characterization of the pathophysiological changes in these mice. In vitro 
studies had also been performed aiming at elucidating the responses resulting from the 
interaction between the patching antigens and the dermal fibroblasts. Dermal 
fibroblasts are an essential component of skin involved in the production and 
organization of the extracellular matrix of the dermis. Fibroblasts also play a crucial 
role in regulating skin physiology by communicates with other cell types (Sorrell JM 
et al., 2004). It is now clear that fibroblasts take much more active role in both the 
inflammatory and wound healing responses (Smith RS et al., 1997; Wynn TA 2004). 
Fibroblasts define a tissue’s microenviroment by synthesizing chemokines, cytokines, 
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and extracellular matrix, and participate in direct cross-talk with lymphocytes via the 
CD40-CD154 pathway (Smith RS et al., 1997; Kaufman J et al., 2001; Buckley CD et 
al., 2001). Fibroblasts have been shown to express functional CD40 and ligation of 
CD40 causes the fibroblasts to synthesize high levels of the proinflammatory 
cytokines IL-6 and IL-8 (Sempowski GD et al., 1997 &1998). In addition, it has been 
shown that dermal fibroblasts response to several cytokines for examples IL-4, IL-13, 
IFN-γ, TNF-α and therefore secrete chemokines that are thought to contribute to 
inflammatory cell infiltration (Petering H et al., 1998; Mochizuki M et al., 1999; 
Fukuda K et al., 2003; Villagomez MT et al., 2004). Chemokines are classified 
according to the position of cysteine residues in their amino terminal domain into two 
major subclasses, CXC and CC chemokines. Most CXC chemokines (eg IL-8) act as 
potent chemoattractants for neutrophils whereas members of the CC chemokine 
subfamily (eg. monocyte chemoattractant protein (MCP)-1, macrophage 
inflammatpry proteins (MIP) and RANTES) mediated the chemotaxis of mainly 
mononuclear cells. 
 
In vitro studies using cultured dermal fibroblast aimed to determine the type of 
chemokines produced when dermal fibroblasts are stimulated with a panel antigen 
including allergenic and nonallergenic proteins as well as control antigen LPS. The 
combination of Th1 and Th2 cytokines with the various antigens were used to study 
synergistic and inhibitory effects on chemokine production by dermal fibroblasts. The 
main objective of this part of the study was to determine whether the difference in the 
profiles of chemokines production would have an influence on the pathogenesis of 
inflammatory diseases. 
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5.2 Materials and Methods 
 
5.2.1 Antigens 
Native Fve was purified from the golden needle mushroom, Flammulina velutioes 
(Seow SV et al., 2003). Recombinant Der p 2 and Der p 8 were expressed in the 
Pichia pastoris expression system. OVA, BSA, and LPS were purchased from Sigma-
Aldrich (St Louis, MO, USA). Recombinant mouse IL-4 and IFN-γ were purchased 
from PharMingen (San Diego, CA, USA). Recombinant mouse IL-13 was purchased from 
R&D systems (Minneapolis, MN, USA).  
 
5.2.2 Sensitization and challenge of mice 
Epicutaneous sensitization was performed according to the methods described in 
Chapter 3 except that the antigens used here were 50 µg of Fve or Der p 2. To 
investigate the airway inflammation and airway hyperresponsiveness, patched mice 
were challenged by inhalation with 1 mg of Fve or Der p 2 at day 49. Inhalation 
challenge was performed by generating the Fve or Der p 2 aerosol by an ultrasonic 
nebulizer (model UltraNEB 99, DeVilbiss Health Care, Sommerset, PA) with 0.1 
mg/ml of Fve or Der p 2 in PBS. The mice were kept unrestrained in a desiccator 
chamber with continues flow of aerosol for 30 minutes. Sera were collected weekly 
during the whole experimental procedure. 
 
5.2.3 Measurement of airway hyperresponsiveness and collection of 
bronchoalveolar lavage  
Measurement of airway hyperresponsiveness and collection of BAL were performed 
by the methods as described in Chapter 4 (section 4.2.17).  
 
5.2.4 Splenocytes culture in vitro 
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Splenocytes were prepared and cultured with 10 µg/ml of Fve or Der p 2 in vitro 
using the protocols as described in Chapter 4 (section 4.2.6 &4.2.7). 
 
5.2.5 Detection of antibodies in sera and cytokines in culture supernatants 
Fve or Der p 2 specific IgG1, IgG2a and IgE and the amounts of IL-4, IL-5 and IFN-γ 
in culture supernatants were detected by ELISA. The methods were described in 
Chapter 4 (section 4.2.13).  
 
5.2.6 Preparation of dermal fibroblast 
Ears of naïve Balb/c mice were washed in 70% ethanol, dried, splitted, placed dermal 
side down on a 1% trypsin (GIBCO BRL) diluted in PBS, and incubated at 37°C for 
35 (thin ear side) or 45 min (cartilage ear side). Epidermal sheets were peeled from 
the underlying dermis. Dermis layers were rinsed with HBSS and placed on a HBSS 
solution containing 100 U/ml collagenase D (Roche Diagnostics GmbH, Mannheim, 
Germany), 0.5 mM MgCl2, 1.3 mM CaCl2, 0.6 mM MgSO4 and incubated at 37°C for 
40 min. The dermis layer was disrupted into small pieces with two forceps. Resulting 
cell suspensions were passed through a cell strainer (70 µm; Falcon) to remove the 
debris. Dermis cells were centrifuged and washed twice with HBSS. The cells were 
seeded on Petri-dishes in RPMI-1640 supplemented with 10% heat-inactivated bovine 
calf serum (Stem Cell Technologies, Vancouver, BC, Canada), 2 mM L-glutamine, 
antibiotics (100 U/ml penicillin and 100 µg/ml streptomycin) and 1 mM sodium 
pyruvate (Hyclone Laboratories, Logan, UT) and incubated at 37°C. On the second 
day, the unattached cells were removed and the Petri-dishes were replenished with 10 
ml of RPMI medium. When the cells grew to about 70% confluent (about 3-4 days), 
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the attached cells were trypsinized, washed with HBSS and resuspended in RPMI 
medium. 
 
5.2.7 Stimulation of fibroblast with different stimuli 
Dermal fibroblasts were seeded in 24-well (2.5×104 cells/well) or 6-well (1.5×105 
cells/well) plates and incubated at 37°C. Two days later, the culture supernatants were 
removed and 0.5 ml (24-well plate) or 2 ml (6-well plate) of culture medium was 
added into the well in the presence or absence of 100 µg/ml, 50 µg/ml, or 10 µg/ml of 
Der p 2, Der p 8, OVA, Fve, or 10 µg/ml of LPS or in combination with recombinant 
IL-4 (1 ng/ml) (PharMingen, San Diego, CA, USA), IL-13 (10 ng/ml) (R&D systems, 
Minneapolis, MN, USA) or IFN-γ (1 ng/ml) (PharMingen, San Diego, CA, USA).  
 
5.2.8 Detection of eotaxin by ELISA 
The supernatants were collected from the 24-well plate after fibroblasts were co-
cultured with different stimuli. The amounts of eotaxin in the supernatant were 
detected by ELISA. The 96-well half area plates (Costar Co., Cambridge, MA, USA) 
were coated with 25 µl of purified goat anti-mouse eotaxin polyclonal antibodies 
(R&D systems, Minneapolis, MN, USA) diluted in coating buffer (0.1M NaHCO3, 
pH8.2) to a concentration of 0.4 µg/ml and incubated at 4°C for overnight. After 
washing the plates with 0.05% Tween-20/PBS, 75 µl of blocking buffer (1% 
BSA/PBS) was added to each well and incubated at room temperature for 2 hours. 
The plates were washed again. Fifty microliters of cultured supernatants were added 
to wells and the plates were incubated at 4°C for overnight. For quantification 
purpose, fifty microliters of recombinant mouse eotaxin (R&D systems, Minneapolis, 
MN, USA) prepared in two-fold serial dilution in blocking buffer were included in 
each plate. The next day, plates were washed and twenty-five microliters of 
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biotinylated anti-mouse eotaxin polyclonal antibodies (400 ng/ml) diluted in blocking 
buffer were added to each well. The plates were incubated at room temperature for 1 
hour followed by washing with 0.05% Tween-20/PBS. Fifty microliters of 
ExtraAvidin®-alkaline phosphatase (Sigma, St Louis, MO, USA) (1:2000) diluted in 
blocking buffer was added and incubated at room temperature for additional 1 hour. 
The signals were developed with the addition of 50 µl of phosphatase substrate p-
nitrophenyl phosphate, disodium (Sigma, St Louis, MO, USA). Plates were read in a 
microplate reader at wavelength of 405 nm. 
 
5.2.9 RNA extraction 
The fibroblasts were harvested and washed twice with PBS after forty-eight hours of 
culture with different stimuli. Total RNA was extracted using RNeasy Mini Kit 
(Qiagen Inc., Germany). The amount of total RNA was determined by the absorbance 
at 260 nm. The RNA was stored at -80°C until further usage. 
 
5.2.10 Real-time RT-PCR for IL-5 
One microgram of total RNA was mixed with 1 µg of oligo(dT)16 and the final 
volume was adjusted to 28 µl with DEPC-H2O. The sample was heated at 70°C for 10 
mins and put immediately on ice.  Reverse transcription was carried out with adding 2 
µl of dNTPs (10mM), 8 µl of 5×MMLV buffer (Promega), 1 µl of recombinant 
RNase inhibitor (40U/µl) (Promega) and 1 µl of MMLV reverse transcriptase 
(10U/µl, Promega) into the RNA-oligo(dT)16 mixture at 42°C for 1hour. The cDNA 
was stored at -80°C before usage. Real-time PCR was performed using LC-FastStart 
DNA Master SYBR Green I and the PCR reaction was performed using LightCycler 
(Roche Molecular Biochemicals, Mannheim, Germany). The primers used for PCR 
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were 5´- GAAAGAGACCTTGACACAGCTG -3´ (sense) and 5´- 
GAACTCTTGCAGGTAATCCAGG -3´ (anti-sense). One microliter of cDNA was 
mixed with 1 µl of sense (10 pmole/µl) and 1 µl of anti-sense primers (10 pmole/µl), 
2 µl of MgCl2 (25mM), 2 µl of CyberGreen mixture and 13 µl of H2O. The PCR 
reaction was performed as: step 1, 95°C for 10 min; step 2, 95°C for 5 sec followed 
by 58°C for 5 sec and 72°C for 12 sec for 40 cycles; step 3, 58°C for 15 sec; step 4, 
40°C 30 sec.  
 
5.2.11 Detection of chemokines in fibroblasts by RNase protection assay  
RiboQuant™ multi-probe RNase protection assay system (RPA) (PharMingen, San 
Diego, CA, USA) was used to detect the RNA expression of chemokines in 
fibroblasts. The mouse chemokines template set mCK-5 was used to synthesize the 
non-radioactive probes.  
 
I. Synthesis of biotin-labeled probes 
In vitro transcription reactions were performed to generate the biotin-labeled probes. 
In a 1.5 ml Eppendorf tube the following reagents were added in order, 9 µl of 
RNase-free H2O, 4 µl of 5X transcription buffer, 2 µl of 10X biotin RNA labeling mix 
(Roche Molecular Biochemicals, Mannheim, Germany), 2 µl of 100 mM DTT, 1 µl of 
RNasin (40 U/µl), 1 µl of template set DNA (50 ng) and 1 µl of T7 RNA polymerase. 
The mixture was incubated at 37°C for 2 hours. 2 µl of DNase were then added to the 
tube and incubated at 37°C for another 30 min. After that, 26 µl of 20 mM EDTA, 25 
µl of Tris-saturated phenol, 25 µl of CHCl3:isoamyl alcohol (50:1) and 2 µg of yeast 
tRNA were added into the mixture. The mixture was mixed vigorously by vortex and 
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spun for 5 min at 15,000 rpm. The upper aqueous phase was transferred to a new 1.5 
ml Eppendorf tube. RNA probes were precipitated by adding 26 µl of 4 M ammonium 
acetate and 250 µl of ice-cold absolute ethanol and the tube was incubated at -70ºC 
for 1 hr. The tube was centrifuged at 4°C for 15 min and the supernatant was carefully 
removed. The pellet was washed with 100 µl of 70% ethanol, air-dried, and 10 µl of 
hybridization buffer was added into the tube to solubilize the pellet. One microliter of 
RNA probe was added into 99 µl of RNase free water and the probe concentration 
was determined by reading the absorbance at 260nm. The probe was then diluted with 
the hybridization buffer to a concentration of 10 ng/ml. 
 
II. RNA hybridization 
Five microliters of RNA sample was added to a 1.5 ml Eppendorf tube. The tube was 
incubated at -70ºC for 30 min to freeze the sample. The sample was then dried 
completely in a vacuum evaporator centrifuge (without heating). Eight microliters of 
hybridization buffer was added into the tube to solubilize the RNA and then 2 µl (10-
20 ng) of biotin-labeled probe was added to each sample. The sample was mixed 
gently by repeated pipetting and centrifuged briefly. A drop of mineral oil was added 
to each RNA sample to prevent evaporation. The sample was incubated in a 90ºC heat 
block (pre-warmed) for 10 min. After the denaturation step, the heat block was 
immediately turned to 56ºC to allow the temperature to ramp down slowly and 
incubate for 12-16 hour. Before the RNase treatment at the second day, the sample 
was moved out from the heat block and placed at RT to allow temperature to ramp 
down slowly for 15 min. 
 
III. RNase treatment  
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One hundred microliters of RNase cocktail was added directly into the aqueous phase 
of each sample. After quick spinning, the samples were incubated at 30°C for 45 min. 
During the incubation, the Proteinase K cocktail was prepared and 18 µl of cocktail 
was aliquoted to new Eppendorf tubes. The RNase-treated probe was carefully 
removed from the aqueous phase and transferred to the tubes containing the aliquoted 
Proteinase K cocktail. The tubes were incubated at 37°C for 15 min. After that the 
phenol/chloroform extraction was performed by adding 65 µl of Tris-saturated phenol 
and 65 µl CHCl3:isoamyl alcohol (50:1). One hundred and twenty microliters of the 
upper aqueous phase was transfer to a new tube and ethanol precipitation was 
performed by adding 120 µl of 4 M ammonium acetate and 650 µl of ice-cold 
absolute ethanol. After incubation at -70°C for 1 hour, the samples were spun at 
15,000 rpm at 4°C for 15 min. The pellets were washed with 100 µl of ice-cold 70% 
ethanol and spun again. The pellets were air-dried and 5 µl of 1X loading buffer was 
added to dissolve the pellet. The samples were heated at 90°C for 3 min and then 
cooled immediately on ice prior to loading. 
 
III. Electrophoresis, gel transfer and signal development  
The sample was run on 5% acrylamide gel (19:1 acrylamide/bis-acrylamide) using the 
Model S2 gel electrophoresis apparatus (GIBCO BRL, Life Technologies, Paisley, 
UK). The separated sample was then transferred onto the Hybond-C® membrane 
(Pharmacia, Uppsala, Sweden) using the Hofer semi-dry blotting apparatus 
(Amershan Biosciences AB, Uppsala, Sweden) at 0.8 mA/cm2 of membrane for 15-20 
min. The membrane was subjected to UV crosslinking using the Stratalinker® UV 
Crosslinker (Stratagene, La Jolla, CA, USA). The signals were detected using 
North2South® chemiluminescent nucleic acid hybridization and detection kit 
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(PIERCE, Rockford, IL, USA) and exposed to X-ray film (Kodak, Rochester, NY, 
USA). The amount of protected RNA was semi-quantified by Bio-Rad Model GS-700 





5.3.1 Induction of specific humoral responses in mice patched with Der p 2 and 
Fve  
The humoral immune response was investigated by monitoring the antibody 
production after three courses of patching. Results showed that low levels of Der p 2 
specific IgG1 could be detected after the second patch (i.e. from week 4 onward) and 
the antibody titer was boosted significantly after the third patch, whereas IgG2a was 
only detected in one mouse out of 5 mice throughout the whole experiment and the 
titer was very low. In contrast, Fve-specific IgG1 and IgG2a could be detected as 
early as 1 week after the first patch and the antibody titres increased remarkably with 
time (Fig 5.1A & B). The amount of Fve-specific IgG1 was 86 folds higher than that 
of Der p 2 patched mice, however, the titer of antigen-specifc IgE produced was at 
basal levels in both groups (Fig 5.1C). However, total IgE titer was significantly 
elevated in Der p 2-, but not in Fve-patched mice as compared with that of PBS 
patched mice (Fig 5.1D). 
 
5.3.2 Induction of specific cellular responses in mice patched with Der p 2 and 
Fve 
To examine the antigen specific cellular responses in the patched mice, primary and 
secondary in vitro cultures of cells from spleens of these mice were performed. For 
the primary in vitro culture, total splenocytes from the patched mice were stimulated 
with the respective antigen and the splenocytes from PBS patched mice were used as 
controls (Fig 5.2). When splenocytes of Der p 2 patched mice were stimulated with 
Der p2, significantly high levels of IL-4, but not IFN-γ and IL-5, were detected (Fig 
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5.2 black bar), indicating that Th2-skewed immune responses were induced in these 
mice. In the case of Fve patched mice, splenocytes stimulated with Fve antigen 
produced high levels of IL-5 and IFN-γ (Fig 5.2 open bars). The levels of IL-4 
produced were relatively low, revealing that patching with Fve induced a mixed Th1 
and Th2 cytokine profiles with a predominant higher IFN-γ (Th1) than IL-4 and IL-5 
(Th2). This phenomenon is probably caused by the mitogenic effect of Fve on naïve T 
cells in the splenocytes as described earlier. However, it is noted that splenocytes of 
Fve patched mice produced higher levels of IFN-γ than that of Der p 2 patched mice, 
whereas Der p 2 induced higher IL-4 production than that of Fve patched mice. As 
mentioned, Fve could induce mitogenic stimulation on naïve splenocytes. To avoid 
such interfering non-antigen specific stimulation, Fve and Der p 2 specific T cells 
were enriched by performing short-termed antigen-specific T cells cultures and the 
enriched T cells were then stimulated with anti-CD3 and anti-CD28 mAbs in vitro. 
The Der p 2-specific T cells showed a typical Th2 skewed cytokine profile with 
increased production of IL-4 and IL-5 as compared to that of PBS patched mice 
(p<0.05) and there was no difference in levels of IFN-γ (Fig 5.3 black bar). In 
contrast, Fve-specific T cells of Fve patched mice showed significant elevated IFN-γ 
production but unlike the primary culture of splenocytes, the enriched Fve-specific T 
cells produced only low levels of both IL-5 and IL-4 as compared to the PBS patched 
mice (open bar). These results indicated that patching with Der p 2, alike Der p8, 
induced a systemic Th2-skewed immune response in mice, whereas patching with Fve 
induced a systemic Th1 –skewed immune response.  
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5.3.3 Histopathology of the patched skins 
To examine the skin histopathology of mice patched with Der p 2, Fve and PBS, skin 
biopsies were taken from the patching sites and fixed in formalin. H&E stained 
parafilm sections were prepared for microscopic examinations and the numbers of 
infiltrating neutrophils, eosinophils and mast cells were counted. It is noted that both 
Der p 2 and Fve patching could induce significant skin inflammation and the 
histopathology for these two groups of mice were highly similar as shown in Figure 
5.4B and 5.4C. In addition, the numbers of infiltrating eosinophils and neutrophils, as 
well as the number of mast cells found in the dermis was similar in the patched skins 
of these mice (Fig 5.4D). The PBS patched skin showed some but relative low degree 
of cellular infiltration, however there was no sign of thickening of epidermal and 
dermal layers.  
 
5.3.4 In-vitro studies to examine the interaction of antigen and dermal fibroblasts 
As described above, both Der p 2 and Fve patching could induce similar degree of 
cutaneous inflammation and histopathology in the patching sites despite the facts that 
Der p 2 patching developed Th2-skewed responses and Fve patching induced Th1-
skewed responses. In order to further address the underlying mechanisms involved in 
the induction and maintenance of inflammation in these two scenarios, experiments 
were designed to examine the interactions of the patching antigens with target cells in 
the skin tissue aiming to understand the roles of non-lymphoid cells in the immediate 
microenvironment in the development of skin inflammation and pathology induced by 
Fve or Der p 2. Since fibroblast is the major cell type found in the dermis and its has 
been reported that fibroblast plays significant roles in the pathogenesis of 
inflammatory diseases such as asthma and atopic dermatitis (Smith RS et al., 1997; 
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Hogaboam CM et al., 1999; Schmidt M et al., 2003). Therefore the subsequent in 
vitro studies were focused on dermal fibroblasts. Dermal fibroblasts were freshly 
isolated from the skins of mouse ears and cultured in RPMI medium for 5 days and 
the cultured fibroblasts (Fig 5.5) were then used for the following in vitro 
experiments. 
 
5.3.4.1 Expression of IL-5 mRNA by antigen stimulated dermal fibroblasts  
Cultured fibroblasts were stimulated with Fve or Der p 2 protein for 48 hrs, Der p 8, 
OVA and LPS were included as control antigens in the in vitro culture experiments. 
The IL-5 mRNA expression was determined by real time PCR. All the antigens tested 
except Fve protein failed to augment IL-5 mRNA expression by fibroblasts. The 
amount of Fve-induced IL-5 mRNA expression was about 3.5 folds above basal levels 
(Fig 5.6).  
 
5.3.4.2 Eotaxin production by dermal fibroblasts 
It has been reported that both IL-4 and IL-13 cytokines could stimulate eotaxin 
production by fibroblasts (Mochizuki M et al., 1999; Terada N et al., 2000). This has 
been further verified by my data showing that when the dermal fibroblasts were 
cultured with IL-4 or IL-13 cytokine, a significant amount of eotaxin was produced in 
a dose dependent manner (data not shown). Further in vitro studies were then 
performed to test for the eotaxin production by fibroblasts upon stimulation with a 
panel of antigens including dust mite allergens (Der p 2, Der p 8), OVA, Fve and 
LPS. All the tested antigens, with the exception of Fve, augmented eotaxin production 
by fibroblasts stimulated with high but not low dose of antigens (100 µg/ml) (Fig 
5.7A). LPS was shown to be a potent eotaxin inducer as low dose LPS could induce 
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high levels of eotaxin (Fig 5.7A). It was noted that the levels of eotaxin produced by 
antigen stimulated fibroblasts were much lower than that induced by Th2 cytokines. 
Further studies were performed to examine the effects of IL-4 and IL-13 cytokines on 
the eotaxin production by fibroblasts induced by antigen stimulation. Fibroblasts were 
stimulated with various antigens in the presence or absence of IL-4 or IL-13. 
Interestingly, the combination of Fve and IL-4 or IL-13 appears to have synergistic 
effects on eotaxin production (Fig. 5.7B and 5.7.C) although Fve alone had no 
significant effect on eotaxin production by fibroblast (Fig. 5.7A). Another intriguing 
observation was that IL-13, but not IL-4, seems to exert an inhibitory effect in LPS 
induced eotaxin production (Fig 5.7 B and 5.7C).  
 
5.3.4.3 Expression of MCP-1 mRNA by dermal fibroblasts 
In addition to eotaxin, MCP-1 mRNA was induced by IL-4, IL-13 and IFN-γ. The 
Th1 cytokine IFN-γ seemed to be a more potent MCP-1 inducer than Th2 cytokine 
IL-4 and IL-13 (Fig 5.8A). All the stimuli used here induced various amounts of 
MCP-1 mRNA expression by dermal fibroblasts (Fig 5.8B). LPS again was the most 
potent inducer for MCP-1. Both IL-4 and IL-13 enhanced the MCP-1 mRNA 
expression by Der p 2, Der p 8, OVA and Fve stimulated dermal fibroblasts but not 
LPS stimulated fibroblasts (Fig 5.8C). In contrast, IFN-γ dramatically enhanced the 
MCP-1 mRNA expression by LPS stimulated fibroblasts. 
 
5.3.4.4 Expression of MIP-1α and MIP-2 mRNA by dermal fibroblasts 
Fve was the potent inducer for mRNA of both MIP-1α and MIP-2. IL-4 and IL-13 
enhanced the expression of MIP-1α and MIP-2 mRNA in unstimulated, Der p 2-, Der 
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p 8- and OVA-stimulated fibroblasts. In contrast, IL-4 and IL-13 inhibited the 
amounts of MIP-1α and MIP-2 mRNA in LPS stimulated fibroblasts (Fig 5.9). 
 
5.3.5 Induction of airway inflammation and hyperresponsiveness in mice patched 
with Der p 2 and Fve 
To assess whether mice patched with Der p 2 and Fve can develop airway 
inflammation and airway hyperresponsiveness (AHR) upon inhalation challenge with 
the specific antigen concerned, animals were exposed to aerolized Der p 2 or Fve 
once and  the AHR was measured 24 hour after the aerosol challenge. Unexpectedly, 
results showed that both Fve and Der p 2 patched mice showed airway hyper-
responsiveness upon methacholine challenge (Fig 5.10). To examine the airway 
inflammatory response, BAL fluids were obtained from these mice and differential 
cell counts were performed and the data revealed some intriguing observations. It was 
noted that the percentages of infiltrating lymphocytes, neutrophils and eosinophils 
were increased in Der p 2 patched mice (Der p 2/Der p 2) as compared to PBS 
patched mice (PBS/Der p2). Interestingly, Fve-patched mice showed significantly less 
eosinophils infiltration in the BAL fluids as compared to Der p 2-patched mice. In 
general, less infiltrating cells were found in the BAL fluids of Fve –patched mice as 
compared to that of PBS patched mice upon challenged with Fve (PBS/Fve) (Fig 
5.11). Another interesting observation was that when the PBS-patched mice were 
challenged with either aerosolized Fve or Der p2, there was a significant infiltration of 
both lymphocytes and neutrophils, but not eosinophils, into the airways of these mice 
(Fig 5.11). The AHR data showed that the airways of these mice remained normal 
despite the presence of infiltrating cells in the airways (Figure 5.10). Taken together, 
it seems that the recruitment of antigen-specific T cells and eosinophils is correlated 
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with the development of AHR in Der p 2 –patched mice, but the AHR seen in Fve-
patched mice appears to be not correlated with eosinophils infiltration. However 











































Figure 5.1. Humoral immune responses in mice sensitized with Der p 2 or Fve by 
epicutaneous patching. Mice (n=5/group) were epicutaneously sensitized with 50 µg 
of Fve or Der p 2 for three courses. Sera were collected weekly and stored at -20oC 
until assay. Antigen specific IgG1(A), IgG2a(B) and IgE(C) (week 7) and total IgE 
(D) were determined by ELISA. One antibody production unit represents one 
nanogram of corresponding type of mouse Ig per ml of serum. Results are expressed 
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Figure 5.2. Production of cytokines by splenocytes in mice sensitized with Der p 2 
or Fve. Freshly isolated splenocyts from Der p 2-, Fve- or PBS-patched mice (n=6-
7/group) were cultured with Der p 2 (black bar) or Fve (open bar) for 72 hours. 
Culture supernatants were collected and stored at -20 oC until cytokine ELISA. 





























































































Figure 5.3 Production of cytokines by secondary T lymphocytes. Freshly isolated 
splenocyts from Der p 2-, Fve- or PBS-patched mice (n=6-7/group) were cultured 
with Der p 2 (black bar) or Fve (open bar) for 10 days. Viable cells purified by Ficoll-
Hypaque were stimulated with anti-CD3 and anti-28 for 48 hours. Culture 
supernatants were collected and stored at -20 oC until cytokine ELISA. Results are 
























































































Figure 5.4 Histopathology of PBS, Der p 2 and Fve patched skin. Mice were 
patched 3 times with PBS (A), 50 µg of Fve (B) or 50 µg of Der p 2 (C). One week 
after the last patch the skins of the patched site were taken and fixed in formalin. 
After embedding the tissue in parafilm, 5µm of sections were prepared and H&E 
staining was performed. The infiltrated mast cells, neutrophils (Neu) and eosinophils 
(Eos) were counted (D). The cell numbers represented the numbers obtained from 20 








































Figure 5.5. Cultured dermal fibroblasts. Fibroblasts were obtained from dermis 














Figure 5.6. The expression of IL-5 mRNA by fibroblasts in the absence or 
presence of various antigens. Fibroblasts were cultured in the presence of 50 µg/ml 
of Der p 2, Der p 8, OVA, Fve or 10 µg/ml LPS or maintained in medium without 
antigen stimulation (control) for 48 hours. The total RNA was extracted and the 



























































Figure 5.7 Eotaxin production by dermal fibroblasts. (A) Dermal fibroblasts were 
stimulated with 100 µg/ml or 10 µg/ml of antigen or maintained in medium alone. 
Culture supernatants were collected at 72 hours. (B) Eotaxin production in the 
presence of 1ng/ml of IL-4. (C) Eotaxin production in the presence of 10 ng/ml of IL-
13. In both (B) and (C), dermal fibroblasts were stimulated with 50 µg/ml of Der p 2, 








































































































































































































Figure 5.8. MCP-1 mRNA expression by dermal fibroblasts. (A). Dermal 
fibroblasts were stimulated with IL-4, IL-13, IFN-γ or remained unstimulated 
(medium). (B) Dermal fibroblasts were treated as unstimulated (control) or 
stiumulated with 50 µg/ml of Der p 2, Der p 8, OVA, Fve or 10 µg/ml of LPS. (C) 
Dermal fibroblasts were treated as unstimulated (control) or stiumulated with 50µg/ml 
of Der p 2, Der p 8, OVA, Fve or 10 µg/ml of LPS in the absence (medium) or 
presence of IL-4 (1 ng/ml), IL-13 (10 ng/ml) or IFN-γ (1 ng/ml). Forty-eight hours 
later, total RNA was extracted. The chemokine RNA were detected by multi-probe 
RNase protection assay system. The relative amounts of MCP-1 were determined by 




























































Figure 5.9. MIP-1α and MIP-2 mRNA expression by dermal fibroblasts. Dermal 
fibroblasts were treated as unstimulated (control) or stiumulated with 50µg/ml of Der 
p 2, Der p 8, OVA, Fve or 10 µg/ml of LPS in the absence (medium) or presence of 
IL-4 (1ng/ml), IL-13 (10ng/ml) or IFN-γ (1ng/ml). Forty-eight hours later, total RNA 
was extracted. The chemokine RNA MIP-1α (A) and MIP-2 (B) were detected by 
multi-probe RNase protection assay system. The relative amounts of MIP-α and MIP-















































Figure 5.10. Airway hyperresponsiveness in Der p 2, Fve-patched mice. Der p 2, 
Fve and PBS patched mice (n=7/group) were challenged with Der p 2 or Fve aerosol 
on day 49. Twenty-four hours later, airway hyper-responsiveness was measured. 
PBS/Fve group represents PBS patched mice were challenged with Fve aerosol. 
Fve/Fve group represents Fve patched mice were challenged with Fve aerosol. Der p 
2/Der p 2 group represents Der p 2 patched mice were challenged with Der p 2 
aerosol. PBS/Der p group 2represents PBS patched mice were challenged with Der p 
2 aerosol. Results are expressed as means + SEM for each group. p<0.05 (*) 








































































Figure 5.11. Differential cell counts of bronchoalveolar lavage fluids. Der p 2, Fve 
and PBS patched mice (n=7/group) were challenged with Der p 2 or Fve aerosol on 
day 49. Forty-eight hours later, BAL fluid was collected and differential cell count 
was performed. PBS/Fve denotes group of mice received PBS patching and Fve 
aerosol challenge. Fve/Fve denotes group of mice received Fve patching and Fve 
aerosol challenge. Der p 2/Der p 2 denotes group of mice received Der p 2 patching 
and Der p 2 aerosol challenge. PBS/Der p denotes group of mice received PBS 
patching and Der p 2 aerosol challenge. Results are expressed as means + SEM for 






As described in the previous chapter, epicutaneous patching with mite allergens could 
induce Th2-skewed immune responses coupled with prominent allergic inflammation 
both in skin and lungs. The research questions to be addressed in this chapter are: (1) 
whether the nature or intrinsic properties of the patching protein itself played a role in 
determining the quality and magnitude of immune responses. (2) whether skin is a 
specific anatomic site for Th2 immune responses. The experimental strategy used was 
to compare and evaluate the immunological and pathophysiological responses 
induced by epicutaneous patching with an allergenic protein Der p 2 and a 
nonallergenic protein Fve in the absence of adjuvant. The humoral and cellular 
immune responses of treated mice were examined after three patching with either Der 
p 2 or Fve protein. In the Der p 2 patched mice, Der p 2 specific IgG1 but not IgG2a 
was detectable. Although the titer of Der p 2 specific IgE was low, the patched mice 
showed an elevated level of total IgE especially after the third patch. The profile of 
the antibody response after patching with Der p 2 was similar to that of Der p 8 
patched mice as described in Chapter 4. In addition, the Der p 2 patched mice showed 
a typical Th2-skewed cytokine profile with significantly higher IL-4 and IL-5 
production by cultured T cells as compared to PBS patched mice and there was no 
significant difference in the amount of IFN-γ between the two groups . In contrast to 
Der p 2 patched mice, remarkably high levels of Fve specific IgG1 as well as IgG2a 
were induced in the Fve patched mice. Although IgG1 antibody was conventionally 
associated with Th2 immune response, however a recent report demonstrated that 
IgG1 could be generated via IL-12 and/or IFN-γ dependent pathway (Faquim-Mauro 
EL et al., 1999). In the Fve patched mice, it is conceivable that most of the IgG1 
antibodies were produced via the Th1 pathway in view of the following observations. 
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First, the Fve specific IgG1 didn’t showed any correlation in terms of kinetics and 
titers to the Fve specific IgE but it correlated well to Fve specific IgG2a. Second, 
although Fve patched mice showed an increased levels of both IFN-γ and IL-4 as 
compared to PBS patched mice, the amount of IFN-γ (705 pg/ml) was 28 times higher 
than that of IL-4 (25 pg/ml) (Fig 5.2). Third, when the cytokine profile of the short-
term cultured T cells of Fve patched mice were examined, only IFN-γ but not IL-4 
and IL-5 showed a significance difference in levels as compared to the PBS patched 
mice. Taken together, the T cell cytokine data suggested that Fve patched mice 
produced a mixture of Th1 and Th2 phenotypes and that the number of Th1 cytokine 
producing Fve specific cells is greater than the Th2 cytokines producing T cells. 
However, further studies using the ELISPOT assay to quantify the numbers of Th1 or 
Th2 cytokine producing cells may help to further elucidate this phenomenon. 
 
It is worth noting that unlike the Der p 2 patched mice, levels of total IgE were not 
elevated in Fve patched mice (Fig 5.1D). Elevation of total IgE has been 
demonstrated in not only in Der p 2 but also in Der p 8 as well as in the natural rubber 
latex patched mice (Lehto M et al., 2003). The major mite allergen Der p 1 was 
shown to promote type 2 responses by modulating the balance between IL-4 and IFN-
γ (Comoy EE et al., 1998). These results imply that allergens may have some unique 
intrinsic properties to drive Th2-skewed responses in both antigen specific and 
nonspecific manners and therefore enhance the production of antigen specific IgE and 
total IgE. In allergic patients, especially in AD patients, elevation of total IgE was 
observed. The results here also indicated that not all proteins could elicit Th2 skewed 
immune responses by epicutaneous patching and the nature and some characteristic 
properties of protein itself may play some roles in determining the type or quality of 
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immune responses. Toll-like receptors (TLRs) have recently emerged as a key 
component of the innate immune system that detect microbial infection and trigger 
antimicrobial host defense responses (Yang RB et al., 1998, Brightbill HD et al., 
1999; Aliprantis AO et al., 1999; Hemmi H et al., 2000; Hayashi F et al., 2001; Tada 
H et al., 2002; Wagner H et al., 2002). Stimulation of different TLRs induces distinct 
patterns of gene expression, which not only leads to the activation of innate immunity 
but also instructs the development of antigen-specific acquired immunity. In view of 
this, it is highly probable that the difference in the immune responses induced by the 
allergenic and nonallergenic proteins may also be controlled at the innate immunity 
levels. The allergenic and nonallergenic proteins may interact differentially with 
TLRs or other unidentified pattern-recognition receptors and then prime T cells to 
drive to Th1 or Th2 polarisation or a mixture of both phenotypes. 
 
When the pathophysiological changes in skin and lung tissues in the treated mice 
were examined, some interesting but rather unexpected observations were found. 
Prominent inflammation characterized by infiltration of inflammatory cells in skin as 
well as lungs tissues after aerosol challenge with the respective protein was observed 
in both Der p 2 and Fve-patched mice. Both Der p 2 and Fve patched mice developed 
indistinguishable and similarly pronounced inflammation at the site of the patched 
skin (Fig 5.4D). Pulmonary inflammation was also observed in both Der p 2 and Fve 
patched mice after a single inhalation challenge with the respective specific protein. 
The differential cell counts of the BAL fluids from these two groups of mice indicated 
that the percentage of infiltrating cells seen in the Fve treated mice was relatively less 
and the number of infiltrating eosinophils in particular, was significantly lower in the 
Fve treated mice as compared to Der p 2 treated mice (Fig 5.11). These data 
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suggested that there was a qualitative difference in the induction of airway 
inflammation seen in these mice. The lack of eosinophils infiltration in the Fve 
challenged mice may suggest that unlike the typical allergic inflammation seen in Der 
p 2 challenged mice, pulmonary inflammation seen in Fve was not linked to Th2 
reaction. The proposed alternative induction mechanism for pulmonary inflammation 
seen in Fve treated mice will be discussed in the subsequent section below.  
 
Both groups of mice developed airway hyperresponsiveness (AHR) following 
methacholine challenge (Fig 5.10). As discussed above, there were qualitative and 
quantitative differences in the infiltrating cells in the inflamed airways of the two 
experimental groups of mice, implying that the triggering factors for the induction of 
AHR in these mice could be different. In the Der p 2 treated mice with Th2 skewed 
responses, but not in the Fve treated mice with Th1-skewed responses, the airway 
inflammation was accompanied by the increased percentage of infiltrating eosinophils 
suggesting a link with allergic reactions. Therefore it is possible that the airway 
inflammation and the subsequent AHR development in Fve treated mice were induced 
by some alternative mechanisms. It had been reported that the airway-
hyperresponsiveness could be triggered by the cross-interaction of immune and 
nervous systems (Groneberg DA et al., 2004). Such neurogenic inflammation could 
be responsible for the AHR seen in the Fve treated mice. Further studies such as 
detection of neuropeptides in the inflamed lungs can be performed to address this 
question. Interestingly, it was observed that the PBS patched mice that received one 
aerosol Fve challenge induced lymphocytes and neutrophils infiltration into the lungs. 
One possible explanation for such observation is that the Fve protein could have a 
direct interaction with the resident cells of the lungs to induce secretion of 
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proinflammatory chemokines. This suggestion can be partially supported by the data 
derived from the in vitro studies showing that Fve could induce chemokines 
production by dermal fibroblasts (Fig 5.6, 5.8 & 5.9). Such chemokines and cytokines 
networking can create a proinflammatory microenvironment for the induction of 
pulmonary inflammation independent of Th2 responses. In fact it has been well 
documented that proinflammatory cytokines such as IL-1β and TNF-αl could 
argument the production of chemokines (Watanabe K et al., 2002; Fukuda K et al., 
2003) and might therefore contribute to chronic inflammation. 
 
It has been proposed that the cutaneous immune surveillance is dependent on the 
resident cells in the skin which function as sentinels for danger signals and therefore 
alter the innate immune system (Kupper TS & Fuhlbrigge RC 2004). These cells 
include the keratinocytes and Langerhans cells in the epidermis as well as the mast 
cells, dendritic cells and macrophages in the dermis. They provide early warning 
signals by releasing stored and inducible antimicrobial peptides, chemokines and 
cytokines. These warning signals further initiate the innate immune responses as well 
as the adaptive immune responses (Heufler C et al, 1993; Kupper TS & Groves RW. 
1995; Murphy JE et al, 2000; Yang D et al., 2001; Gallo RL et al., 2002; Supajatura 
V et al., 2002; Marshall JS et al., 2003; McCurdy JD et al., 2003). Fibroblasts are the 
most abundant cells in the dermis and are shown to response to several cytokines, 
however the roles of fibroblasts in the innate immune responses are not fully 
understood. The results here demonstrated that the dermal fibroblasts could respond 
directly to exogenous antigens and enhanced the expression of eotaxin, MCP-1, MIP-
1α and MIP-2 as well as IL-5. Eotaxin and IL-5 are potent chemoattractants for 
eosinophils whereas MIP-2 involved in recruitment of neutrophils (Takaoka A et al., 
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2001). MCP-1 and MIP-1α play important roles in recruitment of macrophages and 
monocytes to the site of inflammation (Lu B et al., 1998). Interestingly, the in vitro 
studies showed that allergens, Der p 2, Der p 8 and OVA, but not the nonallergenic 
Fve, could induce the eotaxin production by dermal fibroblasts indicating that 
allergenic proteins might possess intrinsic ability to initiate and perpetuate the 
recruitment of eosinophils. However the level of antigen induced eotaxin production 
was relatively low, further studies are needed to determine whether this low level of 
eotaxin has any effector function to recruit eosinophils. The study here also confirmed 
data from other studies showing that Th2 cytokines IL-4 and IL-13 are potent 
inducers of eotaxin by dermal fibroblasts (Mochizuki M et al., 1999; Terada N et al., 
2000). Interestingly, although Fve itself could not induced eotaxin production, the 
combination of Fve and Th2 cytokines induced enhanced eotaxin production. In 
addition, Fve appears to be a potent inducer of IL-5 as shown by the real-time PCR 
result (Fig 5.6). Such induction of IL-5 production by dermal fibroblasts might help to 
explain the recruitment of the eosinophils into the inflamed skin (Fig 5.4). However 
further studies are required to further understand that the types of responses associated 
with the dermatitis seen in Fve and Der p 2 patched skins. 
 
Besides IL-5 and the eotaxin, MCP-1, MIP-2 and low level of MIP-1α  (Fig 5.8 & Fig 
5.9) but not RANTES, MIP-1β, IP-10 and TCA-3 (data not shown) were detected in 
the cultured fibroblasts. It was observed that the nonallergenic protein Fve was a more 
potent inducer for MCP-1, MIP-2 and MIP-1α production as compared to the 
allergenic proteins. Both IL-4 and IL-13 could enhance the expression of these 
chemokines. In addition, IFN-γ was more potent than IL-4 and IL-13 in the induction 
of MCP-1 whereas there was no significant enhancement on the induction of MIP-2 
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and MIP-1α (data not shown). A biphasic cytokine expression pattern had been 
demonstrated in the lesional skin of AD showing a shift of Th2 cytokines expression 
in acute AD to Th1 cytokines expression pattern in the chronic AD (Hamid Q et al., 
1994). The prominent enhancement of MCP-1 expression by dermal fibroblasts in 
response to IFN-γ could be responsible for the recruitment of monocytes to the 
inflamed skin and contribute to the accumulation of macrophages that was usually 
seen in the chronic lesions of AD.  
 
TLRs have recently recognized as a key component of the innate immune system that 
detect microbial infection and trigger antimicrobial host defense responses. Innate 
recognition of pathogen-associated molecular patterns (PAMPs) through TLRs 
initiates an inflammatory response characterized by the recruitment of cells to the 
sites of infection to augment the killing of invading pathogens and to halt their spread 
(Iwasaki A and Medzhitov R, 2004). In addition, different subsets of dendritic cells 
were found to express different patterns of TLRs and therefore could elicit different 
adaptive immune responses (Iwasaki A & Medzhitov R, 2004). However there is no 
reported study on why allergen has a higher tendency to prime and polarize Th2 
responses. This study had attempted to address some aspects of such important 
research question. Taken together, the results derived from this study suggested that 
allergens may have some unique properties that preferentially induce and drive-Th2-
skewed immune responses. Recently studies had indicated that chemokines also play 
some roles in regulating T cell differentiation and the chemokines may act on the 
APC or on the T cells to regulate the Th1 or Th2 immune responses (Luther SA & 
Cyster JG, 2001). All the resident cells in the skin have the potential to produce 
chemokines in response to various cytokines stimulation. However it is not clear 
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whether these cells can response differently to exogenous protein resulting in 
secretion of different chemokines. The preliminary results here using dermal 
fibroblast as target cells showed that dermal fibroblasts may react differently to 
different stimuli, it will be interesting to investigate whether these chemokines have 
any effect on dendritic cell and T cells. Besides dermal fibroblasts, similar studies on 
keratinocytes and Langerhans’ cell are important and should be carried out in order to 




Conclusions and Future Prospects 
 
The main objective of this study was to establish a murine allergy model using 
chemically well defined allergens that are clinically relevant to human allergic 
diseases for studies related to the understanding of sensitization, immunopathogenesis 
and disease development for allergic inflammatory diseases such as asthma and atopic 
dermatitis. It is well documented that house dust mite allergy is one of the major 
triggering factors for development of AD and asthma in atopic population worldwide. 
High titres of mite allergen-specific IgE could be detected in AD and asthmatic 
patients. Therefore I have chosen allergen(s) from Dp mites, a worldwide mite 
species, as sensitizing antigen(s) and the approach was to perform epicutaneous 
patching without adjuvant for induction. The underlying rationale was to induce 
sensitization and inflammatory responses locally on skin and then examine the 
subsequent systemic effects on the lungs upon airway exposure of allergen(s). This 
approach was taken with the intention of inducing a murine AD model per se for 
immunopathogenesis studies of AD and then further exploits the model for studies on 
systematic dissection and elucidation of the immunological and physiopathological 
sequential events that are related to the phenomenon of “atopic march” seen in atopic 
children. 
 
In the search of suitable mite allergens for establishing the mouse model, as discussed 
previously, Der p 8 has been selected as the first allergen of choice mainly based on 
the observation from previous work on AD model in our laboratory. In view of this, 
the first part of this study focused on cloning and characterization of Der p 8 allergen. 
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The native Der p 8 (nDer p 8) was affinity purified from crude mite extract and the 
existence of multiple Der p 8 isoforms was shown by 2D-electrphoresis and 
immunoblotting. The cDNA for Der p 8 was isolated from Dp mite cDNA library by 
PCR approach and sequence analysis revealed that the cDNA clone obtained differed 
from the published Der p 8 cDNA sequence by 6 amino acids and it represents a novel 
isoform of Der p8 with a pI of 8.5.This isoform was produced as recombinant protein 
in prokaryotic and eukaryotic expression systems, designated as erDer p and yrDer 
p8, respectively. The human IgE binding study showed that yrDer p 8 was better than 
erDer p 8 for diagnostic purposes as yrDer p 8, but not erDer p8, showed comparable 
IgE binding frequency to nDer p 8. However, the titers of IgE bound to erDer p 8 and 
yrDer p8 were lower than that of nDer p 8. This discrepancy perhaps due to the fact 
that the recombinant Der p 8 used here was one of the isoforms of nDer p 8. 
Therefore, further study is needed to characterize the degree of allergenicity of the 
different isoforms and their relative clinical importance in allergic patients has to be 
assessed by both in vitro IgE binding tests as well as the skin prick tests. Alike 
tropomyosin and paramyosin, GST has been suggested as possible panallergen 
between arthropod and other invertebrate but such notion was not supported by any 
experimental evidence. This issue has now been addressed by the current study. IgE 
cross-inhibition assay showed that Der p 8 exhibits considerable but variable IgE 
cross-reactivity with cockroach but not parasite GST. As both mites and cockroaches 
are important sources of indoor allergens in tropics and subtropics, the cross-reactivity 
between mite and cockroach GSTs could have an important clinical impact. It is 
therefore worth investigating whether the sensitization to mite GST will boost the 
sensitization to cockroach GST and whether the recent immunotherapy using mite 
crude extract will increase the chances of developing cockroach allergy. 
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The second part of the study was to establish a mouse model for allergic dermatitis 
using recombinant Der p 8 by epicutaneous sensitization approach. Der p 8 patching 
resulted in localized dermatitis characterized by pronounced epidermal hyperplasia 
and spongiosis, which was associated with infiltration of eosinophils and neutrophils, 
degranulated mast cells, CD4+ and CD8+ T cells, and dendritic cells. There was 
increased innervation of neurofibers with calcitonin gene-related peptides and 
substance P in inflamed skins, interactions between nerve fibers and mast cells were 
seen, indicating the coexistence of neurogenic inflammation. Splenic T cells produced 
T helper 2-polarized cytokines in response to allergen stimulation in vitro, indicating 
systemic allergen sensitization. In summary, I have successfully established a mouse 
allergic dermatitis model using a single allergen that is relevant to human. This is also 
the first report of a mouse model of eczema, accompanied by neurogenic 
inflammation, which shows close resemblance to human allergic diseases. 
 
The epicutaneous sensitization approach is also a good strategy to verify and gain 
further understanding of the concept of atopic march in human which suggests that 
AD is an entry point for subsequent allergic disease and the skin is an important site 
for the initiation of primary allergen sensitization. In this regards, similar patching had 
been carried out on mice using Der p 2, a well documented major mite allergen that 
has high clinical impacts. Results indicated that Der p 2 could also induce Th2-
skewed responses coupled with pronounced inflammatory responses and development 
of physiopathology in the skin after three patchings. In addition, the sensitized 
animals developed chronic airway inflammation with the signs of cellular 
inflammation, mucus production and airway remodeling upon airway challenge with 
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Der p2. This model mimics the natural history of allergic disease development in 
human; it is therefore a useful model, for mechanistic studies and it also serves as a 
versatile disease model for the development of therapeutic and prophylactic vaccines 
for allergy. In addition, it is known that itching of skin and bronco-contraction of 
airway are related to the neuroendocrine systems. The neuroinflammation seen in the 
animal model will be useful for study of the interaction of immune and 
neuroendocrine systems and may also be useful for study of other stress-associated 
neuroinflammatory skin disorders such as neurogenic pruritus and psoriasis. Another 
interesting aspect to be investigated is whether the allergen patched mice can develop 
rhinitis after receiving further aerosol challenge. 
 
Furthermore, I had carried out comparative study to examine the immune responses 
induced by allergenic (Der p 2) and nonallergenic (Fve) protein after epicutaneous 
sensitization. The results indicated that immune cells responded differently to Der p 2 
and Fve. A typical Th2-skewed responses were seen in the Der p 2 patched mice; in 
contrast the nonallergenic protein Fve induced a Th1-skewed responses indicating that 
nature of protein has some direct effects in determining the quality of the responses. 
This observation raises some interesting questions concerning the ways in which 
allergen interact with cells involved in innate immunity or with tissue cells in the 
mucosal microenvironment. It is well known that recognition of pathogen-associated 
molecular patterns (PAMPs) by different TLRs can initiate both the innate and 
adaptive immune responses differently. Allergens are a group of proteins that appear 
to have some intrinsic properties to drive the development of Th2 immune responses 
coupled with the upregulation of specific and nonspecific IgE, but the precise 
mechanisms involved remain unclear. It is conceivable that the allergenic proteins 
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possess some unidentified molecular patterns similar to the PAMPs, which are 
specifically recognized by antigen presentation cells or other cell types involved in the 
innate immunity to drive allergic reactions. This is a crucial question to be addressed 
in order to shed new light in the understanding of underlying mechanisms for 
development of allergy. 
 
In the Der p 2 and Fve patching animal experiments, the only variable factor was the 
patching antigen. The difference in the type of immune responses induced by Der p 2 
and Fve imply that the resident cells in the skin may react differently to these two 
proteins. Langerhans’ cells are the major antigen presenting cells that will capture 
antigens that penetrate into the skin and then migrate to regional lymph node where 
they present antigens to T cell. In the context of the current study, the Langerhans’ 
cells may respond differently to allergenic and nonallergenic protein in the skin and 
then express different profiles of co-stimulatory molecules resulting in the differential 
regulation of Th1 or Th2 polarization. Another possibility is that allergenic and 
nonallergenic protein may stimulate keratinocytes or dermal fibroblasts to secret 
different chemokines profiles. These chemokines may therefore play an inductive role 
on APC and control the T cell differentiation. My study here used the dermal 
fibroblasts as target cells and tested the chemokines production by these cells after 
stimulation with a panel of antigens or in combination of antigens and cytokines. 
Eotaxin was induced by allergens (Der p 2, Der p 8 and OVA). In contrast, Fve alone 
could not induce the eotaxin production by dermal fibroblasts. In addition antigen 
stimulation could induce the expression of MCP-1, MIP-1α and MIP-2 by dermal 
fibroblast in various degrees. Whether these chemokines produced by dermal 
fibroblasts can play an active role on Langerhans’ cells and thus regulate T cell 
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differentiation is unknown and further in vitro studies on the antigen priming using 
the conditional medium from cultured fibroblasts can be performed to gain more 
information. On the other hand, expression of these chemokines could be enhanced by 
Th2 cytokines indicating that the fibroblasts might play an active role in the 
recruitment of cells to the inflammatory skin in the later stage of skin inflammation. 
These works can be further extended to keratinocytes as well as Langerhans’ cells to 
evaluate and elucidate the possible mechanism that controls the T cell differentiation 
by allergenic and nonallergenic proteins. 
 
In summary, the research work performed in this study has made some useful 
contributions in the field of allergy research. The successful establishment of animal 
disease models will be potentially useful for both clinical and basic research to 
address fundamental questions related to allergen sensitization and development of 
allergic and nonallergic inflammation. Furthermore, the allergen-induced disease 
models are useful tools for development of vaccines and immunotherapeutics for 
prevention and treatment of allergic diseases. The Fve-induced inflammatory model is 
potentially useful for screening and development of drugs for other chronic 
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